Sonochemical Production of Hollow Polymer Microspheres for Responsive Delivery by Skinner, Emily
        
University of Bath
PHD








Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.










Attention is drawn to the fact that copyright of this thesis rests with
the author. A copy of this thesis has been supplied on condition that
anyone who consults it is understood to recognise that its copyright
rests with the author and that they must not copy it or use material
from it except as permitted by law or with the consent of the author.
This thesis may be made available for consultation within the Univer-




Ultrasound irradiation of a protein or polymer solution at the air:water
interface can be used to form hollow microspheres containing an air
bubble. By introducing a layer of oil and sonicating the oil:water in-
terface, microspheres containing an oil droplet are formed. The mi-
crospheres are stabilised by disulfide crosslinking, have diameters of
between 1-20 µm and have a number of applications; gas filled pro-
tein microspheres are used as ultrasound contrast agents and oil filled
microspheres are being developed for delivery of lipophilic drugs.
This project extends the scope of sonochemically produced micros-
pheres to include water-in-oil emulsion filled microspheres, which fa-
cilitate encapsulation of hydrophilic species, and polymer microspheres
that release their contents in response to an external stimulus. Success-
ful encapsulation of a water in oil emulsion phase is demonstrated
using confocal microscopy. Release studies are reported for a num-
ber of hydrophilic species (in vitro) including 5,6-carboxyfluorescein,
5-fluorouracil and sodium chloride. Release can be triggered by so-
nochemical disruption of the microsphere shells or cleavage of the
disulfide cross links.
Thiol-ene coupling reactions initiated by ultrasound irradiation are
reported. In water, ultrasound initiation of thiol-ene reactions with
electron rich alkenes results in rates of reaction which compare favou-
rably with conventional thermal initiation. Thiol-ene crosslinking is
proposed as an alternative to disulfide crosslinking to stabilise sono-
chemically produced microspheres.
Temperature responsive microspheres are produced via the sonoche-
mical method using a block copolymer of N-isopropylacrylamide and
thiolated methacrylic acid, P(MASH-b-NIPAm). The block co-polymer
is synthesised using reversible addition-fragmentation transfer (RAFT)
polymerisation and has a lower critical solution temperature (LCST) of
37 ºC. The microspheres formed from this block copolymer can be seen
to rupture, releasing their internal oil phase, when heated above 37 ºC.
These findings provide a basis from which to develop sonochemically
produced polymer microspheres for responsive delivery of both hy-
drophilic and lipophilic species.
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The sonochemical method for protein microsphere production was
first introduced by Suslick and co-workers in 19901. Since then
sonochemically produced microspheres and microbubbles (Figure 1.1)
have been the subject of active research both as contrast agents for
medical imaging and as therapeutic delivery devices. Although recent
advances have broadened the scope of shell materials to include DNA
and RNA2;3, graphene oxide4 and Chitosan5, the most common shell
material for sonochemically produced microspheres and microbubbles
is still protein. Sonochemical production of microspheres and mi-
crobubbles is dependent upon emulsification or foaming caused by
ultrasound irradiation at the interface of the protein solution, hence
microspheres reported to date have encapsulated either a hydrophobic
(oil) droplet or a gas bubble6.
Figure 1.1: (left) Scanning electron microscopy (SEM) image of
air filled lysozyme microspheres formed sonochemically,
(right) “Confocal laser scanning microscopy (CLSM) image
of lysozyme microbubbles.” (sic) Reprinted with permis-
sion7. Copyright (2012) American Chemical Society.
This project aims to extend the scope of sonochemically produced
microspheres from that reported in the literature to date. There
are four fundamental factors in the sonochemical method which
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can be altered or developed to improve performance: the shell
material, the crosslinking mechanism, the encapsulated core and
surface functionalisation. These factors have been addressed within
the objectives of this project, the results of which are discussed in later
chapters.
Firstly the encapsulated core was considered. Literature reports des-
cribe the encapsulation of hydrophobic species within the oil core8;9
or entrapment of more hydrophilic species in the shell region10–12 of
microspheres. Simultaneous encapsulation of both hydrophobic and
hydrophilic species within the core of microspheres would facilitate
controlled tandem delivery of two species or co-transport of an
imaging agent alongside a therapeutic agent. It was proposed that
simultaneous encapsulation could be achieved by using a pre-formed
water in oil (w/o) emulsion as the ’hydrophobic’ phase in the
sonochemical method. Chapter four reports the novel production of
water in oil in water (w/o/w) protein microspheres for encapsulation
and subsequent delivery of hydrophilic species.
Of equal importance when developing microspheres for delivery
applications is the choice of shell material. Proteins and naturally oc-
curring polymers have been extensively studied and characterised as
suitable shell materials6. However the extent to which microspheres
can be ’designed’ for a delivery purpose is limited unless the scope
of microspheres is extended to include synthetic polymers. This is
particularly of interest with respect to designing responsive delivery
systems which can be triggered to release their pay load by an external
stimulus, for example, heating, light or mechanical stress. At present
protein microspheres release their cargo as a result of mechanical stress
from ultrasound irradiation13 or enzymatic degradation14. Chapter
five reports the synthesis of block copolymers designed for use in
the production of temperature responsive microspheres and the initial
characterisation of the responsive microspheres produced.
Further to considering the core and shell materials used in sono-
chemical microsphere synthesis, an alternative method of stabilising
and functionalising the microsphere shell has been investigated.
Protein microspheres are stabilised either by covalent (disulfide) cross
linking1;15 or by favourable intermolecular forces, most notably the
hydrophobic effect16. The use of polymers as shell materials opens
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up the opportunity to explore alternative methods of stabilising and
subsequently functionalising the microsphere shells. Chapter three re-
ports the novel use of ultrasound to initiate thiol-ene coupling of small
organic molecules. It is anticipated that this coupling method would
have useful application as an alternative sonochemical cross linking
mechanism with the potential to include ’one-pot’ functionalisation of
polymer microspheres with alkene or thiol containing ligands.
The developments described above and detailed in later chapters have
their basis in the model lysozyme and poly(methacrylic acid) (PMA)
systems developed by our collaborators8;17 and transferred to the
research laboratories in Bath by the author. Initial studies carried out
at the Universities of Melbourne and Bath, together with additional
release studies conducted in Bath are described in chapter three.
In summary the project objectives are:
- To encapsulate an aqueous phase within protein or polymer micros-
pheres in order to facilitate transport of hydrophilic species in addition
to lipophilic species. Then to characterise release of these hydrophilic
species upon destruction of the microspheres.
- To demonstrate ultrasound initiation of radical mediated thiol-ene
coupling and establish its practicality as an alternative to conventional
thermal initiation. Apply this sonochemical methodology as an
alternative to disulfide cross linking in the microsphere protocol.
Investigate the potential for using thiol-ene chemistry as a means of
functionalising the microsphere shells.
- To synthesize a thiolated triblock copolymer of methacrylic acid
and N-isopropylacrylamide and use it to form microspheres with
the sonochemical method. Characterise the temperature responsive
behaviour of the microspheres formed and release of hydrophilic or
lipophilic species on heating.
The following literature review gives a background to sonochemistry,
describes the sonochemical method and places this project in the
context of the ’state of the art’ with respect to sonochemical production
of microspheres and their use in delivery applications as well as com-
paring the sonochemical method to other commonly used methods of
hollow/liquid core microsphere production.
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1.1 Ultrasound and Sonochemistry
Sonochemistry is a term that refers to the chemistry which occurs
when a system is irradiated with sound18 and it is frequencies in the
ultrasound range which are used to induce these chemical reactions.
Ultrasound can be defined as having a frequency higher than the limit
of human hearing i.e. greater than 20 kHz19.
Low frequency ultrasound (20-100 kHz) is termed power ultrasound,
it is in this frequency range that the majority of sonochemistry
occurs18. However it is possible to observe some sonochemical effects
at frequencies as high as 2 MHz18. High frequency ultrasound
(0.5 MHz – 10 MHz)20 is typically used in medical applications for
diagnosis and therapy.
The chemical effects of ultrasound were first observed in 1927 and re-
ported by Loomis et al.21. Since then many applications of ultrasound
and sonochemistry have been found. High frequency ultrasound
is well known for its diagnostic uses in medicine, for sonography
imaging22. However ultrasound at frequencies around 1 MHz is
also used to aid drug delivery23;24, discussed later in this chapter,
and High Intensity Focussed Ultrasound (HIFU) is used in surgery
to breakdown blood clots and destroy tumours25–29. Both of these
applications utilise the micro jets created as a result of cavitational
collapse of bubbles caused by ultrasound. Cavitation, described in
more detail below, results in radical production and is the source of
the chemistry caused by ultrasound30.
Sonochemistry has been utilised in synthetic chemistry31, and has
been widely researched as a means to purify water by degrading
contaminants, for example textile dyes32. Ultrasound irradiation
is used in polymer chemistry both as a means to initiate radical
mediated polymerisations33 and to cleave polymer chains34. Further
to these uses the strong mixing effect created by ultrasound can be
used as a means of emulsifiying oil and water phases35. This makes
ultrasound irradiation a useful means by which to carry out emulsion
polymerisations36. These mixing and cavitation effects also mean that
ultrasound is a very efficient method of cleaning debris from surfaces
which has lead to wide use in industry and research. Many chemistry
laboratories are equipped with an ultrasonic cleaning bath18.
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Ultrasound is generated from electrical energy using a transducer.
Two of the most commonly used transducer types are piezoelectric
and magnetostrictive transducers20. Magnetostrictive materials are
ferromagnetic and change their dimensions in response to changes
in the applied magnetic field, examples include nickel, nickel-iron
and iron-cobalt alloys22. A magnetostrictive transducer is comprised
of an electrical coil wrapped around the magnetostrictive core. The
oscillating magnetic field generated by the coil causes the core to
deform, these vibrations are converted to ultrasound22. The frequency
of ultrasound produced is dependent on the size of the magnetic core
which, for practical reasons, restricts these transducers to 20-100 kHz.
Magnetostrictive transducers also generate a large amount of heat
which must be removed by a cooling system22.
Piezoelectric crystals are so called because when pressure is applied
along a crystallographic axis, electrical charges are produced on the
perpendicular crystal faces. This is as a result of electric dipoles in
the crystallographic planes aligned in parallel to one another and
perpendicular to the surfaces. Application of pressure or tension to
the surfaces results in movement of the charges in the dipoles22. The
inverse is also true, so if a voltage is applied to the crystal surface stress
is generated along the crystallographic axis and the crystal will expand
or contract according to the potential. Hence, the piezoelectric element
in an ultrasonic transducer subjected to an oscillating voltage gene-
rates ultrasound at the corresponding frequency22. Lead zirconate
is a commonly used piezoelectric material in ultrasonic transducers,
including those used in this project. Piezoelectric materials can be
used to generate ultrasound across the whole frequency range and
the transducers require less cooling than magnetostrictive transducers.
However the piezoelectric element is fragile and is destroyed if over
heated22.
The most common use of ultrasound in a general chemistry laboratory
is for cleaning and in such cases an ultrasound bath can be used. Ho-
wever in order to carry out sonochemistry a more powerful ultrasound
source is normally required. In this project horn transducers are used
to supply high intensity power ultrasound to small volumes of liquid.
The horn assembly utilises a piezoelectric transducer to convert the
supplied electrical energy into 20 kHz ultrasound which is transmitted
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to the sonicated liquid via a titanium horn. A photograph of the horn
used is shown in Figure 2.1.
Sonochemistry
A sound wave is a longitudinal pressure wave. As the wave moves
through a medium the medium experiences phases of compression
and rarefaction. Particles in the medium respond to these pressure
cycles, resulting in propagation of the sound wave. Figure 1.2
shows a representation of this effect in a schematic of beads on a
thread corresponding to an acoustic pressure plot. At low ultrasonic
frequencies and high intensities the negative pressure experienced
during the rarefaction phase is sufficient to overcome intermolecular
interactions and form voids. This is the start of cavitation.
Figure 1.2: Schematic of the interaction of a cavitation bubble with
a propagating sound wave, including particle movements
under ultrasound irradiation and an acoustic wave form.
Cavitation is the process whereby a bubble is formed in a liquid as
a result of the propagation of a sound wave, and then collapses19.
Cavitation bubbles are usually nucleated by microscopic particles in
the liquid which cause weak spots37. Once the bubble has formed it
can remain trapped in the acoustic pressure field and will expand and
contract accordingly whilst growing in volume as solvent vapour and
dissolved gases diffuse into the cavity, a process known as rectified
diffusion (Figure 1.2). After a period of time the bubble will have
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grown to a size that is no longer stable, at this point the bubble will
undergo implosive collapse18. Adiabatic collapse of the cavitation
bubble results in the formation of a micro-scale ‘hotspot’ which
experiences high temperature (4000-6000 K) and pressure (1000-2000
bar)19. The associated heating and cooling rates, 1010 Ks-1, are far
more rapid than thermal diffusion meaning that the hotspots only exist
for a matter of microseconds creating a unique environment in which
to carry out chemistry30. These transient hotspots provide conditions
which facilitate solvent lysis and degradation of molecules in solution,
resulting in the formation of radicals which are responsible for many
chemical reactions, whilst mild conditions are maintained in the bulk
solution. In an aqueous system, H• and OH• are formed from the
lysis of water upon cavitational collapse. These radicals are capable
of diffusing out of the hotspot to undergo further radical reactions
(Figure 1.3). Of particular interest in microsphere production is the










Figure 1.3: Sonochemical reaction scheme in water.
There are three main environments in the sonochemical system:
The bulk liquid where there are no direct sonochemical events but
sonochemically formed radicals may diffuse into the bulk before
reacting further. In the centre of the bubble itself, the hotspot, the
conditions are very harsh causing reactions to occur in the gases
present in the bubble. Between the bubble centre and the bulk
liquid is the interfacial region where large gradients of temperature,
pressure and shear are experienced19. Based on ’comparative rate
thermometry’ experiments carried out with volatile metal carbonyl
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complexes Suslick et al.30 propose a two site model for regions of
sonochemical reactivity (Figure 1.4). The most important site is
the bubbles interior vapour phase where the majority of radical
production is thought to occur, the second site is the layer of liquid
immediately surrounding the cavitation bubble which is injected into
the bubble upon cavitational collapse30.
Figure 1.4: Two proposed sonochemical sites30.
The lifetime of a cavitation bubble before collapse varies. Transient
cavitation bubbles collapse after one acoustic cycle having grown
quickly to a large size. These bubbles are the ones thought to be
responsible for the majority of chemical activity in the system. Stable
cavitation bubbles persist for a greater number of acoustic cycles
and create large shear gradients when they collapse19. These shear
forces perform an important role in sonochemical systems and allow
emulsions to be formed very efficiently in a two phase liquid system.
Superoxide formation and the emulsification caused as a result of
cavitation are important in contributing to the formation of protein
microspheres1. A horn assembly is used to generate ultrasound in the
microsphere system. The cavitation bubbles can be seen to form in a
cloud at the end of the horn tip.
Cavitation also causes sonoluminescence, emitted as a result of
reactions between sonochemically produced radicals in the vicinity
of cavitational hot spots. Multibubble sonoluminescence provides a
useful tool for mapping cavitation clouds and sonochemical activity.
The intensity of the light given out can be enhanced by using
a solution of 5-amino-2,3-dihydro-1,4-phthalazinedione (luminol) to
generate sonochemiluminescence. The luminol molecules react with
HO• and emit intense blue light in the vicinity of the cavitation
bubbles38, this blue light can be captured photographically. The
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sonochemiluminescence produced by the probe used for microsphere
production is shown in Figure 1.5.
Figure 1.5: (a) Sonochemiluminescence observed in a luminol solution
when irradiated with ultrasound from the 3 mm micro-tip
attached to generator B (section 2.1.11).
1.2 Sonochemical Microsphere Production
There are a number of benefits associated with using the sonochemical
method to produce microspheres for delivery applications: The
experimental method facilitates rapid production of microspheres,
sonication times range from 30 seconds to 10 minutes. The equipment
required is cost effective and simple to use compared to microflui-
dics and Coaxial Electro Hydrodynamic Atomisation (CEHDA). The
method is versatile allowing a range of proteins and other materials
to be used in the production of stable microspheres6. In addition
the sonochemical method can be used to carry out simultaneous
surface functionalisation of microspheres produced39;40. Development
of innovative shell materials and surface functionalisation chemistries
for drug delivery applications are active areas of research and are ad-
dressed in this thesis. The sonochemical method has not, historically,
provided such effective size control as the methods detailed below
but new technological developments are being made which have been




In 1990 Suslick and co-workers reported an investigation into the
formation of protein microspheres under sonochemical conditions1.
The microspheres consisted of a disulfide crosslinked protein shell
encapsulating an oil core. The proteins chosen in that initial study
were bovine serum albumin (BSA), human serum albumin (HSA) and
haemoglobin (Hb) all of which contain cysteine residues (Figure 1.6)
that are capable of forming disulfide bonds.
Figure 1.6: Cysteine
In this first study Suslick’s group focussed on the synthesis of micros-
pheres encapsulating the hydrophobic liquids; n-dodecane, n-decane,
n-hexane, cyclohexane and toluene. Successful encapsulation of
the hydrophobic liquids was demonstrated using a solution of the
lipophilic molecule 10,15,20-tetraphenylporphyrin (H2TPP) in toluene
as a model. Microspheres which had encapsulated H2TPP showed a
strong absorbance in the blue region of the visible spectrum.
In later papers the group also demonstrated the formation of air filled
microspheres using BSA, HSA42 and Hb15. The Hb microspheres
formed were shown to be approximately 2.5 mm in diameter, smaller
than red blood cells, with shells that were 6 protein molecules thick15.
Figure 1.7: Sequence of events leading to the formation of disulfide
cross-linked microspheres.
From their investigations Suslick’s group were able to propose a
mechanism for the formation of such microspheres based upon the
emulsification and cavitation effects observed in the sonochemical
system1;42. Amphiphilic protein molecules aggregate at the interface
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of bubbles (or droplets) formed in the foam (or emulsion) in order
to reduce the surface energy7. However emulsification alone is
not sufficient to generate stable protein microspheres. When the
proteins were emulsified using a high shear stirring system no stable
microspheres were formed1.
Chemical cross-linking of the aggregated proteins to form a network of
intermolecular disulfide bonds between the thiol groups present in the
cysteine residues facilitated the production of stable microspheres. By
studying the effect of introducing a number of different radical traps
into the system, Suslick’s group showed that superoxide (HO•2) acts as
the oxidising agent in the sonochemical formation of intermolecular
disulfide bonds1 illustrated in Figure 1.7. Superoxide is formed in an
oxygen rich system as a result of the reaction of hydrogen radicals (ge-
nerated during cavitational collapse) with oxygen molecules (Figure
1.3).
As a proof of principle Suslick’s group compared Hb and Myglobin
(Mb) systems. Hb and Mb are very similar in structure with the
exception that Mb does not contain any cysteine residues. When
both solutions were sonicated under the same conditions many fewer
microspheres were formed from Mb than were formed from Hb.
This demonstrates the key importance of cysteine residues in the
stabilisation of microspheres. The presence of disulfide bonds in the
shells of BSA/toluene and Hb/toluene microspheres was confirmed
by adding a disulfide cleavage agent, DL-dithiothreitol (DTT), to
suspensions of the microspheres. In both cases the protein shells of
the microspheres were destroyed1.
Lysozyme microspheres
More recent work conducted in the area of protein microspheres has
been presented by Cavalieri et al. and focuses on the synthesis of
lysozyme microspheres7;8. It is this work that will form the basis for
the initial stages of the investigation reported below.
Lysozyme (Figure 1.8)a is an enzyme that has antibacterial properties
due to its ability to catalyse hydrolysis of 1,4-beta-linkages in the
aImage on right generated using the protein work-
shop software run by the RCSB Protein Data Bank.
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peptidoglycans that make up bacterial cell walls43. It is made up
of 129 amino acids (approximately 14.7 kDa). The variant used in
this investigation is isolated from chicken egg white. The structure
contains four intra-molecular disulfide bonds attached to cystine
residues which must be reduced leaving eight free thiol groups which
can take part in the intermolecular covalent bonding at the interface as
described by Suslick1.
Figure 1.8: Lysozyme molecule (left) Primary amino acid sequence
showing 4 disulfide bonds between cysteine residues44,
(right) image shows the secondary structural elements
together with the amino acid sequence. The pink dotted
lines represent disulfide bonds.
In the existing papers on sonochemically produced air filled lysozyme
microspheres it is demonstrated that microspheres are only formed
after the disulfide bonds within lysozyme have been reduced, lending
evidence to the suggestion that thiol cross-linking is the stabilisation
mechanism at work7. It is also shown that the extent of cross-linking




resulting, in turn, in different size distributions7. These microspheres
are interesting because, not only are they stable for several months, but
it has also been shown that the surface can be modified by carrying
out layer by layer deposition of polyelectrolytes. This suggests that
surface functionalisation with drug molecules may be possible in the
future7. Lysozyme microspheres can also be formed by encapsulating
hydrophobic liquids including sunflower oil, tetradecane, dodecane
and perfluorohexane8. The encapsulation of oil containing the
fluorescent dye nile red is also demonstrated8. This supports the
hypothesis that lipophilic drug molecules could be encapsulated using
this methodology without damage from the high intensity ultrasound,
a promising indication for future research in this area. A recent study
on the behaviour of lysozyme microspheres in vivo has shown them
to be biodegradable in the presence of proteolytic enzymes with no
residual, potentially toxic, insoluble protein fragments14, an important
criterion for a drug delivery system.
PMASH microspheres
In 2011 Cavalieri et al.17 reported the first sonochemical synthesis
of microspheres from a synthetic polymer. The microspheres are
formed from thiol functionalised poly(methacrylic acid) (PMASH)
(Figure 1.9). Functionalisation of PMA with cysteamine not only
provides thiol groups for cross-linking purposes, but also increases
the hydrophobicity of the polymer giving it the foaming properties
required for successful microsphere formation. The authors report
co-formation of perfluorohexane (PFH) filled microspheres and gas
filled microspheres. Interestingly they were unable to form gas filled
microspheres in the absence of PFH. The authors suggest that the
co-formation of gas filled microspheres is due to the presence of PFH
gas which provides osmotic stabilisation to the gas core17.
The mean diameter of the PFH filled microspheres decreased as
the thiol content of the PMASH increased (from 1.8 µm for 5%
functionalised PMASH to 0.7 µm for 30% functionalised PMASH), it
was suggested that this was due to a higher likelihood of cross-linking
prior to coalescence of the droplets. The converse was true in the
case of the gas filled microspheres (4.3 µm for 10% functionalised
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Figure 1.9: PMASH
PMASH compared to 8.0 µm for 30% PMASH, 5% PMASH microspheres
were not stable) and it was suggested that this was due to loss of
the gas bubbles to dissolution before cross-linking could occur due
to the slower diffusion rate of the more highly functionalised, and
therefore more hydrophobic, PMASH nano-aggregates. Changes in
shell thickness were also observed, via SEM, with changing thiol
content. The shells containing a higher thiol content undergo more
cross-linking and hence are thicker and more textured in appearance,
it was suggested that this would enhance the mechanical stability of
the microspheres17. The microspheres were loaded with Doxorubicin,
a positively charged anti-cancer drug, in order to demonstrate the
potential for encapsulation of drug molecules. Breakdown of the
microspheres using 1 MHz ultrasound was reported although no
release curves for Doxorubicin were published17.
Size distribution
In order to be used safely as ultrasound contrast agents or drug
delivery agents microspheres must be small enough to pass easily
through the circulatory system without causing a blockage i.e. less
than 10 µm diameter45. The production method used must form
microspheres within the chosen size range consistently in order to
allow safe administration and in this respect a narrow size distribution
is preferential. A narrow size distribution of microspheres is less
easily achieved in sonochemical systems than in the case of some of
the synthetic methods discussed below. There is, however, precedent
for gaining some control over the size distribution of microspheres
produced sonochemically by understanding and controlling some of
the variables in the system.
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Han et al.46 synthesised silicone oil filled HSA microspheres and
demonstrated that for their system the mean size decreased with
increasing sonication time up until an equilibrium point. In addition
it was demonstrated that the mean size decreased with increasing
acoustic intensity. Absolute values for the mean sizes varied between
35 mm and 2 mm for sonication times between 30 seconds and 5
minutes, and intensities between 125 W and 500 W46. However due
to the fact that the acoustic effects created by ultrasound pressure
waves are not only volume dependent but are also affected by the
shape of the vessel, comparison of absolute sizes is of limited value.
It is more useful to discuss the general trends observed. Zhou et
al. published a report describing how lysozyme microsphere size
distributions and morphologies can be affected and controlled by
altering the sonication time and sonication intensity47. Contrary to
Han’s report, Zhou et al. found that microsphere size increased with
sonication time and/or power. It was suggested that this was due to
the increased coalescence that would occur as a result of the high shear
forces experienced at high intensities and that a similar argument
could be used at long sonication times which would allow more time
for coalescence processes to occur. Successful microsphere formation
is a balance between microsphere production and degradation. This
was demonstrated at longer sonication times and higher intensities
where fragments of broken shell were observed in the SEM images
of microspheres produced and reduced yields were obtained47.
It was noted by Han et al. that in a system which has poor circulation
the distribution of power is inhomogeneous across the volume of the
vessel46. As a result a broad distribution of microsphere sizes will be
observed. This is a problem that can be overcome by ensuring that
there is sufficient circulation in the system to create a homogeneous
distribution of power.
Makino et al. observed that for BSA microspheres formed with a
number of different hydrophobic liquids the size distribution narro-
wed at higher ultrasonic frequency (45 kHz compared to 28 kHz)48.
This suggests that the emulsion formed at higher frequency is more
monodisperse. They also found that the nature of the encapsulating
liquid affects the size distribution of the microspheres produced48.
Toluene filled HSA microspheres were not only smaller than their
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chloroform analogues but they also had a narrower size distribution.
It is suggested by the authors that this was a result toluene being
less miscible in water than chloroform and hence the interface at the
surface of the toluene emulsion droplet is finer than for a chloroform
droplet. Hence the region in which the protein can aggregate around
a toluene droplet is much more narrowly defined giving a smaller
range of sizes. In the case of vegetable oils (soy bean oil and peanut
oil) the microspheres formed were much smaller than those formed
from either toluene or chloroform48. It is thought that this is due to
the higher viscosity of the vegetable oils in comparison to the organic
solvents, resulting in a smaller emulsion droplet size.
In addition to adapting experimental parameters during production
of microspheres and microbubbles, techniques such as filtration or
further sonication can be employed ’post production’ to reduce the
size distribution of a sample. Zhou et al. report the use of a ’post
sonication’ technique to adjust the size distribution of lysozyme mi-
crobubbles produced according to their standard procedure7;45. It was
shown that sonication of an aqueous dispersion of microbubbles at 212
kHz could reduce the size distribution from an initial distribution of
diameters between 0.5-4.0 µm (mean: 2 µm) to a final distribution of
0.5-2.0 µm (mean: 1 µm), albeit with a sacrifice of yield that results
from destruction of the larger microbubbles.
In developing the sonochemical method as a microsphere/bubble
production technique it is of more interest to obtain a controlled
size distribution without the inevitable sacrifice in yield made by
post production processes. In a recent paper Zhou et al. report
the first example of a sonication technique capable of producing
near monodisperse populations of nano and microbubbles41. The
technique uses a flow through horn (20 kHz) to confine the active
cavitation zone in which microspheres are produced, this results
in a more homogeneous distribution of power than is achieved by
the standard probe horns and therefore a narrower distribution of
diameters (Figure 1.10). The technique can also be run in a continuous
manner, facilitating scale-out of the sonochemical method.
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Figure 1.10: “SEM images of lysozyme microbubbles synthesized
using (a) a 1 cm standard horn (160 W), (b) a 3 mm
standard horn (120 W), and (c) a flow-through horn (240
W). Inset (c): Broken nanobubbles. Size distribution of
lysozyme bubbles (d): (1) a flow-through horn, (2) a 3
mm standard horn, and (3) a 1 cm standard horn” (sic).
Reprinted with permission41. Copyright (2012) American
Chemical Society.
Non-covalently stabilised microspheres
Since the initial investigations of Suslick et al. Gedanken’s group
have broadened the field of sonochemical microsphere production to
proteins which do not contain sulfur residues49. Streptavidin was
used as a model protein because it has a similar structure to avidin,
which has been shown to form disulfide cross linked microspheres50,
but does not itself contain any sulfur residues. At acidic pH, decalin
filled streptavidin microspheres were formed sonochemically and
were stable for several hours at 25°C or 1 month at 4°C16. The fact
that an acidic pH was required to facilitate microsphere formation was
believed to give some indication as to the mechanism of microsphere
stabilisation. It was shown that streptavidin microspheres can
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be formed both in an air saturated solution and argon saturated
solution16. This suggests that the mechanism for formation is not
dependent on superoxide. Instead it is thought that the main factor
in the formation and stabilisation of streptavidin microspheres is the
hydrophobic effect.
The hydrophobic effect occurs when proteins are placed in a polar
solvent such as water. In order to reduce unfavourable interactions
between the hydrophobic parts of the protein and the polar solvent
the protein will fold and converge into a smaller volume, reducing its
surface area51. It is proposed by Gedanken et al. that this hydrophobic
effect leads the proteins to aggregate in a stable manner around oil
droplets formed in the sonochemical emulsion16. Aggregating at the
interface allows the proteins to stabilise one another by creating a more
hydrophobic environment for their neighbour. Microsphere formation
is promoted in an acidic medium because the carboxylic acid groups
on the protein are neutralised thus increasing the hydrophobicity of
the protein surface and reducing electrostatic repulsions16.
Its is important to emphasise that although this hydrophobic me-
chanism does increase the scope for hollow microsphere formation
in terms of the number of proteins or polymers that can be used,
it is limited by the lack of long term stability in the microspheres
formed. Microspheres formed as a result of thiol cross-linking are
stable for several months at room temperature as compared to hours
for streptavidin microspheres16.
In an effort to further prove the action of the hydrophobic mecha-
nism Gedanken et al. demonstrated the formation of decalin filled
poly(glutamic acid) microspheres49. Poly(glutamic acid) is an amide
linked backbone with only carboxylate side chains (Figure 1.11).
Poly(glutamic acid) was chosen as a simplified model of streptavidin
and it was hoped that it would confirm the effect of the carboxylic
acid groups on microsphere formation. The study showed that these
microspheres could only be formed below pH 4.5. The pKas of aspartic
and glutamic acid are between 4.0-4.849. Hence it was concluded
that microspheres could only form when the carboxylic acid groups
were in the protonated form and the hydrophobic interactions were
dominant. The microspheres formed were reported to be stable for one
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month, a significant improvement on the stability of the streptavidin
microspheres49.
Figure 1.11: Poly(glutamic acid)
Suslick et al. also conducted an investigation into the synthesis of
poly(glutamic acid) microspheres this time encapsulating vegetable
oil52. They used the sodium salt, polyglutamate. The microspheres
formed were only 1 mm in diameter, small enough to allow extrva-
sation (escape from the blood pool) especially in tumours where the
vasculature is known to be more permeable52. The microspheres were
very stable, with a half life of over a month at 2 °C, they were also
demonstrated to be thermally stable for over an hour at 60 °C.
Contrary to Gedanken’s hypothesis, Suslick suggested that the domi-
nant intermolecular interaction was in fact hydrogen bonding between
carboxylates. Suslick et al.52 found that it was not possible to form
microspheres in the low pH range quoted by Gedanken. They hypo-
thesised that this was due to the fact that at low pH the protonated
carboxylic acid groups would not be able to hydrogen bond. Suslick
demonstrated that hollow microspheres had been formed at higher pH
using Transmission electron microscopy (TEM) pictures that clearly
show the core shell nature of the microspheres52. It was suggested
that the microspheres formed in Gedanken’s investigation were in fact
solid particles due to the fact that poly(glutamic acid) (MW > 6000
Da) is insoluble at low pH. Hydrogen bonding between carboxylates
is the strongest form of hydrogen bonding52 which may account
for the extended shelf life of the poly(glutamic acid) microspheres
synthesised by Suslick et al. as compared to other non-covalently cross
linked systems.
The observations found in the literature suggest that the mechanism
by which non chemically cross-linked microspheres are stabilised can
be as a result of one or a number of intermolecular forces including
hydrogen bonding, van der Waals, hydrophobic and electrostatic
interactions49. It is likely that the mode of stabilisation will vary
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with the system used. A very recent study conducted by Silva
et al. into the mechanism of sonochemical microsphere formation
provides further insight into the stabilisation of microspheres with
and without disulfide bonds53. Computer simulations were used to
demonstrate that BSA was able to adapt its tertiary structure to fit the
oil-water interface so as to expose hydrophobic regions of the protein
to the internal oil phase and hydrophilic regions of the protein to the
external aqueous phase. In addition greater colloidal stability could
be achieved by increasing the surface charge of the microspheres, a
function of the number of BSA molecules in the shell. Building on
these observations Silva et al. were able to demonstrate the importance
of clearly defined hydrophobic and hydrophilic regions in the protein
for shell stability by trialling a range of synthetic polypeptides53. It
was found that polypeptides which mimicked a fatty acid model;
a short hydrophilic section coupled with a longer hydrophobic tail
were most effective in forming a high yield of stable microspheres.
Based on this study, it appears that it is these structural factors that
are most important in the initial formation of microspheres and that
disulfide bonding is not crucial to the initial formation, provided that
the protein fragments have strong intermolecular interactions at the
oil:water interface53.
Further to polypeptide and protein based microspheres Gedanken
et al. have reported microspheres formed using the sonochemical
method from the polysaccharides starch12 and chitosan5 as well as
graphene oxide4. None of these systems accommodate disulfide
crosslinking and the mechanisms of stabilisation in each case, whilst
proposed as being sonochemical in basis, are yet to be fully unders-
tood.
1.3 Methods for producing polymer and
protein microspheres
Aside from the sonochemical method there are a number of other
methods commonly used to synthesise hollow protein or polymeric
microspheres. These methods fall broadly into four categories; emul-
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sion techniques, layer-by-layer assembly, inkjet printing and coaxial
electro hydrodynamic atomisation, and microfluidic techniques.
Emulsion techniques and Interfacial polymerisation
All of these techniques create similar emulsion systems from which
hollow microspheres can be formed. The differences are in the means
of producing the emulsion which in turn affect the breadth of utility of
the system.
One of the simplest techniques is high shear emulsification. As the
name implies an emulsion is formed under high shear stirring. This
emulsion is then stabilised by an amphiphilic polymer or protein.
The amphiphilic molecules are attracted to the oil:water interface
where they will either chemically crosslink or aggregate due to the
hydrophobic effect16;54. Often a volatile oil phase is used, the oil will
evaporate causing the polymer surrounding the emulsion droplets to
precipitate over the internal surface of the droplet forming a hollow
or partially liquid filled shell55. The size of the microspheres formed
in this system can vary from the nano scale to the micro scale55. In
addition, stabilisers such as poly(vinyl alcohol) (PVA) can be used to
change the interfacial energy of the system and thus change the size
distribution of the spheres formed55.
High shear emulsification is commonly applied synergistically with
interfacial polymerisation to stabilise emulsion droplets and form
capsules56–58. Interfacial polymerisation describes polymerisation
reactions which occur either at an air:water interface or the interface
between a hydrophilic region and a hydrophobic region and is there-
fore ideal suited to capsule formation. An example of this approach is
provided by Jiang et al. who use interfacial polymerisation to crosslink
oligomers of poly(methacrylic acid) (PMA) and polylactide (PLAM)
in an oil/water emulsion with a water soluble free radical initiation
system55. The hydrophobic PLAM crosslinks with hydrophilic PMA
across the oil/water interface of the emulsion droplets forming a mesh
of copolymer which surrounds the oil droplet. Again a volatile solvent
is used, chloroform, which evaporates after a period of continued
stirring to leave hollow capsules. It was observed that once a thin shell
of copolymer had formed around the emulsion droplet diffusion of the
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initiator across the interface and interaction between the two types of
oligomer was hindered preventing further polymerisation. As a result
unreacted PLAM oligomers precipitated onto the internal surface of
the microspheres as the chloroform evaporated increasing the shell
thickness but perhaps not its strength55.
Figure 1.12: Schematic of the membrane emulsification process; dark
grey: oil phase, pale grey: aqueous phase, black: mem-
brane, black dot: surfactant molecule.
Membrane emulsification provides an alternative method of forming
an emulsion system without the need for high shear forces. This
has advantages for more fragile systems where high shear forces
might damage the proteins used59. In membrane emulsification
the oil is forced through a porous membrane into a bulk aqueous
phase generating an emulsion with a narrow distribution of droplet
sizes60(Figure1.12). As a result this system gives better control over the
microsphere size distribution than in the high shear case60. After the
emulsion has been generated a methodology similar to that described
above (utilising amphiphilic molecules or interfacial polymerisation)
can be used to stabilise the emulsion and form microspheres. A recent
example from Akamatsu et al.61 demonstrates the use of a porous glass
membrane to form Chitosan microspheres and shows that is possible
to form a monodisperse emulsion with a droplet size controlled by the
pore size of the glass membrane. Although the microspheres formed
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were solid the method could be used to form oil/water emulsions
which could be further modified to form hollow microspheres61.
Layer-by-layer assembly
Layer-by-layer (l-b-l) assembly of capsules provides a means of
forming capsules with a controlled wall thickness by using a sacrificial
template, usually monodisperse silica particles62. Originally l-b-l
capsules were formed from polyelectrolytes in a step wise manner:
The template particles used had a surface charge and were incubated
with oppositely charged polyelectrolytes which coated the template.
The excess polyelectrolyte was removed by centrifugation and rinsing,
the coated particles were then incubated with the oppositely charged
polyelectrolyte to form a second layer of polymer on the particles.
This process of incubation with polymers of opposite charges could be
repeated as many times as desired to form capsules with the required
wall thickness (Figure 1.13). After deposition of the layers the template
particle was removed to leave a hollow capsule62.
Figure 1.13: Schematic of layer by layer capsule assembly. Red and
blue strands denote oppositely charged polymers.
More recent investigations have explored hydrogen bonding and
covalent bonding strategies, including disulfide bonding63 and click
chemistry64, as alternative means of stabilising l-b-l capsules. Uti-
lising hydrogen bonding as a means of building microspheres has
extended the scope of l-b-l capsules to include neutral responsive
polymers, for example PNIPAm65, providing potential for use of
l-b-l capsules as responsive delivery systems. A recent paper from
Caruso et al.66 reported the synthesis of polymer capsules stabilised
by thiol-ene cross-linking. The group used l-b-l deposition at pH 4
to alternately deposit PMASH and PMAene interspersed with layers
of poly(vinylpyrrolidone) onto a silica particle forming a coating
which was stabilised by hydrogen bonding. The coated particles were
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exposed to UV light (256 nm) for two hours and thiol-ene cross-linking
occurred between the deposited layers of PMA. The particles were
exposed to pH 7 to disrupt the hydrogen bonding and wash away the
poly(vinylpyrrolidone) leaving a thiol-ene stabilised shell. Finally the
silica particle was etched away to leave a stable thiol-ene cross-linked
capsule.
Loading of l-b-l films and capsules with therapeutic species such
as drug molecules or DNA for delivery can be achieved via three
different methods67. The stepwise approach to shell formation
allows incorporation of drug species into the capsule shell during
production68–70. For small drug molecules this can be achieved by
first encapsulating the drug species within polymeric micelles, these
micelles can then be introduced into the shell as one of the layers69;70.
Alternatively in order to form capsules that have an oil core containing
the lipophilic species, dehydrated l-b-l capsules can be soaked in
an oil phase containing the drug, for example a solution of the
anti-cancer drug doxorubicin in oleic acid71. When the capsules are
then transferred to a buffer and rehydrated they retain their oil core.
This method is effective in forming very similar structures to those
formed via the sonochemical method but wastes a large percentage
of the oil phase used in loading the capsules67;71. More efficient
loading can be achieved if the molecules are loaded onto the sacrificial
particle prior to layer assembly, this technique has been demonstrated
in the case of loading PMASH capsules with DNA72. Loading and
subsequent release of DNA was achieved whilst maintaining the
structural integrity of the DNA strands.
Layer-by-layer deposition provides a means of forming capsules with
well controlled size distributions from a variety of polymers and
has great potential for future development of drug delivery agents.
Unfortunately the process of formation is relatively labour intensive
and loading of lipophilic species into the core is inefficient compared
to the sonochemical method and emulsion techniques available.
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Ink jet printing and Coaxial Electro Hydrodynamic Atomisation
(CEHDA)
Ink jet printing provides an efficient method of generating a mo-
nodisperse population of microspheres. A ‘drop on demand’ ink
jet printing system can be used to dispense uniform droplets of
a hydrophobic liquid into a bulk aqueous phase at a very fast
drop rate (4000 drops per second)73. Drop on demand systems
provide a high level of control as droplets will only be produced
when triggered, for example by a voltage pulse passing through a
piezoelectric actuator. The voltage pulse is controlled by a computer
data stream which allows great flexibility and precision in the size of
the droplets produced. Once the emulsion has been formed chemical
cross-linking of polymers or proteins in the aqueous phase can be used
to stabilise the emulsion and form monodisperse microspheres73. Gas
filled microspheres can be generated by using a jet in jet technique
consisting of an inner jet of nitrogen and an outer jet of polymer
solution73. Alternatively the jet in jet technique can be used for drug
encapsulation by replacing the inner gas jet with a stream of drug
solution73.
Figure 1.14: Microbubble production by coaxial electro hydrodynamic
atomisation. Left to right: bubble dripping mode, coning
mode, continuous microbubbling mode60. Image adapted
from reference.
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CEHDA is similar to ink jet printing and can be used to generate well
controlled distributions of hollow or liquid filled microspheres. Two
streams of liquid are focussed into a coaxial jet under the influence
of an electric field. The jet then breaks into droplets and if the two
liquids are immiscible then the outer liquid will encapsulate the inner
liquid to form core shell microspheres60. Alternatively in order to form
gas filled microspheres the inner liquid stream can be replaced with a
stream of gas (Figure 1.14). The size and dispersity of the microspheres
produced can be controlled by adjusting the respective flow rates of
the two liquid streams and the applied voltage of the electric field. For
example the diameter of the microspheres can be reduced by reducing
the flow rate of the inner stream60. Phospholipid microspheres have
been formed by this method with a mean diameter of 6.6 µm ± 2.5
µm and are stable for over 2.5 hours at room temperature60. The
major advantage of this method is that several coaxial jets can be set
up together to generate microspheres with multilayer shells in one
step74. This gives the opportunity for highly controlled drug release
profiles to be designed, however the applicability of this method to
drug delivery is currently limited by the stability of the microspheres
formed. No chemical methods of stabilisation have yet been applied
to the CEHDA system, although more stable microspheres have
been formed from polymethylsilsesquioxane (a biocompatible silicone
polymer)75.
Microfluidics
Microfluidic systems offer a very high degree of control over the size
and dispersity of the microspheres formed achieving near monodis-
perse size distributions. Two types of system are currently in use;
flow focussing units and T-junction units, both form microspheres via
a ‘pinch off’ process.
The flow focussing unit forms microspheres which are small enough
for intravenous injection (nitrogen filled microspheres with a mean
diameter of 1.5 µm ± 0.1 µm have been reported which are stable
for at least 9 hours at room temperature76) however it should be
noted that this system is expensive to run as experiments must be
conducted under clean room conditions in order to prevent blockage
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Figure 1.15: Schematic to show microbubble production using a micro-
fluidic T-junction60. Image adapted from reference.
of the fine channels used60. The T-junction system (depicted in Figure
1.15) is based on capillaries and does not require clean room conditions
making it more convenient. Unfortunately the microspheres produced
are not yet small enough for intravenous injection (mean diameters
in the range of 30-100 µm)77 limiting its utility in drug delivery
applications. However there is future potential is this area as the
formation of hollow microspheres from silk worm cocoon silk (a
biocompatible, biodegradable polymer) has been demonstrated and
may be useful for drug delivery if the mean diameter can be reduced78.
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1.4 Biological Activity and Applications of
Sonochemically produced Microspheres
Conventional administration of drugs in therapy has a number of
pitfalls and drawbacks; side effects can result from systemic delivery
of drug molecules throughout the body, rather than specifically to the
site of action79. This is especially relevant in the case of anti-cancer
drugs which have strong systemic toxicity80. Encapsulation of such
drugs within a biocompatible protein shell is advantageous in terms
of reducing systemic toxicity and increasing the half life of the
drug79 81 81. Loading drug molecules into or onto carriers has the
additional benefit of protecting the drug from degradation in vivo,
therefore reducing the dose required to achieve the desired therapeutic
effect81. The sonochemical approach provides a facile method for
forming biocompatible6;14 microspheres encapsulating hydrophobic
liquids and associated lipophilic solutes1, and additionally provides
a platform for surface coating facilitating the carriage of more hydro-
philic species82 or targeting ligands83.
Biological activity of microspheres
Irradiation of proteins with high intensity ultrasound in the presence
of an organic solvent, as is necessary for microsphere formation,
is known to result in significant levels of inactivation and also
precipitation of the protein84. It is proposed by Krishnamurthy et
al.84 that this inactivation is caused by protein denaturation as a result
of exposure to the aqueous:organic interface, pyrolysis in the vicinity
of cavitation events and degradation of the protein’s active sites by
sonochemically produced free radicals. This is not unexpected, it is
perhaps more surprising to find that some enzymatic activity can be
retained in the microspheres subsequent to formation.
Gedanken et al. have used a sonochemical approach to synthesise
decalin filled microspheres from an enzyme a-amylase which hydro-
lyses polysaccharides85; a-chymotrypsin which is less thermally stable
and breaks peptide bonds85; and avidin which is known to bind
biotin very strongly (Ka ~ 1015 M-1)50. Gedanken et al. observed
that although the activity of the proteins was reduced in all three
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cases it was not destroyed totally. This suggests that the sonochemical
treatment does not denature all of the active sites responsible for
the activity of the proteins. From these results it can be inferred
that the secondary structure of the proteins is left partially or wholly
intact despite the large shear forces acting in the solution and the
formation of intermolecular disulfide bonds. Further information
could be gathered on this aspect of microsphere formation through
using circular dichromism spectroscopy to study changes in the
protein’s secondary structure more closely7. A report from Suslick
et al. also indicates the retention of secondary structure; microspheres
formed from Hb retain the secondary structure surrounding the Heme
site and Hb molecules in the microsphere shell are still able to bind
oxygen in a reversible manner and display cooperative behaviour15.
In fact the microspheres had better oxygen binding efficiencies than
red blood cells. Residual enzymatic activity may have implications
for drug delivery applications, if enzymatic activity is retained it
may cause harmful side effects if microspheres are administered
in vivo. Alternatively, as with the case of Hb microspheres, the
retained activity may offer useful applications, for example as a blood
substitute.
Beyond simply using the cross-linked protein shell as a carrier for the
encapsulated payload, it is interesting to consider forming the shell
itself from a therapeutic agent to create a very simple carrier. DNA is a
large negatively charged molecule which cannot readily pass through
cell walls and into the cell nucleus, it is also subject to attack and
breakdown by nucleases present in cells. Therefore in order to carry
out effective gene therapy an efficient and safe means of facilitating
entry of DNA into cells needs to be developed86. Shimanovich et
al.2;3 have demonstrated that stable nanospheres could be formed by
sonicating DNA or RNA with dodecane. The nanospheres can be
taken up by mammalian cancer cells and these nanospheres could
provide a potential method of delivery for DNA and RNA in gene
therapeutics. Its is suggested that forming nanospheres can protect the
strands from in vitro and in vivo degradation, enhancing the efficacy
of delivery to the cell without the need for additional mediators2;3.
Preliminary experiments show that plasmid DNA can be released
from the nanosphere shells and can replicate2 (within E-coli) and,
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under denaturing conditions, RNA molecules can be released and are
able to refold into their native form87.
Drug encapsulation/entrapment
There have been a number of reports in the literature of success-
ful drug9–12;79;88 and dye8;89 encapsulation within sonochemically
produced microspheres. Encapsulation can be carried out in a
one step process during microsphere production, the drug molecule
is either dissolved in the oil core material or the aqueous buffer
resulting in encapsulation within the core of the microspheres or
entrapment under/in the protein shell. Gedanken et al. demonstrated
encapsulation of a mesitylene phase containing Taxol within BSA
spheres9, loadings of over 90% were achieved (as a function of the total
amount of taxol initially added to the system). The taxol microspheres
were tested for their anticancer activity against cells taken from a
mouse myeloma cell line and it was found that the deaths of cancer
cells increased with increased taxol loading but that in addition the
mesitylene solvent was responsible for further cell death. Aside
from protein microspheres Zhou et al. demonstrated, qualitatively,
encapsulation of the fluorescent anti-cancer drug Doxorubicin within
PMASH microspheres17.
Similar studies were carried out with Gemcitabine79, another anti-
cancer drug, and Tetracyline10, an antibiotic, in these cases the drug
was loaded from the aqueous protein solution into microspheres
containing a dodecane core. The action of sonication resulted in
partial solubilisation of the drug molecules in the oil core in both
cases and the microspheres produced contained drug encapsulated
in the core and drug entrapped in the shell, 30% and 65% loadings
were achieved respectively10;79. Again the drugs’ activities were
maintained on incorporation into the microspheres, indeed in this case
the Gemcitabine was seen to exhibit greater activity than standard
Gemcitabine; only a fifth of the dose of microspheres was required
compared to standard Gemcitabine to achieve the same extent of cell
death79. The Gemcitabine microspheres are stable to release in buffer
at 37 ºC over a period of 100 hours so it was thought that release in
the cell environment was triggered by protease degradation of the
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shells79. The mechanism for release and observed activity is still under
investigation.
An interesting alternative method of loading a therapeutic agent
within the microspheres is to incorporate it structurally into the shell
wall as was demonstrated with starch-insulin microspheres12. Insulin
contains disulfide bridges in its protein structure and hence is a
potential candidate for microsphere formation, however starch being
a polysaccharide does not have any such functionality. Despite this
it was shown by Gedanken et al.12 that starch microspheres can be
formed, the authors suggest that the mechanism of stabilisation of
the microspheres results from sonochemical reduction of glycosidic
bonds and thermodynamically driven assembly of starch fragments.
If insulin is added to the starch solution prior to sonication ’double
walled’ microspheres can be formed containing an inner structural
component of insulin and an external shell of starch. The microspheres
formed incorporate up to 93% of the insulin present in the starting
solution and are stable to release making them potential future
candidates for insulin delivery12.
More recently interest has focussed on characterising the release of
drug molecules from microsphere carriers with a view to further
developing their potential as drug delivery agents. Prolonged
release of a hydrophobic dye, sudan III, from BSA microspheres into
chloroform or sodium dodecyl sulfate solution has been studied89. It
was shown in this study that release could be sustained over several
days and that the rate of release could be enhanced by heating the
microspheres from ambient to physiological temperature89. Silva et
al. report encapsulation of the hydrophilic drug Piroxicam within
BSA or HSA microspheres using polyvinyl alcohol (PVA) as a
stabiliser11. PVA was found not only to reduce the z-average diameter
of the microspheres produced, perhaps due to steric stabilisation of
smaller droplets/microspheres during formation, but also a greater
proportion of the available drug was incorporated when PVA was
present. The PVA-BSA microspheres were stable over several months
but when incubated with protease 100% release was achieved within
a two hour period. The release profile initially followed that typical
of a ’burst’ release followed by slower continuous release, suggesting
release from the surface followed by release of those molecules bound
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on the inside of the shell. It is likely that introduction of the additional
PVA layer provided greater protection to the drug trapped within in
the shell, preventing it from leeching away on storage.
An example of functionalising the surface of microspheres in order
to achieve a therapeutic effect can be seen in the case of BSA mi-
crospheres which have recognition peptides for Amyloid-β covalently
attached39. Amyloid-β is the main pathogen in Alzheimer’s disease,
its toxicity is derived from its tendency to form neurotoxic aggregates.
The surface functionalised microspheres were able to bind Amyloid-β
and, in fact, were more effective in binding and reducing the toxicity of
Amyloid-β than the free recognition peptide chains. It was proposed
that this was due to the multivalency effect created by the relatively
large microsphere structures, as also observed in the case of Hb
microspheres15;39;90.
The formation of microspheres from DNA or RNA was discussed
above, however it is also possible to protect DNA for delivery by
coating it on the surface of protein microspheres. The surface of
protein microspheres is often highly charged due to the number of
ionisable groups in the protein molecules. For example at pH 7 the
net charge on a BSA molecule is -17, a typical microsphere (with
a diameter of 2 µm) has approximately 106 BSA molecules in the
shell, hence the microsphere shell is highly negatively charged83.
This makes protein microspheres ideal substrates for electrostatic
layer by layer deposition. Lentacker et al. report the synthesis of
perfluorocarbon filled BSA microspheres which are coated with a layer
of poly(allylamine hydrochloride) (PAH). The coating of PAH gives
the microspheres a cationic surface which can bind the negatively
charged DNA molecules86. Firstly this protects the DNA from
attack by nucleases at the point of delivery, secondly it facilitates
the transfer of the DNA molecules into the cell under ultrasound
irradiation86;91, see below. A similar study has been carried out by
Melino et al. and used the cationic surface of lysozyme microspheres
to bind DNA without the need for additional polymer coatings14.
They too were able to show protection of the loaded DNA with
respect to enzymatic breakdown. Further studies are now required




In the context of considering microspheres for drug delivery appli-
cations it is important to address the way in which microspheres are
distributed in the body and the measures which can be undertaken
to influence that distribution. Sonochemical microspheres can be
formed in a size range of 1-15 µm47, it is widely accepted that particles
greater than 7 µm in diameter are cleared from the circulation by
mechanical filtration in the lungs whereas those with a diameter
smaller than 5 µm are taken up in the vasculature of the liver92.
Thus controlling the size distribution of microspheres administered
can facilitate passive targeting of the pulmonary vasculature for the
delivery of drugs specific to the respiratory system92. Alternatively,
Albunex93 microspheres with a smaller number average diameter
(4 µm) are subject to hepatic uptake as a result of macrophages
present in the liver. In a study of the biodistribution of polystyrene
spheres labelled with intercellular adhesion molecule 1 (ICAM-1)
antibodies (ICAM-1 is upregulated in endothelial cells as a result of
a number of disease states) it was found that spheres in the size range
1-10 µm were cleared from the blood circulation more quickly than
sub-micron diameter spheres but that once inside the cell sub-micron
spheres were transported much more rapidly into lysozomes90. These
factors are important considerations in designing microsphere based
drug delivery systems, however there is also significant interest
in decorating the surface of microspheres in order to achieve site
specific targeting of microspheres further reducing the occurrence of
unwanted side effects.
Suslick et al. have used layer by layer deposition to functionalise the
surface of BSA microspheres with peptides which contain sequences
that are specific for intergrin receptors83. Intergrin receptors are
known to be over-expressed in tumour cells so the peptides on the
microsphere surface will cause the microspheres to accumulate in
areas which have a high density of cancer cells and this has been
demonstrated in vitro using colon tumour cells83. At the current time
the localisation of microbubbles by targeting moieties is yet to be fully
optimised, the quantity of microspheres that retain their ligands and
reside at the target site is small94, so there is significant scope for future
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development. In an alternative approach to the classical layer by layer
functionalisation of microspheres, Skirtenko et al.40 report a one pot
method to functionalise tetracyline loaded BSA microspheres with a
thiol functionalised mannosyl derivative which can be bound by E-coli.
Targeting the microspheres to E-coli facilitates maximum antibacterial
activity of the loaded tetracyline and gives the synergistic effect of
disabling the bacteria through agglutination40.
As an adjunct to chemical and biological targeting the use of magnetic
microbubbles is emerging as a method of increasing the dwell time
of drug carriers in the vicinity of a desired administration site95.
Magnetic nanoparticles alone are imperfect transport mediators, the
diminutive magnetic strength which results from their small size
means that a strong magnetic field must be applied in order to achieve
effective localisation95. However systems incorporating magnetic
nanoparticles within the shell of sonochemically produced protein
microspheres, either via post production layer-by-layer deposition96
or in one step using protein coated nanoparticles97, are showing
promise as effective targeted drug delivery agents.
Ultrasound Contrast Agents and Bimodal Imaging
Ultrasound is widely used in clinical applications for imaging parts
of the body. The area under examination is irradiated with high
frequency ultrasound (2-10 MHz98). When the sound waves reach
boundaries between different tissue types some will be reflected as
echoes due to the change in tissue density at the boundary. It is these
echoes which are detected and processed to generate an image of the
internal organs99. The intensity of the echoes reflected depends on the
difference in density between the two tissue types. A large difference
will result in more echoes and hence a greater signal intensity. Soft
body tissues often have very similar densities and as a result it can be
difficult to generate strong echo signals and achieve good contrast in
the images generated99. Ultrasound contrast agents offer a solution to
this problem and can be defined as follows:
“An ultrasound contrast agent is an exogenous substance, consisting
of gas or air microbubbles encapsulated by a shell of different
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composition, that can be administered intravenously or into a body
cavity to enhance ultrasonic signals.”99
The difference in density between the gas encapsulated in the micros-
phere and the surrounding body tissues is large. This creates greater
contrast in the image generated and allows tissues containing mi-
crospheres to be clearly distinguished. The microspheres commonly
used in imaging have a diameter of between 2-6 µm and as such are
confined to the blood pool99. As a result organs which are highly
perfused will show strong contrast to other tissues.
Microbubbles have soft shells and are able to resonate with a sound
wave and so have harmonic frequencies. The resonant frequency of a
microsphere is dependent on its diameter98. Normal body tissue does
not resonate and therefore does not have harmonics. Hence the tissue
under investigation can be irradiated at the resonant frequency of the
microspheres and the detector can be set to only detect a signal at twice
the applied frequency (second harmonic). Any signal detected will be
as a result of the microspheres, not the surrounding tissue, giving a
clear indication of the distribution of blood in a tissue98. This can be
particularly useful when screening for tumours which are known to
be more highly perfused than normal tissue.
Ultrasound contrast agents need to be biocompatible, in particular the
breakdown products must be readily processed and disposed of by
the body so that side effects are minimised. It is also important that
the microspheres used have a narrow size distribution. A broad size
distribution would mean that the tissue would need to be irradiated
with a wide range of ultrasound frequencies in order to generate a
strong resonance field98. This would reduce the quality of the image
produced. The in vivo half life of the microspheres must also be
considered. At present the commercial microspheres used persist in
the blood for a matter of minutes, for example, LevovistTM (galactose
based microspheres) is stable in the blood for 1-4 minutes98. It would
be useful to develop microspheres which persist in the blood stream
for longer to allow more detailed diagnosis to be carried out.
It is also possible to use microspheres for Magnetic Resonance Imaging
(MRI). MRI imaging traditionally uses the signals from 1H nuclei in
water to image regions of tissue, 19F can be used as an alternative
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nucleus for MRI imaging100. The 19F isotope is 100% abundant but is
only present in the body as a solid (in teeth and bones) and is therefore
not detectable by MRI. Hence small quantities of injected 19F nuclei
introduced into the body can be imaged without competition from
naturally occurring nuclei100. Perfluorocarbons provide a sufficiently
high local concentration of 19F nuclei that an adequate signal to
noise ratio can be achieved and the transit or localisation of small
volumes of perfluorocarbons can be imaged in the body101. Webb
et al. encapsulated perfluorocarbons within BSA microspheres to
produce robust MRI agents which increased the observed signal
to noise ratio by up to 300% compared to similar emulsions of
the time102. Microbubbles that contain magnetic nanoparticles in
their shells95;96;103 can also be used as contrast agents for MRI. The
nanoparticles provide contrast in 1H-MRI by increasing the relaxation
rate of protons adjacent to the microspheres and therefore reducing the
signal observed in regions where microspheres are present104. These
microbubbles provide the additional benefit of also being able to act
as ultrasound contrast agents, bimodal imaging facilitates improved
accuracy and greater flexibility in clinical diagnosis95;96;103 .
Image aided delivery and triggered release
In surgical procedures using high intensity focussed ultrasound
(HIFU) (1 MHz, typical peak negative acoustic pressure: 4.6 MPa)29
it has been demonstrated that the presence of microbubbles can
increase cavitation in the chosen location25. It has also been reported
that low intensity diagnostic ultrasound irradiation (typical peak
negative pressure 0.4 MPa)105 in vivo, in the presence of microbubbles,
can result in localised heating and some cavitation106. Ultrasound
irradiation in the presence of microbubbles is known to improve drug
and gene uptake86;107;108. This effect is given the umbrella term ’sono-
poration’107. Although sonoporation has been shown empirically to
aid uptake86;107 the mechanisms involved are not fully understood.
It is proposed that irradiation of a tissue with medical ultrasound
(0.5-2 MHz91) in the presence of microspheres results in temporary
perforation of cell walls facilitating delivery of molecules that would
otherwise struggle to traverse the cell membrane readily, for example
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DNA86. The upper pore size limit is estimated to be approximately 75
nm and the larger pores can be viewed by SEM107. The pores exist in
a transient manner so delivery across the cell membrane is limited by
the proximity of drug molecules to the pore sites, in this sense it is an
asset to deliver the drug on the surface of the microbubbles. In this
way it is more likely that the drug molecule can be propelled across
the cell membrane by a micro-jet107. A more recent study has shed
some further light on the mechanism, establishing that the shear stress
induced by microstreaming in the vicinity of cavitating microbubbles
causes increased F-actin production and cytoskeleton rearrangement,
indicative of transient changes to the cell’s structure108. Additionally it
was found that sonochemically produced hydrogen peroxide resulted
in increased membrane permeability to calcium ions, indicating that
local effects of ultrasound irradiation have a notable effect on cell
signalling and transport mechanisms. Finally there is evidence to
show that cell viability is not changed by ultrasound irradiation and
that the cell membrane integrity is restored within 30 minutes108.
The sonoporation effect can be utilised to convey large molecules , e.g.
DNA, into cells and to aid uptake of drugs either from the surface
of microbubbles or co-administered with microbubbles. Ultrasound
triggered delivery is appealing because it can be focussed accurately
and precisely into a specific region of tissue to maximise therapeutic
uptake and minimise unwanted side effects whilst being minimally
invasive13. Sonochemically produced liquid filled microspheres have
their primary application in drug delivery whereas traditionally
sonochemically produced microbubbles have their application in
imaging as ultrasound contrast agents.
Surface functionalisation of microbubbles, opens the opportunity for
combined imaging and therapy106. Administration of microbubbles
that have been surface-loaded with drug molecules can be guided by
ultrasound imaging. Fokong et al.23 report an example of polymer
microbubbles which have been surface functionalised with antibodies
to target tumour vasculature. The microbubbles could be clearly
imaged in the tumour and subsequently burst open to release their pay
load of 2 ’model drug’ fluorescent dyes (Rhodamine B and Coumarin
6)23. Hence sonochemically produced microspheres provide a straight
forward method by which to form drug carriers which can act
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simultaneously as imaging agents, opening up the potential for
accurate, monitored delivery of a drug payload to a specific disease
site.
Further to this Moehwald et al. demonstrate the use of protein
microspheres containing a gel core to carry out temperature respon-
sive release of a lipophilic drug, Indomethacin109. By incorporating
a gelator, 12-hydroxystearic acid, into the vegetable oil core BSA
microspheres could be formed which had a gel core at 25 °C but
underwent a phase transition to an oil phase at 40 °C. The phase
transition occurs as a result of breakdown of the hydrogen bonding
network between the gelator molecules which removes the porous
gel structure, causing the microspheres to shrink around the more
compact liquid oil phase109. As a result drug release can be observed
over a 20 hour period, culminating in 100% release, compared to 16%
release observed at 25 °C. In control experiments it was demonstrated
that similar behaviour was observed at 25 °C with simple gel particles
(without the protein shell), this indicates that the protein shell adds
little benefit to the stabilisation of the system on storage. This work
opens up new potential for controlling drug release from protein
microspheres in response to external stimuli by adapting the core
substituents, it was suggested by the authors that these microspheres
could be further adapted for temperature responsive release by
incorporating light sensitive nanoparticles, e.g. gold aggregates into
the shells of the protein containers to allow remotely controlled release
by infra-red laser irradiation109.
Topical Delivery
Beyond systemic delivery, sonochemically produced microspheres
lend themselves well to topological delivery. There is evidence to
show that protein microspheres can be attached to the fibre strands
in cotton and polyester fabrics110–112. This is achieved by carrying
out the standard sonochemical preparation procedure with a piece
of fabric present in the protein solution. After extensive washing
the microspheres can be seen to have been retained on the fabric
fibres112, although more so in the case of cotton than polyester. The
significant question of how the microspheres attach to the fabric fibres
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still remains unanswered but this methodology provides potential for
future development, particularly in the production of antimicrobial
fabrics for wound dressings.
An alternative approach is to trap microspheres containing the desired
therapeutic molecules in a thin film, as demonstrated by Borodina et
al.88, with calcium alginate films. They were able to show that by
entrapping Vitamin E in gum acacia microspheres release could be
controlled and sustained over a much longer period than if vitamin E
was entrapped in the film in its free state (100% release was observed
after 96 hours as compared to 5 hours). Such biodegradable films have
potential for use in topical delivery applications.
Other delivery applications
The ability to encapsulate molecules within a protein or polymeric
shell has the potential for applications which extend beyond drug
delivery and therapeutics. Flavour encapsulation is one area where the
biocompatibility of microspheres could be utilised. By encapsulating
flavour compounds and incorporating the microspheres formed into
manufactured foods, for example biscuits, flavours could be locked
away and protected from degradation processes increasing the shelf
life of the food. The flavour would be released upon chewing as
the microspheres were mechanically broken open. This would extend
work already reported in the literature where flavour compounds are
encapsulated in the matrix of an edible film113.
Beyond flavour enhancement the same approach could also be used to
encapsulate nutrients allowing foods to be fortified with a wider range
or higher concentration of nutrients than would naturally be present,
possibly an important application in an ever more health conscious so-
ciety. Nutrient encapsulation has previously been demonstrated using
emulsion technology to fortify processed cheese with an emulsion of
fish oil in order to provide the consumer with an alternative source of
omega 3 oils114 and there have been other examples of proteins used
for nutrient delivery115. Microspheres would provide an alternative
approach to delivering these so-called nutraceuticals by stabilising the
emulsion over a longer time period, improving the product shelf life.
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Protein microspheres have been investigated as potential carriers for
fragrant molecules; Gedanken et al. have demonstrated that fragrance
can be released over a 24 hour period if amyl acetate, a fragrant oil,
is encapsulated within BSA microspheres116. Considered alongside
the recent developments in modification of fabrics with microspheres
(discussed above) this system has potential for slow release fragrances
built into fabric products
A further potential application for biodegradable microspheres is in
fertiliser and pesticide release. Over application of fertilisers and
pesticides is a well known environmental problem. Slow release of
chemicals could be achieved by applying a solution of microspheres
which degraded over a period of days or weeks gradually releasing
a known quantity of chemical which had been tuned to meet the
needs of the crop. Hence the problems of run off and pollution could
be reduced without the need for multiple applications. There does
not appear to be a precedent yet for encapsulation of agricultural
chemicals in microspheres, although some similar work has been
reported based on polyelectrolyte complexes117.
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2 Experimental methods
2.1 Chapter 3: Lysozyme and
poly(methacrylic acid) microspheres
All reagents were purchased from Sigma Aldrich and used without
further purification.
A Bruker Avance 300 MHz NMR was used to collect the 1H NMR
spectra used during this study. DOSY NMR experiments were
performed using the 400 MHz Bruker Avance NMR spectrometer.
The DOSY spectra were acquired using the ledbpgp2s pulse program
provided with the Bruker topspin software The gradient strength was
incremented in 8 steps from 5 to 95% of the total gradient strength. The
gradient pulse length was set at 4 ms to ensure full signal attenuation
and the relaxation delay was 5 s (5 x T1 relaxation). The probe head
temperature was kept at 298 K during the experiments. The data set
was processed using the dosy2d program provided with the Bruker
topspin software.
Fluorescence images were captured using an Olympus IX71 micro-
scope fitted with a mercury lamp. Optical microscopy images were
captured using a GX optical L3001 microscope fitted with an Infinity 2
camera. Laser scanning confocal microscopy experiments were carried
out using a Zeiss LSM 510 META microscope at the University of Bath
Microscopy and Analysis Suite.
The microsphere diameters were measured from the optical micro-
graphs taken. A calibration slide was used to define the length scale
in terms of mm/pixel. Measurements were made using the freely
available graphics software ImageJ 1.42q. A sample size of 75-100
microspheres was typically used to estimate size distributions.
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UV/VIS spectra were collected using an Agilent 8453 spectrophoto-
meter and quartz cuvette (path length: 1 cm). Fluorescence spectra
were collected using a Perkin Elmer LS 55 luminescence spectrometer
(excitation slit: 10.0 nm, emmission slit: 4.0 nm, scan speed: 300
nm/min).
Fourier Transform Infra-Red (FTIR) spectra were collected using a
Perkin Elmer FT-IR Spectrometer fitted with an ATIR (Diamond PIKE
MIRacle) attachment. Raman spectra were collected using a Renishaw
inVia Raman microscope. In both cases the samples were oven dried
as amorphous powders prior to measurement.
Two ultrasonic generators were used during the course of this study;
generator A: a Branson digital sonifier (20 kHz/400 W) connected
to a horn with a microtip (diameter: 3 mm) at the University of
Melbourne and generator B: a Sonics and Materials VC600 generator
(23 kHz/600W) also connected to a horn with a microtip (diameter 3
mm) at the University of Bath.
2.1.1 Calibration of ultrasound generator B and horn
100 g of de-ionised water, equilibrated to the ambient room tempera-
ture, was accurately measured into a 150 mL beaker. The micro-tip was
positioned in the mid-depth of the water and the water was sonicated
at a chosen arbitrary power level. The temperature was monitored
with a thermocouple over a known time period in order to establish
the heat energy dissipated into the water. The power output of the
horn was then calculated as a function of the surface area of end of the
micro-tip using equation 2.1 where P: power, m: mass, c: specific heat
capacity of water, T: temperature, t: time and SA: tip surface area. The
surface area was calculated from the tip diameter which was measured
with callipers. The measured intensities are reported in Table 2.1 and













Table 2.1: Ultrasonic intensities calculated from thermal calorimetry
data for generator B.
2.1.2 Air filled lysozyme microspheres
Figure 2.1 shows the experimental set up for microsphere production
used with generator B in the laboratories at Bath (which was identical
to the set up used with generator A in the laboratories at Melbourne).
The tip of the horn was placed at the solution-air interface in order to
maximise foaming, promoting microsphere formation. If the protocol
is carried out with the tip submerged in the protein solution then
microsphere production is negligible. The large scale photograph
in figure 2.1 was taken during sonication and shows the foaming
achieved with the tip positioned at the interface.
Figure 2.1: Experimental apparatus for microsphere production, horn
transducer attached to generator B and the microsphere
suspension during sonication.
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In a 15 mL plastic centrifuge tube, 50 mg of lysozyme was dissolved in
1 mL of 50 mM pH 8 tris(hydroxymethyl)aminomethane (tris) buffer
and left to stand for 1 hour. 30 mg of DL-dithiothreitol (DTT) was
added to the lysozyme solution and left to stand at 22 °C for 2 minutes.
The horn tip was placed at the air:water interface and the solution was
sonicated at 7, 14, 29 or 45 Wcm-2 for the required time (15-60 s). After
sonication the solution was diluted up to 14 mL with deionised water
and left to stand overnight. The microspheres formed were washed by
replacing the deionised water 5 times at 6 – 24 hour intervals.
2.1.3 Tetradecane filled lysozyme microspheres
In a 15 mL plastic centrifuge tube, 50 mg of lysozyme was dissolved in
1 mL of 50 mM pH 8 Tris buffer and left to stand for 1 hour. 30 mg of
DTT was added to the lysozyme solution and left to stand at 22 °C for
2 minutes. 100 mL of tetradecane was layered on top of the lysozyme
solution. The horn tip was then placed at the oil:water interface and
the solution was sonicated at 7, 14, 29 or 45 Wcm-2 for the required
time (15-60 s). After sonication the solution was diluted up to 14 mL
with deionised water and left to stand overnight. The microspheres
formed were washed by replacing the deionised water 5 times at 6 –
24 hour intervals. For the encapsulation studies tetradecane saturated
with nile red was used.
The yield of tetradecane filled microspheres was estimated by imaging
an accurately measured volume of microsphere suspension by optical
microscopy. The number of microspheres in the micrographs taken
was scaled to represent the contents of the coverslip and in turn the to-
tal population of microspheres produced. The extent of encapsulation
was estimated from the mean diameter of the microspheres measured
and the estimated microsphere population.
2.1.4 High speed video imaging
The video footage was collected according to the method reported by
T.J. Tiong118. “A high-intensity white light connected to a fibre-optic
tube was used to shine through a 3.5 mL cuvette without giving out
much heat as compared to a xenon light source. The light source used
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for our experiment was a Solarc®-powered metal-halide light (Everest
VIT, ELSV-60 light source operating at 90-240 VAC 50-400 Hz, 1 A (@
120 VAC). The experiments were performed by using a high speed
video camera (Photron FASTCAM Digital Video Recorder (DVR)),
mounted onto a Navitar 18-108 mm zoom lens with an aperture value
of f2.8. The videos were captured at 1000 frames per second, so as
to obtain a good resolution per frame rate ratio for all the files taken.
Videos were exported out on two different formats: Bitmap (.bmp)
and Audio Video Interleave (.avi) for both image frames and videos
respectively”118. Microsphere preparation was carried out as per the
standard protocol but in a 3.5 mL cuvette to facilitate filming of the
microspheres.
2.1.5 Fluorescent staining of air filled lysozyme
microspheres
500 mL of air filled microspheres in aqueous suspension were added to
a concentrated aqueous solution of Fluorescein isothiocyanate isomer
1 and left to stand for 10 minutes.
2.1.6 SEM sample preparation
Scanning electron microscopy (SEM) micrographs were taken at the
SEM facility (FEI Quanta) in the Bio 21 Institute, University of
Melbourne. Samples were prepared for SEM by first drying in air on
a SEM stub covered with carbon tape and then sputter coating with a
thin film of gold.
2.1.7 Incubation of air filled lysozyme microspheres
with DTT
A sample of air filled microspheres was made according to the
procedure in section 2.1.2. A 1 mL aliquot of concentrated microsphere
suspension was collected from the surface of the washed solution and
placed in a plastic vial. 60 mg of DTT was added to the suspension; the
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suspension was shaken gently and left to stand at room temperature
for 24 hours.
2.1.8 Homogenisation of aqueous lysozyme solution
A 50 mg/mL solution of lysozyme solution in 50 mM tris buffer
was treated with 30 mg/mL DTT at 22 °C for 2 minutes and then
homogenised at 24000 rpm for 1 minute at the air:water interface with
a IKA T18 basic Ultra-turrax homogeniser.
2.1.9 tert-butanol radical trapping
Air filled lysozyme microspheres were synthesised according to the
procedure in section 2.1.2. Directly prior to sonication (after treatment
with DTT) 10 mL of tert-butanol was charged to the lysozyme solution.
The solution was sonicated for 1 min at 14 Wcm-2.
2.1.10 Superoxide radical trapping
Air filled lysozyme microspheres were synthesised according to the
procedure in section 2.1.2. Directly prior to sonication (after treat-
ment with DTT) a prescribed portion of 0.1599 mg/mL superoxide
dismutase (SOD) in 0.1 M phosphate buffer at pH 7.5 was added to the
lysozyme solution. The solution was sonicated for 1 min at 14 Wcm-2.
2.1.11 Sonochemiluminescence imaging with luminol
The distribution of the cavitation cloud produced by the horn and
microtip attached generator B was mapped by photographing (in a
dark box) the sonochemiluminescence generated in a luminol solution
when sonicated. Luminol solution: 1 mM luminol and 0.1 mM
Ethylenediaminetetracetic acid (EDTA) in aqueous solution buffered
to pH 12 with sodium hydroxide. 0.1 mM of hydrogen peroxide
was added to the solution immediately prior to sonication. A Canon
EOS 500D camera was used with a 60 mm EF-S macro lens. Camera
settings: F2.8, ISO 3200, focal length: 20 cm, exposure: 30 s.
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2.1.12 Measurement of Sonoluminescence
The experimental setup used for this experiment was that used by
Lee et al.119 200 mL of MilliQ water (18.2 MΩ·cm) was placed in a
cylindrical Pyrex cell which was mounted over a 35 mm 236 kHz
flat plate unfocused transducer. The transducer was connected to a
236 kHz generator (Undatim Ultrasonics D-reactor). The power was
adjustable between 0 and 100 W. The generator had been modified
in-house to allow pulsed energy delivery so that both the pulse on and
off time could be varied. For this investigation the acoustic pulse was
fixed at 4 ms on and 12 ms off. The power amplitude used was 40 %.
An end on photomultiplier tube (Hamamatsu model No. R647-04) was
used to record the sonoluminescence intensity. The output from the
photomultiplier was fed to a digital oscilloscope (Tektronix, model no.
TDS 320). The oscilloscope was triggered by the ultrasound generator
and recorded the signals at set time intervals. The equipment was set
up within a light proof box. For the first experiment air saturated
water was used. For the second the water was degassed under a
vacuum for 20 minutes before sonication. In the final experiment 2
mL of a concentrated suspension of air filled microspheres was added
to the degassed water before sonication.
2.1.13 Synthesis of PMASH
10 g of 30 wt% PMA sodium salt solution (4 kDa) (0.83 mmol of
PMA) was diluted into 200 mL of 0.1 M pH 7.2 phosphate buffer
in a 500 mL round bottomed flask. 2.8 g (18 mmol) of N-ethyl-N´-
(3-dimethylaminopropyl)carbodiimide (EDC) and 2.0 g (18 mmol) of
N-hydroxysuccinimide (NHS) were charged to the solution and the
solution was allowed to stir for 15 minutes. 2.1 g (18 mmol) of
cysteamine HCl was charged to the solution. The solution was left
to stir overnight at room temperature. The reaction solution was
dialysed for 5 days in deionised water. The polymer was then isolated
using a rotary evaporator, re-dissolved in a small volume of deionised
water and precipitated in a 10x excess of 1:1 methanol:diethyl ether.
The precipitated polymer was collected by vacum filtration and dried
under a vacuum at 40 °C. Yield: 2.43 g (20%). 1H-NMR (250 MHz, D2O)
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δ: 0.84 (3H, br m), 1.12 (br t), 1.56 (1H, br m), 1.96 (1H, br m), 2.90 (2H,
br m), 3.06 (br m), 3.20 (br d), 3.28 (br t), 3.46 (br t), 3.55 (2H, br m), 3.86
(br t) ppm.
2.1.14 PMASH tetradecane or perfluorohexane filled
microspheres
A 50 mg/mL solution of PMASH (prepared according to the procedure
in section 2.1.13) was made up in 1 mL of 50 mM pH 8 Tris buffer. 50
mL of tetradecane or perfluorohexane was placed in a layer on top of
the PMASH solution. The horn tip was then placed at the oil:water
interface and the solution was sonicated for 60 s at 14 Wcm-2. After
sonication the solution was diluted up to 14 mL with deionised water
and left to stand overnight. The microspheres formed were washed by
replacing the deionised water 5 times at 6 – 24 hour intervals.
2.1.15 Homogenisation of PMASH
A 50 mg/mL solution of PMASH in 50 mM Tris buffer was acidified to
form a small amount of fine white precipitate and then homogenised at
24000 rpm at the air:water interface with a IKA T18 basic ultra-turrax
for 1 minute.
2.1.16 Surface tension measurements
The surface tension of lysozyme and PMASH solutions were measured
using an Attension Sigma701 tensiometer (KSV Instruments) fitted
with a Du Noüy ring. All solutions were prepared in deionised
water (Milli Q, 18.2 MΩ·cm). The surface tension was measured
continuously in a cyclical manner until a constant value was reached.
In the case of denatured lysozyme the solution was treated with 30
mg/mL DTT for two minutes directly prior to measurement.
2.1.17 Effect of external pH
PMASH microspheres were produced from a 40 mg/mL solution of
PMASH in tris buffer according to the method described in section
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2.1.14 and left to stand overnight. 100 µL of microsphere suspension
was mixed with 200 µL of 100 mM phosphate buffer at pH 4,5,6,7,8 or
9, left to stand for 2 hours and observed under the optical microscope.
2.1.18 Release of nile red from lysozyme microspheres
Lysozyme microspheres were formed from 50 µL of nile red saturated
tetradecane using the method described in section 2.1.2, sonicating at
14 Wcm-2 for 1 minute. The batches of microspheres were dialysed
into 10 mL of deionised (MilliQ, 18.2 MΩ·cm) water or DMSO for
24 hours. The microspheres were then broken by sonication at 40
Wcm-2 for 2 minutes and returned to the dialysis system for a further
24 hours. Samples were taken from the dialysis receptor before and
after sonication. In the aqueous dialysis the samples were freeze dried
and the residues re-dissolved in DMSO. The samples were analysed
for nile red concentration by fluorescence intensity, ex: 550 nm, em:
630 nm. The fluorescence intensities measured were within the linear
range established upon calibration with standard DMSO solutions of
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Figure 2.2: Fluorescence calibration plot for nile red in DMSO
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2.1.19 Release of sudan III from PMASH microspheres
PMASH microspheres were formed from a 50 mg/mL solution of
PMASH with 50 µL of tetradecane saturated with sudan III according
to the method described in section 2.1.14, sonicating at 14 Wcm-2 for
1 minute. The microsphere suspensions were treated either with 60
mg/mL DTT, or sonication at 40 Wcm-2 for 2 minutes, or acidification
to pH 1 with HCl or pH 14 with NaOH. The released oil phase
was extracted into 2 mL of isopropyl mysristate (IPM) by gentle
shaking of the two phases together for two minutes, the IPM phase
was then immediately removed. The concentration of sudan III was
quantified by UV/VIS spectroscopy, the linear range of absorbance
was established from standard solutions of sudan III in IPM, ε: 0.0267
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Figure 2.3: UV/VIS calibration plot for sudan III in IPM
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2.2 Chapter 3: Thiol-ene chemistry
All chemicals used were purchased from Sigma Aldrich and used as
received (with the exception of 2,2-diphenyl-1-picryhydrazyl which
was purchased from Fluka).
Samples for absorbance were measured using an Agilent 8453 UV-
Visible Spectrophotometer with a quartz cuvette, path length: 1 cm.
Samples for fluorescence were measured using a Gilden Photonics
FluoroSENS fluorimeter with a polystyrene cuvette.
The ultrasound generators used were a Sonics and Materials VC600
generator (20 kHz / 600W) (generator B) connected to an ultrasound
horn fitted with a micro-tip (3 mm diameter) and a Sonic Systems So-
nic Processor L500-20 generator fitted with a 20 kHz Horn attachment
(generator C). The generator was calibrated for ultrasonic intensity
at each arbitrary power level according to the method described in
section 2.1.1, see Table 2.2.






Table 2.2: Ultrasonic intensities calculated from thermal calorimetry
data for generator C.
Bruker Avance 250 and 400 MHz NMR spectrometers were used to
collect the 1H-NMR spectra.
Samples for GC and GCMS analysis were prepared by taking a 300
mL sample from the reaction which was made up to 1500 mL with
methanol diluent.
GC method: Samples were analysed for % conversion on an Agilent
6890N Network GC System using the following method: Injection
volume: 1.0 mL, N2 carrier gas, Split Ratio: 50.0, Flow rate: 2 mL/min,
FID detector temperature: 300 °C, Column: Agilent 19091J-413 HP-5
5% Phenyl Methyl Siloxane 300 m x 320 mm x 0.25 mm, Temperature
program: starting temperature; 50 °C, ramp: 40 °C/min to 70 °C (hold
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for 0.25 min), ramp: 60 °C/min to 85 °C, ramp 15 °C/min to 100 °C,
ramp 100 °C/min to 300 °C (hold for 4 min).
Alkene Alkene RT / min Thioether RT / min
Norbornene 2.17 5.32




Allyl amine 1.82 n/a
Allyl butyl ether 2.38 5.45
Table 2.3: GC retention times (RT)
GC-MS method: Thioether products were identified by GCMS ana-
lysis using an EI-MS Agilent 5975C inert MSD Triple Axis Detector
coupled to an Agilent 7890A GC System with a HP 5MS 30 m x 25 mm
x 0.25 mm column: carrier gas: He, flow rate: 2 mL/min, split ratio:
10:1, inlet temperature: 300 °C, oven temperature ramp: 20 °C/min
from 70 °C to 230 °C, FID: 300 °C, MS Source 230 °C, MS Quad 150 °C.
Alkene Alkene RT Thioether RT
/ min / min
Norbornene 2.7 9.8




Allyl amine 1.65 n/a
Allyl butyl ether 3.7 10.0
Table 2.4: GCMS retention times (RT)
2.2.1 DPPH dosimetry
Radical production was quantified using a 0.08 mM solution of
2,2-diphenyl-1-picryhydrazyl (DPPH) in toluene. In the sonochemical
case a 4 necked pear shaped flask was assembled with the ultrasound
horn connected to generator C. 90 mL of DPPH solution and the
prescribed amount of 2,2’-Azobis(2-methylpropionitrile) (AIBN) were
then charged to the flask. The solution was purged with nitrogen for
45 minutes at a moderate flow. The solution was cooled to 24 °C
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with a constant water flow. The nitrogen flow was then reduced to
a slow flow in order to maintain a positive pressure of nitrogen in the
flask. The solution was sonicated for 20-60 minutes at an intensity
of 17 W/cm-2. Samples were taken at periodic time intervals and the
absorption was measured at a wavelength of 520 nm, all samples taken
were within a linear concentration range for absorbance, ε: 1.135 mol-1
dm3 cm-1, Figure 2.4.
In the thermal case the glassware was assembled as in the protocol
detailed below. 25 mL of DPPH solution was charged to the flask and
the solution was purged with nitrogen for 15 minutes. The solution
was then heated to 50 °C. When at 50 °C, the prescribed amount
of AIBN was charged as a solution in 5 mL of toluene. Samples
were taken periodically over a 10 minute period and the absorbance



























Figure 2.4: UV/VIS DPPH calibration in toluene at 520 nm.
2.2.2 Terephthalic acid dosimetry
Radical mediated production of fluorescent 2-hydroxyterephthalic
acid (HTA) from an aqueous solution of terephthalic acid (TA) can
be used to gain a measure of relative rates of radical production in
thermal and sonochemical systems. HTA production, and therefore,
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the change in solution fluorescence is directly proportional to radical
production in a given system. Comparison of the rate of change of
fluorescence in different systems can be used as a means to compare
the radical production in those systems.
In order to conduct the sonochemical dosimetry 85 mL of a 0.0002
M solution of TA in pH 8 phosphate buffer and 0.04 g (0.15 mmol,
1.75 mM) of potassium persulfate were charged to the 4 necked
pear shaped flask (assembled with the ultrasound horn connected
to generator C). The solution was cooled to 24 °C with a constant
water flow. The solution was sonicated for 60 minutes at an intensity
of 17 W/cm-2. Samples were taken at periodic time intervals and
fluorescence was measured using an excitation frequency of 310 nm
and an emission frequency of 410 nm.
The thermal dosimetry was conducted in a similar manner using the
apparatus described below. 20 mL of 0.0002 M TA solution in pH 8
phosphate buffer was heated to 45 °C and 0.012 g (0.04 mmol, 1.75
mM) of potassium persulfate in 5 mL of TA solution was then charged
to the flask. Samples were taken periodically over a 60 minute time
period and the fluorescence of each sample was measured as above.
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Figure 2.5: Calibration of the fluorescence 2-hydroxyterephthalic acid
in aqueous solution.
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2.2.3 Sonochemical protocol in toluene with AIBN
85 mL of toluene and 0.3 g (18 mmol., 0.03 molar eq.) of AIBN were
charged to a 3 necked pear shaped jacketed flask which fitted the
ultrasound horn assembly for generator C. The flask was fitted with
a thermocouple and the jacket was cooled to 24 °C with a constant
water flow. The flask was covered to protect it from ambient UV
light. The flask was sealed and purged with nitrogen for 45 minutes
on a moderate flow rate. After purging a slow flow of nitrogen was
maintained. 55 mmol (limiting reagent) of alkene and 9 mL (83 mmol,
1.5 molar eq.) of 1-butanethiol were charged to the reaction flask by
injection. The reaction was then sonicated at an intensity of 17 Wcm-2
for 4 hours. Regular samples were taken during the reaction time and
analysed by GC and GC-MS (see details above). Control reactions
were carried out according to this procedure but omitting the AIBN
charge.
2.2.4 Optimised sonochemical reaction conditions for
butyl-vinyl-ether in toluene with AIBN:
The reaction was conducted according to the protocol described in
section 2.2.3, but with a higher ultrasound intensity (21 Wcm-2) and
the following reagent charges: 7.2 mL (55 mmol, limiting reagent) of
butyl vinyl ether, 30 mL (278 mmol, 5 molar eq.) of 1-butanethiol, 0.9
g (54 mmol, 0.09 molar eq.) of AIBN and 50 mL of toluene.
2.2.5 Thermal protocol in toluene with AIBN
25 mL of toluene was charged to a 2 necked 50 mL round bottomed
flask fitted with a thermometer and a magnetic stirrer hot plate
assembly. The flask was covered to protect it from ambient UV light.
The flask was then sealed and purged with nitrogen for 15 minutes
on a moderate flow rate. After purging, a slow flow of nitrogen was
maintained and the flask was heated to 50 °C. Once the solvent was at
50 °C, 6.6 mmol (limiting reagent) of alkene and 9.9 mmol (1.5 molar
eq.) of 1-butanethiol were charged to the flask. The reaction was
started by charging 0.025 g (0.15 mmol, 0.02 molar eq.) of AIBN in 5
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mL of toluene to the reaction. The reaction was allowed to proceed
for 2 hours. Regular samples were taken during the reaction time
and analysed by GC and GC-MS. Control reactions were carried out
according to this procedure but omitting the AIBN charge.
2.2.6 Sonochemical protocol in water with potassium
persulfate
85 mL of de-ionised water, 6.6 mmol (limiting reagent) of alkene, 0.04
g (0.15 mmol., 0.02 molar eq.) of potassium persulfate (K2S2O8) and
3.75 g (33 mmol., 5 molar eq.) of cysteamine HCl were charged to a
3 necked pear shaped jacketed flask which fitted the ultrasound horn
assembly for generator C. The flask was fitted with a thermocouple
and the jacket was cooled to 24 °C with a constant water flow. The
flask was covered to protect it from ambient UV light. The reaction
was then sonicated at an intensity of 17 Wcm-2 for 2 hours. Regular
samples were taken during the reaction time, quenched into 2 wt%
hydroquinone solution in D2O to prevent any further reaction and
analysed for conversion by 1H-NMR. Control reactions were carried
out according to this procedure but omitting the potassium persulfate
charge.
2.2.7 Thermal protocol in water with potassium
persulfate
25 mL of deionised water, 1.95 mmol. (limiting reagent) of alkene,
1.12 g (9.86 mmol., 5 molar eq.) of cysteamine HCl and 0.012 g (0.04
mmol 0.02 molar eq.) of K2S2O8 was charged to a 2 necked 50 mL
round bottomed flask fitted with a thermometer and a magnetic stirrer
hot plate assembly. The flask was covered to protect it from ambient
UV light. The flask was heated to 45 °C. The reaction was allowed to
proceed for 2 hours. Regular samples were taken during the reaction
time, quenched into 2 wt% hydroquinone solution in D2O to prevent
any further reaction and analysed for conversion by 1H-NMR. Control
reactions were carried out according to this procedure but omitting the
K2S2O8 charge.
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Alkene Alkene CH2(ppm) Thioether CH2(ppm)
4-pentenoic acid 5.8 (2H, m) 1.5 (2H, m)
3-allyloxy-2-hydroxy- 5.9 (1H, dd) 1.8 (2H, m)
1-propanesulfonic acid
N-isopropylacrylamide 5.6 (1H, dd) 2.4 (2H, t)
Allyl alcohol 5.9 (1H, dd) 1.8 (2H, m)
Acrylamide 6.2 (2H, d) 2.5 (2H, t)
Allyl amine 5.8 (2H, m) 3.2 (2H, t)
Table 2.5: 1H-NMR Marker peaks.
2.2.8 PMAene synthesis
10 g of 30 wt% PMA sodium salt solution (4 kDa) (0.83 mmol of
PMA) was diluted into 200 mL of 0.1 M pH 7.2 phosphate buffer
in a 500 mL round bottomed flask. 2.8 g (18 mmol) of N-ethyl-N´-
(3-dimethylaminopropyl)carbodiimide (EDC) and 2.0 g (18 mmol) of
N-hydroxysuccinimide (NHS) were charged to the solution and the
solution was allowed to stir for 15 minutes. 1.4 mL (18 mmol) of
allyl amine was charged to the solution. The solution was left to stir
overnight at room temperature. The reaction solution was dialysed
for 5 days in deionised water. The polymer was then isolated using a
rotary evaporator, re-dissolved in a small volume of deionised water
and precipitated in a 10x excess of 1:1 methanol:diethyl ether. The
precipitated polymer was collected by vacuum filtration and dried
under a vacuum at 40 °C. Yield: 0.3 g (3%). 1H-NMR (400 MHz, D2O)
δ: 0.88 (3H, br m), 1.09 (t), 1.60 (1H, br m), 1.85 (1H, br m), 2.56 (s),
2.785 (s), 3.26 (q), 3.48 (d), 3.69 (2H, br m), 5.09 (2H, br m), 5.36 ppm
(1H, br m).
2.2.9 PMAene/DTT microsphere production
50 mg of PMAene was made up in 1 mL of pH 8 50 mM tris buffer,
35 mg (0.23 mmol, 2 mol. eq.) of DTT was charged to the solution
and the solution was then sonicated at 14 Wcm-2 for 30 s with 100 µL
of tetradecane (using generator B). After sonication the solution was
diluted up to 14 mL with deionised water and left to stand overnight.
The microspheres formed were washed by replacing the deionised
water 5 times at 6 – 24 hour intervals.
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2.3 Chapter 4: Water in oil emulsion filled
microspheres
All chemicals were purchased from Sigma Aldrich and were used as
received. Generator B was used in the microsphere synthesis and
release studies.
Dynamic light scattering (DLS) studies were carried out using a
Malvern Nano-S instrument.
Optical micrographs were captured using a GX optical L3001 mi-
croscope fitted with an Infinity 2 camera. Laser scanning confocal
microscopy experiments were carried out using a Zeiss LSM 510
META microscope.
Fluorescence experiments were carried out using a Spectrostar Omega
plate reader (BMG Labtech) with NUNC 12 plates, the cycle time was
299s, 20 flashes per cycle with double orbital shaking at a frequency of
300 rpm for 289 s after each cycle, excitation filter; 485 nm, emission
filter; 520 nm.
A Mettler Toledo Seven Easy conductivity meter was used to carry
out the conductivity measurements together with a Techne Tempette
Junior TE-8J water bath.
HPLC method for 5FU: Dionex machine (Sunnyvale, CA, USA).
Column: HiQ Sil C18HS 250×4.6 mm, Flow rate: 0.7 mL/min,
Mobile phase: 40:60 methanol:water, Temperature 25 ºC, UV detection
wavelength: 265 nm, Injection volume: 20 µL, Run time: 15 minutes,
5-fluorouracil retention time: 4.7 - 4.9 min.
2.3.1 w/o emulsion preparation
An oil phase of tetradecane containing Span 80® and an aqueous
phase of pure water or sodium chloride solution were sonicated at the
oil : water interface at a power of 45 Wcm-2. The initial experiments
covered a variety of different conditions, the following optimised
conditions were chosen for later experiments: oil phase: 4 wt% Span
80® in tetradecane, aqueous phase: 1 M NaCl(aq), emulsion: 40%
aqueous phase, sonication time: 5 minutes.
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2.3.2 Dynamic Light Scattering (DLS)
Water in oil emulsions were prepared as detailed in section 2.3.1 then
diluted to achieve a 4 wt% water fraction. The Span 80® concentration
in the diluent tetradecane was matched to the Span 80® concentration
in the w/o continuous phase. Samples were measured in a 4 mL
polystyrene disposable cuvette.
2.3.3 w/o emulsion filled lysozyme microspheres
In a 15 mL plastic centrifuge tube, 50 mg of lysozyme was dissolved
in 1 mL of 50 mM pH 8 Tris buffer and left to stand for 1 hour. 30
mg of DTT was charged to the lysozyme solution and left to stand
for 2 minutes. 100 mL of freshly prepared w/o emulsion was layered
on the surface of the lysozyme solution. The horn tip was placed at
the emulsion:water interface and the system was sonicated for 30 s
at 14 Wcm-2. After sonication the suspension was diluted to 15 mL
with deionised water and left to stand overnight. If required, the
suspension of microspheres was washed, by sequential re-dilution of
the creamed suspension in clean deionised water.
2.3.4 w/o emulsion filled PMASH microspheres
In a 15 mL plastic centrifuge tube, 50 mg of PMASH was dissolved in 1
mL of 50 mM pH 8 Tris buffer, the solution was slightly acidified. 100
mL of freshly prepared w/o emulsion was layered on the surface of the
lysozyme solution. The horn tip was placed at the oil:water interface
and the system was sonicated for 30 s at 14 Wcm-2. After sonication
the suspension was diluted to 15 mL with deionised water and left
to stand overnight. If required, the suspension of microspheres
was washed by sequential re-dilution of the creamed suspension
in clean deionised water. Samples for confocal microscopy were
prepared using a w/o emulsion in which the tetradecane phase was
saturated with nile red and/or the aqueous phase contained 1 mM
5(6)-carboxyfluorescein.
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2.3.5 Laser Scanning Confocal Microscopy
The LSCM experiments were carried out using a Zeiss LSM 510 META
microscope. The samples were prepared as per the protocols in section
2.3.3 and 2.3.4 with 1 mM carboxyfluorescein solution in 10 mM
HEPEs buffer as the internal aqueous phase and 4 wt% Span 80®
tetradecane saturated with nile red as the oil phase. In analysis of
the micrographs gathered co-localised pixels with an intensity greater
than 100 grays were removed, leaving an image that showed only
those pixels which were not colocalised.
2.3.6 Release of 5(6)-carboxyfluorescein
These experiments were carried out using a Spectrostar Omega Plate
reader (BMG Labtech). NUNC 12 plates were used and the machine
settings were as follows: cycle time; 299 s, 20 flashes per well and cycle,
double orbital shaking with a frequency of 300 rpm for 289 s after
each cycle, excitation filter; 485 nm, emission filter; 520 nm. The fluo-
rescence intensity was calibrated to carboxyfluorescein concentration
using carboxyfluorescein solutions made up in 10 mM HEPEs buffer.
Experiments were conducted within this concentration range that had
a linear relationship with fluorescence intensity. Microsphere samples
were prepared according to the protocol detailed in sections 2.3.3 and
2.3.4 using a w/o emulsion containing 50 mM 5(6)-carboxyfluorescein
in 10 mM HEPEs buffer. The microsphere suspension was washed
once before the release experiment was carried out. Release was
monitored using the fluorescence plate reader, each well contained
50 mL of microsphere suspension in 2 mL of HEPES buffer with the
prescribed amount of DTT. Fluorescence was measured at 5 minute
intervals over a 12 hour time period, during which time the plate was
incubated at 37 °C. Each DTT concentration was run in triplicate.
In the case of mechanical breakdown by ultrasound (45 Wcm-2),
triplicate 50 mL samples were taken from the microsphere suspension
at chosen time points and diluted for measurement on the plate reader
as described above. For both experiments the fluorescence measured
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Figure 2.6: Fluorescence calibration plot for 5(6)-carboxyfluorescein in
HEPEs buffer
2.3.7 Release of sodium chloride
Microsphere samples were prepared according to the protocol detailed
in section 2.3.3 using a w/o emulsion containing a 6.1 M solution of
NaCl. For each experiment the microsphere suspension was diluted
to exactly 10 mL using deionised water (MilliQ 18.2 MΩ·cm). The
suspension temperature was equilibrated to 25 ± 0.5 °C using a water
bath prior to each conductivity measurement. The conductivity of the
freshly prepared suspension was measured, the microspheres were
then sonicated for 2 minutes at 45 Wcm-2 to cause rupture. The
conductivity of the degraded suspension was measured. Control
samples were treated in an identical manner. The first control was
carried out using oil filled microspheres formed according to the
protocol above but with 100 mL of tetradecane in place of the primary
emulsion phase. The second control was carried out using identical
oil filled microspheres but the suspension was doped with 40 mL
of 6.1 M NaCl solution prior to the first conductivity measurement.
Experiments were carried out on each sample type in triplicate and
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Figure 2.7: Calibration plot for NaCl in MilliQ water
2.3.8 Release of 5FU
Microsphere samples were prepared according to the protocol detailed
in section 2.3.3/4 using a w/o emulsion containing a 0.1 M solution
of 5-Fluorouracil in 1 M sodium chloride solution. Release was
measured directly after formation via dialysis into 10 mL of MilliQ
water (18.2 MΩ·cm), samples were taken directly from the receptor. A
schematic diagram of the experimental set up is shown in Figure 2.8.
Release by incubation with DTT was achieved by adding the required
amount of DTT to the receptor. In order to measure release upon
sonochemical breakdown the microsphere sample was sonicated for
a chosen time period before returning it to the dialysis for 30 minutes,
after which time a sample was taken from the receptor. The procedure
was repeated to achieve the cumulative sonication time reported.
The 5FU concentrations in the samples collected were measured by
HPLC, method detailed at the start of this section. A linear range
was established with standard solutions of 5FU, Figure 2.9. Limit of
detection: 0.34 µg/mL, limit of quantification: 1.04 µg/mL.
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Figure 2.8: Schematic of the experimental set up used to carry out the
dialysis described in section 2.3.8; (a) receptor medium, (b)
skirted 100 mL centrifuge tube sealed with film or a lid (c),
(d) 2 mL capped centrifuge tube with its lid hollowed out
so that it acts only to hold the dialysis membrane in place,
(e) microsphere suspension (where the initial release of 5FU
occurs due to rupture of the microspheres), (f) transfer of




















Figure 2.9: HPLC calibration Plot for 5FU in MilliQ water
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2.4 Chapter 5: Responsive polymers and
microspheres
All reagents were purchased from Sigma Aldrich.
N-isopropylacrylamide (NIPAm) was recrystallised from
toluene/hexane (6:4). tert-butyl methacrylate (tBMA) was purified
from its inhibitor using an inhibitor removal column supplied by
Sigma Aldrich and used immediately and methacrylic acid (MA) was
vacuum distilled to purify it from its inhibitor and used immediately.
All other reagents were used as received. All glassware was oven
dried at 80 °C prior to use.
1H-NMR spectra of the polymers were obtained using Bruker Avance
250, 300 and 400 MHz NMR spectrometers. DOSY NMR spectrometer
experiments were performed using the 400 MHz Bruker Avance NMR.
The DOSY spectra were acquired using the ledbpgp2s pulse program
provided with the Bruker topspin software The gradient strength was
incremented in 8 steps from 5 to 95% of the total gradient strength. The
gradient pulse length was set at 4 ms to ensure full signal attenuation
and the relaxation delay was 5 s (5 x T1 relaxation). The probe head
temperature was kept at 298 K during the experiments. The data set
was processed using the dosy2d program provided with the Bruker
topspin software.
Polymer molecular weights and weight distributions were obtained
using a Varian PL-GPC 50 Plus system using THF solvent, calibrated
with 12 polystyrene standards with Mns ranging from 1060 - 2650000.
Optical micrographs were captured using a GX optical L3001 mi-
croscope fitted with an Infinity 2 camera. Laser scanning confocal
microscopy (LSCM) was carried out using a Zeiss LSM 510 META
microscope at the University of Bath Microscopy and Analysis Suite.
Dynamic light scattering experiments were carried out using a
Malvern Zetasizer Nano ZS machine. Sonication protocols used a
Sonics and Materials VC600 generator (20 kHz / 600W) (generator
B) connected to an ultrasound horn fitted with a micro-tip (3 mm
diameter).
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CTA1: 4-cyano-4-(phenylcarbonothioylthio) pentanoic acid, CTA2:
S-(Thiobenzoyl) thio glycolic acid, CTA3: 2-cyano-2-propyl dodecyl
trithiocarbonate.
2.4.1 Synthesis of P(tBMA) with CTA1
12.5 mg (0.045 mmol, 0.25 mol. eq.) of 4,4-Azobis(4-cyanovaleric
acid) (ABCV) and 50 mg (0.179 mmol, limiting reagent (LR)) of
CTA1 were charged to the reaction flask and deoxygenated by five
vacuum-nitrogen purge cycles. In a separate flask 6.36 g (44.74 mmol,
250 mol. eq.) of tBMA and 2.5 mL of 1,4 dioxane were purged for
15 minutes with nitrogen. The monomer solution was charged to the
reaction flask using a nitrogen flushed syringe and the reaction was
heated to 85 ºC with stirring for 17 hours. The polymer was isolated
by precipitation into a 10 fold excess of cold methanol/water (1:1 ratio)
and characterised by GPC and 1H-NMR: Mn: 33.1 kDa, Mw: 42.2 kDa,
ÐM: 1.28. 1H-NMR (250 MHz, CDCl3) δ: 0.97 (3H, br m), 1.35 (9H, br
s), 1.83 ppm (2H, br m). Protocol carried out as part of an attempted
one-pot diblock synthesis so no yield reported.
2.4.2 Synthesis of PNIPAm with CTA1
12.5 mg (0.045 mmol, 0.25 mol. eq.) of ABCV, 50 mg (0.179 mmol,
LR) of CTA1 and 5 g (44.74 mmol, 250 mol. eq.) were charged to
the reaction flask and deoxygenated by five vacuum-nitrogen cycles.
In a separate flask 2.5 mL of 1,4-dioxane was purged with nitrogen
for 15 minutes. The solvent was charged to the reaction flask with a
nitrogen flushed syringe and heated to 85 ºC for 17 hours. A sample of
the polymer was isolated by precipitation into a 10 fold excess of cold
diethyl ether and characterised by GPC and 1H-NMR: Mn: 3.2 kDa,
Mw: 5.4 kDa, ÐM: 1.67. 1H-NMR (250 MHz, CDCl3) δ: 1.07 (6H, br
s), 1.58 (br m), 1.75 (br m), 2.08 (br m), 2.50 (2H, br m) 3.94 ppm (1H,
br m). Protocol carried out as part of an attempted one-pot diblock
synthesis so no yield reported
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2.4.3 Synthesis of PMA with CTA1
The methacrylic acid was purified by vacuum distillation at 50 ºC. 3.85
g (44.74 mmol, 250 mol. eq.) of methacrylic acid, 50 mg (0.179 mmol,
LR) of CTA1, 12.5 mg (0.045 mmol, 0.25 mol. eq.) of ABCV and 15
mL of dry methanol were charged to the reaction flask. The flask was
deoxygenated with four freeze-pump-thaw cycles under argon before
heating to 65 ºC for 19 hours. The polymer formed was precipitated
into a 10 fold volume excess of cold diethyl ether. The precipitate was
collected by filtration and dried under vacuum at 50 ºC. Yield: 120 mg
(3.1%). The product was characterised by1H-NMR (250 MHz, D2O) δ:
0.91 (3H, br m), 1.85 (2H, br m).
2.4.4 Synthesis of PMA with CTA2
The methacrylic acid was purified by vacuum distillation at 50 ºC.
4.24 g (29.8 mmol, 100 mol. eq.) of methacrylic acid, 126.5 mg (0.58
mmol, LR) of CTA 2, 42 mg (0.15 mmol, 0.25 mol. eq.) of ABCV and 30
mL of dry methanol were charged to the reaction flask. The flask was
deoxygenated with four freeze-pump-thaw cycles under argon before
heating to 60 ºC for 10 hours. The polymer formed was precipitated
into a 10 fold volume excess of cold diethyl ether. Yield: 1.28 g (25%).
The product was characterised by1H-NMR (250 MHz, MeOD) δ: 1.11
(3H, br m), 1.90 (2H, br m).
2.4.5 Synthesis of P(tBMA) with CTA3
15 mg (0.089 mmol, LR) of 2,2’-azobis(2-methylpropionitrile) (AIBN)
was charged to the reaction flask and deoxygenated by five vacuum-
nitrogen purge cycles. In a separate flask 6.3 g (44.25 mmol, 500 molar
eq.) of tBMA, 0.122 g (0.35 mmol, 4 molar eq.) CTA3 and 10 mL of
1,4 dioxane were purged with nitrogen for 30 minutes. This solution
was charged to the reaction flask which was sealed and heated to 60 °C
for 15 hours. The polymer was isolated as a yellow amorphous solid
by precipitation into a 10 fold volume of cold methanol/water (1:1).
Yield: 1.90 g (30%). The product was characterized by 1H-NMR and
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GPC: Mn: 6.1 kDa, Mw: 8.3 kDa, ÐM: 1.36. 1H-NMR (300 MHz, MeOD)
δ: 0.96 (3H, br m), 1.38 (9H, br s), 1.78 (2H, br m), 3.31 ppm (2H, t).
2.4.6 Synthesis of PNIPAm in 1,4 dioxane with CTA3
15 mg (0.089 mmol LR) of AIBN and 1 g (8.9 mmol, 100 molar eq.)
of NIPAm were charged to the reaction flask and deoxygenated by
five vacuum-nitrogen purge cycles. In a separate flask 0.122 g (0.35
mmol, 4 molar eq.) of CTA3 and 10 mL of 1,4 dioxane were purged
with argon for 30 minutes. This solution was charged to the reaction
flask which was sealed and heated to 60 °C for 56 hours. Samples
were taken at periodic intervals using an argon flushed syringe and
quenched in ice. The samples were analysed without any purification
step by 1H-NMR for % conversion and by GPC for chain length and
distribution. 1H-NMR (400 MHz, MeOD) δ: 1.17 (6H, br m), 1.61 (2H,
br m), 1.88 (1H, br m), 3.46 (2H, m), 3.99 ppm (1H br m).
2.4.7 Synthesis of PNIPAm in DMSO with CTA3
15 mg (0.089 mmol LR) of AIBN and 1 g (8.9 mmol, 100 molar eq.)
of NIPAm were charged to the reaction flask and deoxygenated by
five vacuum-nitrogen purge cycles. In a separate flask 0.122 g (0.35
mmol, 4 molar eq.) of CTA3 and 10 mL of dry DMSO (dried with
4 Å molecular sieves) were purged with argon for 30 minutes. This
solution was charged to the reaction flask which was sealed and
heated to 70 °C for 5 hours. Samples were taken at periodic intervals
using an argon flushed syringe and quenched in ice. The samples were
analysed without any purification step by 1H-NMR for % conversion
and by GPC for chain length and distribution. 1H-NMR (300 MHz,
DMSO-d6) δ: 1.03 (6H, br m), 1.22 (2H, br m), 1.97 (1H, br m), 3.47 (2H,
m), 3.84 ppm (1H, br m).
2.4.8 Synthesis of P(tBMA-b-NIPAm) with CTA3
3.5 mg (0.01 mmol, LR) of AIBN, 0.5 g (Mn: 6154, 0.08 mmol, 8 molar
eq.) of macro-RAFT agent (PtBMA) and 2.23 g (20 mmol, 1000 molar
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eq.) of NIPAm were charged to the reaction flask and deoxygenated
by five vacuum-nitrogen cycles. In a separate flask 10 mL of 1,4
dioxane was purged with nitrogen for 30 minutes, then charged to the
reaction flask which was sealed and the reaction heated to 60 °C for
20 hours. When the chain length was monitored with reaction time,
the reaction was inerted under argon and samples were taken from
the reaction using an argon flushed syringe, quenched by cooling in
ice and opening to the air. The diblock copolymer was isolated as a
pale yellow amorphous solid by precipitation into a 10 fold volume
of cold methanol/water (1:1). Yield: 2.2 g (80%). The product was
characterized by 1H-NMR and GPC: Mn: 9.5 kDa, Mw: 12.5 kDa, ÐM:
1.31. 1H-NMR (400 MHz, MeOD) δ: 1.08 (3H, br m), 1.17 (6H, br m),
1.31 (br m), 1.49 (9H, br s), 1.60, (2H, br m), 1.87 (1H br m), 2.11 (2H, br
m), 3.46 (2H, m), 3.99 ppm (1H, br m).
2.4.9 Synthesis of P(tBMA-b-NIPAm-b-tBMA) with
CTA3
4 mg (0.01 mmol, LR) of AIBN, 0.5 g (Mn: 10666, 0.05 mmol, 4
molar eq.) of macro-RAFT agent (P(tBMA-b-NIPAm)) and 1.67 g (12
mmol, 1000 molar eq.) of tBMA were charged to the reaction flask
and deoxygenated by five vacuum-nitrogen cycles. In a separate
flask 10 mL of 1,4 dioxane was purged with nitrogen for 30 minutes,
then charged to the reaction flask which was sealed and the reaction
heated to 60 °C for 17 hours. Yield: 30 mg (1.4%). The product was
characterised by 1H-NMR and GPC: Mn: 17.9 kDa, Mw: 23.3 kDa, ÐM:
1.30. 1H-NMR (250 MHz, MeOD) δ: 0.93 (3H, br m), 1.18 (6H, br m),
1.50 (9H, br s), 1.60 (2H, br m), 1.90 (1H, br m), 2.10 (2H, br m), 3.99
ppm (1H, br m).
2.4.10 Hydrolysis of P(tBMA-b-NIPAm)
1.5 g (Mn = 9543, 0.16 mmol, PtBMA DP: 43) of P(tBMA-b-NIPAm)
was dissolved in 25 mL of DCM. 5 mL (65 mmol, 9.5 molar eq.) of
Trifluoroacetic acid was added dropwise to the solution whilst stirring.
The solution was heated to 40 °C (reflux) for 4.5 hours. The DCM
was then removed under vacuum and the resulting polymer was
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dissolved in alkaline aqueous solution. The polymer was recovered
by heating the solution to 50 °C and acidifying to form a precipitate.
The precipitate was filtered and dried under a vacuum. Yield: 0.56
g (41%). The % conversion of the tBMA groups on the polymer was
characterised by 1H-NMR. 1H-NMR (400 MHz, MeOD) δ: 1.16 (6H, br
m), 1.45 (9H, br s), 1.60 (2H, br m), 1.92 (1H, br m), 2.10 (2H br m), 3.99
ppm (1H, br m).
2.4.11 Thiolation of P(MA-b-NIPAm)
0.5 g (Mnth = 7479, 2.4 mmol of MA groups) of P(MA-b-NIPAm) was
dissolved in 10 mL of pH 7 phosphate buffer with 0.07 mL (0.42 mmol,
0.2 mol. eq.) of N-(3-dimethylaminopropyl-N’-ethylcarbodiimide)
(EDC) and 0.05 g (0.042 mmol, 0.2 mol eq) N-hydroxysuccinimide
(NHS) and allowed to stir at room temperature for 15 minutes. 0.38
g (3.34 mmol, 1.5 mol. eq.) of cysteamine HCl was added and the
solution was stirred at room temperature for 7 days. The thiolated
polymer was isolated by removing the aqueous liquors under vacuum.
The polymer was then re-dissolved in methanol and the insoluble
buffer salts were removed by filtration. The polymer was purified
by precipitation from methanol into deionised water at 80 ºC. The
precipitate was collected and dried in an oven overnight at 40 ºC.
Yield: 0.21 g (42%). The LCST was measured using melting point
apparatus and a 10 mg/mL solution of polymer in pH 7 100 mM
phosphate buffer. The LCST of the sample synthesised was 37 ºC.
1H-NMR (400 MHz, D2O) δ: 0.89 (3H, br m), 1.06 (6H, br m), 1.63 (2H,
br m), 1.82 (1H br m), 1.93 (2H, br m), 2.75 (t), 2.79 (2H, br t), 2.94 (t),
3.012 (m), 3.13 (2H br t), 3.32 (t), 3.82 (1H, br m).
2.4.12 Response of P(MASH-b-NIPAm) microspheres to
heating above the LCST, measured by optical
microscopy
The microspheres were formed according to the method described in
section 2.1.14 but using the prepared P(MASH-NIPAm). A sample of
microspheres was imaged by optical microscopy. The sample on the
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microscope slide was then heated to 40 ºC on a hot plate for 10 minutes
before viewing under the microscope again, and then a further 20
minutes before the final image was taken. The same sequence of
images were taken of a sample of PMASH microspheres prepared in
an identical manner.
2.4.13 Response of P(MASH-b-NIPAm) microspheres to
heating above the LCST, measured by LSCM.
The microspheres were formed according to the method described in
section 2.1.14 using nile red saturated tetradecane and the prepared
P(MASH-b-NIPAm). A sample of microspheres was placed in a sample
holder for the confocal microscope and a chosen region was imaged
using the laser scanning mode. The sample was then heated to 43 ºC in
situ using a heated stage and chamber. The same region of the sample
was imaged at regular time intervals during the heating process.
For comparison a sample from the same batch of microspheres was
imaged over a comparable time period without heating.
2.4.14 5FU release study
Microsphere samples were prepared from a w/o emulsion using the
method described in section 2.3.4 but with the prepared P(MASH-b-
NIPAm). The dialysis system described in section 2.3.8 was set up
to facilitate measurement of release. Release in the case of dialysis
heated to 40 ºC was compared to release during dialysis at 21 ºC.
The concentration of 5FU in the receptor was quantified by HPLC as






Sonochemically produced lysozyme microspheres have been well
researched by our collaborators at the University of Melbourne7;8;47.
Initial work carried out with Zhou et al. was used as a basis from which
to further develop the sonochemical methodology in our laboratories
at Bath. This chapter reports optimisation of the sonochemical method
for lysozyme and thiolated poly(methacrylic acid) (PMASH). The
chosen conditions were used as a basis for the work reported in
chapters 4 and 5.
3.1 Lysozyme microspheres
3.1.1 Optimisation and characterisation: Air filled
microspheres
The experimental equipment used is described in section 2.1. Two
ultrasound generators were used; a 20 kHz/400 W Branson generator
(generator A) and a 23 kHz/600 W Sonics and Materials generator
(generator B), both were fitted with a 3 mm diameter microtip to allow
experiments to be carried out on a small scale.
In the initial study the optimised conditions7 using generator A were
used to form air filled microspheres. The ultrasound intensity and
sonication time were the varied in order to understand the effect of
these parameters on the microspheres’ size distribution. Figure 3.1
shows examples the microscopy that was used to characterise the
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microspheres formed; optical microscopy provides a simple, quick
method to gauge the size distribution of microspheres in solution and
when used with a mercury lamp can be used to observe a fluorescent
marker bound to the protein shell. Scanning electron microscopy
(SEM) provides additional information on the morphology of the
protein shells, albeit in a dried state.
Figure 3.1: Air-filled lysozyme microspheres imaged in suspension
by optical transmission microscopy, scale bar: 20 µm
(a) and fluorescence transmission microscopy (fluorescent
stain Fluorescein isothiocyanate excited by emission from
mercury lamp), scale bar: 20 µm (b). Dried microspheres
imaged by scanning electron microscopy, scale bar: 5.0 µm
(c).
When varying sonication time and intensity the experimental protocol
described in section 2.1.2 was kept constant. Prior to sonication the
lysozyme in solution was denatured, in order to expose eight thiol
groups, by incubating with DL-Dithiolthreitol (DTT) for two minutes
at room temperature. After the sonication step the microspheres
produced were washed by dilution with deionised water. This
methodology can be adapted to form oil-filled microspheres which
will be discussed in section 3.1.3. The first parameter to be varied was
ultrasound intensity. Increasing the applied intensity of an ultrasonic
system increases the energy output of the horn which in turn increases
the amplitude of the tip motion. With generator A this was seen to
increase the mean diameter (measured by image analysis of optical
micrographs, see section 2.1) of the microspheres produced from ~2
mm at 10% power to 4-5 mm at 50% power (Figure 3.2) accompanied
by an increase in the standard deviation implying a broader size
distribution. Similarly increasing the sonication time results in an



























Figure 3.2: Change in mean diameter of air filled lysozyme micros-
pheres with intensity for generator A (% of 400 W output of
the generator). Blue: 15 s sonication; green: 30 s sonication
(error bars correspond to one standard deviation from the
mean).
The SEM images shown in Figure 3.3 have been taken from samples
produced at the ultrasound intensities and sonication times included
in Figure 3.2. As the ultrasound intensity increases the walls of the
microspheres appear to become smoother suggesting a lower density
of lysozyme aggregation on the surface of the air bubbles during
shell formation. The shells of the microspheres formed at 50% power
pucker under the electron beam, suggesting that shells formed at
higher intensities are thinner and have less structural integrity than
those formed at lower intensities. When the samples were produced at
50% power some sediment was observed in the tubes after sonication.
This suggests that some of the microspheres had been broken open
by the higher intensity sonication causing them to collapse and
sink. Increasing the intensity results in more cavitation bubbles and
emulsion bubbles being produced, which may lead to less protein
aggregation on each individual air bubble, although it is not clear as
to why this has the effect of increasing the size of the microspheres.
These results are however useful in determining the requirement for
low to moderate power output in order to form robust microspheres
in a size range which is relevant to medical applications99.
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Referring to Figure 3.2 it can be seen that increasing the sonication time
has a similar effect on the mean as increasing the power. This suggests
that generating cavitation bubbles at the same rate for a longer period
of time has the same effect on microsphere morphology as generating
more cavitation within a set time period. The observations from the
SEM images (Figure 3.3) show the same trend in morphology as was
seen with increasing power. These results are in agreement with the
work conducted by Zhou et al.47 using the same generator.
The mean diameters of microspheres formed with generator B show
a similar increase in mean diameter with increasing intensity but
the trend is not well pronounced due to the breadth of the size
distributions. The mean diameter only varies over a range of
approximately 1 mm unlike with generator A (Figure 3.4).
In the box plot (Figure 3.4) the mean diameter is represented by the
dotted line whilst the median is shown by the black line within the
grey box. The grey box defines the interquartile range, bounded by
the upper and lower quartiles, the whiskers the 5 and 95 percentiles
and the dots represent outliers. (Outliers are defined as values within
the sample population that are more than ’1.5 times the interquartile
range’ greater than the lower quartile or less than the upper quartile.)
This allows the shape of the size distribution to be assessed in each
case. If the quartiles are considered, the lower powers appear to give
a narrower size distribution as expected from previous results with
generator A (Figure 3.2). In all cases it appears that the 5 and 95
percentiles are widely spread indicating that the system is not very
well controlled and that some method of fractionation or filtering
would be necessary if a narrow size distribution were required.
The trend in mean diameter with sonication time for samples produ-
ced with generator B is not as well defined (Figure 3.5). The sample
at 15 s of sonication shows a highly symmetrical distribution but
between 15 and 45 s there is no trend in increasing diameter with the
distributions covering approximately the same range. It is interesting
to note that the sample formed at 60 s of sonication has a much broader
distribution of diameters and a significantly larger mean diameter,
suggesting that there is a threshold sonication time between 45 and






Figure 3.3: SEM Images demonstrating the observed change in air
filled lysozyme microsphere morphology with intensity (%
of 400 W generator A output) and sonication time, Scale
bar: 20.0 µm.
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Figure 3.4: Change in size distribution of air filled lysozyme micros-
pheres with intensity for generator B (sonication time 30 s).
(The mean diameter is represented by the dotted line whilst
the median is shown by the black line within the grey box.
The grey boxes define the upper and lower quartiles, the
whiskers the 5 and 95 percentiles and the dots represent
outliers.)
Figure 3.5: Change in size distribution of air filled lysozyme micros-
pheres with sonication time for generator B (intensity 14 W
cm-2).
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3.1.2 Evidence for disulfide cross linking in shell
It has been shown by Gedanken et. al.16 that it is possible to form
hollow microspheres without the need for intermolecular disulfide
bonds. However denatured lysozyme contains thiol groups capable
of cross linking and therefore it is expected that disulfide cross linked
microspheres should form. This is favourable as it has been reported
that microspheres stabilised by covalent cross links have a longer shelf
life than microspheres formed without disulfide cross links, which are
only stable for a matter of hours at room temperature16. Therefore as
part of this investigation a number of control experiments have been
carried out, based on Suslick’s early work1, in order to demonstrate
that the lysozyme microspheres reported herein are stabilised by
disulfide cross linking.
If no denaturation reaction is carried out to expose the thiol groups
prior to sonication microspheres do not form supporting the case for
disulfide bonds playing an important role in microsphere stability.
Incubation of air filled lysozyme microspheres with 60 mg/mL of
DTT, a disulfide cleavage agent (Figure 3.6), overnight led to collapse
of the microspheres. After incubation the microspheres were no
longer floating on the surface of the solution, but had ruptured and
sunk to form a sediment at the bottom of the tube. This suggests
that disulfide crosslinks were a key factor in the stabilisation of the
lysozyme microspheres. Incubation with DTT is reported in later
chapters as a means to trigger release of microsphere contents.
Figure 3.6: Mechanism for DTT mediated disulfide cleavage120.
Further evidence for disulfide bond formation can be provided by ra-
dical trapping experiments. Super oxide radicals are required to facili-
tate sonochemical disulfide bonding, therefore trapping these radicals
should inhibit microsphere formation1;42. Initially the well known
radical scavenger, tert-butanol121 was added during the microsphere
production protocol (described in section 2.1.9) which completely
prevented the formation of microspheres, providing evidence for
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radical driven stabilisation of the lysozyme microspheres. When high
speed homogenisation (section 2.1.8) was used in place of sonication
to provide extensive emulsification without any sonochemical radical
production, then a stable foam formed which lasted for approximately
48 hours but no microspheres were observed.
Superoxide dismutase (SOD) provides a more specific radical trap
which targets super oxide radicals in particular122. SOD acts by
catalysing the conversion of superoxide radicals to hydrogen peroxide
and oxygen:
2O−2 +2H
+ → O2+H2O2 (3.1)
It was found that when the sonochemical protocol was carried out
with 120 units/mL of SOD added to the lysozyme solution (see section
2.1.10) the yield of microspheres was reduced to 0-3% significantly
less than the 8-20% yield observed in the standard reaction (Table 3.1),
although microsphere formation was inhibited by the presence of SOD
the results were variable and do not show a conclusive trend with SOD
concentration.





Table 3.1: Yields of lysozyme microspheres in the presence of SOD.
NB: experiments were carried out in triplicate for each SOD
concentration. Yield defined as the dry mass of microspheres
formed (after washing) expressed as a percentage of the
mass of lysozyme added to the solution before sonication.
SOD contains one intramolecular disulfide bridge which may be
denatured by DTT. Efforts were made in the experimental protocol
to prevent denaturation of the SOD by adding the SOD immediately
before sonication. However it is still possible that a small amount
of denaturation may have occurred and contributed to the variable
results observed.
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The indirect evidence provided by these experiments gives strong
support for the case that sonochemical lysozyme molecules are
stabilised by disulfide bonding, although they do not discount the
possibility that some additional stabilisation may be contributed by
a hydrophobic mechanism.
3.1.3 Evidence of air and tetradecane encapsulation
The air filled lysozyme microspheres produced in the experiments
discussed above float at the surface of the aqueous solution that
they are stored in, indicating that their cores are less dense than
the surrounding solution. This suggests that the microspheres have
encapsulated air bubbles formed in the foam, in line with the
proposed mechanism. The hollow nature of the microspheres can be
demonstrated by rupturing the microspheres with a sharp blade in situ
on the SEM stub before viewing them by SEM (Figure 3.7).
Figure 3.7: Example of an air filled microsphere (produced according
to the protocol in section 2.1.2 using generator A) that has
been mechanically ruptured after sample preparation on
the SEM plate.
Further evidence for air encapsulation can be gained by measuring
the multi bubble sonoluminescence (MBSL) produced on ultrasonic
rupture of a suspension of air filled microspheres. MBSL is light
produced as a result of the cavitational collapse of clouds of bubbles
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in a solution under ultrasonic irradiation. The light is thought to
be produced by radicals, formed as a result of the collapse, recom-
bining123. Sonoluminescence is a useful tool for mapping cavitation
but is very faint so must be observed using a photomultiplier tube.
Alternatively it can be enhanced, for example by sonicating a solution
of luminol38 to give sonochemiluminescence which is sufficiently
bright to be detected by long exposure photography in a dark box
(protocol in section 2.1.11). Figure 3.8 shows an example of how
cavitation can be mapped by capturing sonochemiluminescence. It
can clearly be seen from these images that the distribution of cavitation
in the luminol solution is changed when the horn tip is placed at the
air:water interface as opposed to being fully submerged in solution.
Figure 3.8: Sonochemiluminescence observed in an aqueous luminol
solution when irradiated with ultrasound from generator B
fitted with a 3 mm micro-tip (a) submerged in solution and
(b) positioned at the air:water interface.
By irradiating water with pulsed ultrasound (from a plate transdu-
cer) and detecting the light produced with a photomultiplier tube
connected to an oscilloscope it is possible to monitor the change in
the sonoluminescence produced over time119 (see section 2.1.12 for a
detailed description of the experimental equipment and protocol desi-
gned by Lee et al. at the University of Melbourne119). In air saturated
water a characteristic plot is generated with an initial growth in the
intensity of sonoluminescence followed by a steady state phase (Figure
3.9). This initial period of increasing light intensity is associated with
a build up of transient nuclei produced by ultrasound irradiation,
resulting in increased cavitation and sonoluminescence119. In water
that has been degassed under a vacuum there is insufficient dissolved
gas to allow cavitation bubbles to form and hence sonoluminescence
cannot occur meaning that no peaks are seen in the plot (Figure 3.10).
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If a suspension of air filled microspheres is added to the degassed
water the microspheres will rupture upon irradiation with ultrasound
and the encapsulated air will be released into the water facilitating
cavitation. As a result a small amount of sonoluminescence can be
observed from the suspension of microspheres in degassed water
(Figure 3.11). The sonoluminescence has a much lower intensity than
that observed in the case of air saturated water because the volume of
air held in the microspheres is very small and the suspension used was
very dilute.
Figure 3.9: Sonoluminescence plot recorded by a photomultiplier tube
and oscilloscope in pulsed mode for air saturated water.
85
Figure 3.10: Sonoluminescence plot recorded by a photomultiplier
tube and oscilloscope in pulsed mode for degassed water.
Figure 3.11: Sonoluminescence plot recorded by a photomultiplier
tube and oscilloscope in pulsed mode for degassed water
containing lysozyme microspheres with an air core.
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In addition to air filled microspheres, oil filled microspheres can
be formed by adapting the sonochemical protocol described above.
After denaturing the lysozyme but prior to sonication 100 µL of oil
was layered on the surface of the lysozyme solution. The sonicator
tip was then placed at the oil : water interface. The oil chosen
for this study was tetradecane, because it has been shown to work
well with lysozyme and give microspheres in a size range that is
useful for medical applications8. In a tetradecane/lysozyme system
an emulsion is formed sonochemically between the aqueous solution
and the tetradecane. The lysozyme molecules aggregate and crosslink
on the surface of the tetradecane droplets encapsulating them and
forming tetradecane filled microspheres.
An estimated yield of 2.22× 108 microspheres can be produced from 1
mL of lysozyme solution with 100 µL of tetradecane, corresponding
to quantitative encapsulation of the oil phase (the estimate was
calculated from image analysis of micrographs of a known volume of
the microsphere suspension, see section 2.1.3).
The microspheres formed in the tetradecane emulsion are significantly
smaller than those formed in the air filled microsphere system when
produced under the same conditions (Figure 3.12). This may be due
to the lower interfacial tension at the tetradecane:water interface (52.2
mN/m at 20 ºC)124 compared to the air:water interface (72.8 mN/m at
20 ºC)124 which allows the tetradecane droplets to be smaller than the
air bubbles resulting in smaller microspheres. The distribution of sizes
is also smaller suggesting in turn that the tetradecane emulsion is less
polydisperse than the foam formed in the air filled system.
The SEM images for tetradecane filled microspheres are quite different
to those observed for air filled microspheres (Figure 3.13). The
microspheres collapse under the vacuum used during the sample pre-
paration to leave a honeycomb pattern on the plate. This suggests that
the shells of the microspheres are porous allowing the encapsulated
tetradecane to evaporate and escape from the microspheres under
reduced pressure. It also indicates that the oil-filled shells have less
structural integrity than the those in air filled microspheres. This
collapse implies loss of a liquid core but does not provide direct
evidence for oil encapsulation, in order to achieve this alternative
microscopy methods must be used.
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Figure 3.12: Size distributions of air filled and tetradecane filled lyso-
zyme microspheres produced using generator B. Condi-
tions: 29 Wcm-2for 30 s sonication. (The mean diameter is
represented by the dotted line whilst the median is shown
by the black line within the grey box. The grey boxes
define the upper and lower quartiles, the whiskers the 5
and 95 percentiles and the dots represent outliers.)
Imaging of the microsphere core can be achieved by adding a fluo-
rescent species to the tetradecane prior to forming the microspheres.
Nile red was chosen as a suitable lipophilic dye because it is has
a broad absorption range, 400-600 nm and emits in the green to
red region of the visible spectrum, 500-800 nm when dissolved in
an alkane125;126. This allowed the microspheres to be imaged both
by optical microscopy under irradiation from a mercury lamp and
by laser scanning confocal microscopy using a green laser (543 nm).
When tetradecane filled microspheres containing nile red are viewed
by transmission optical microscopy with a mercury lamp they can be
seen to fluoresce throughout the core (Figure 3.14a). The fluorescence
is brightest at the centre of the microspheres where the depth of
tetradecane is greatest. This can be compared with an air filled
microsphere stained after formation using fluorescein isothiocyanate
(Figure 3.14b). In this case the fluorescent molecules are present only
in the thin shell. This means that the fluorescence is only bright
enough to be visible from the ‘side walls’ of the sphere where there is
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Figure 3.13: SEM Image of tetradecane filled microspheres, the micros-
pheres collapsed under the vacuum used during sample
preparation to leave a honeycomb pattern on the SEM
stub. Scale bar 50 µm.
sufficient depth of shell wall to give a visible intensity. This causes the
3-dimensional microspheres to look like 2-dimensional empty rings, a
stark contrast to when the microspheres are tetradecane filled.
Laser scanning confocal microscopy (LSCM) can be used to image
an optical slice through the centre of the microspheres. This type of
microscopy is useful in obtaining evidence for what resides in the
internal structure of a microscopic structure. A 543 nm laser was used
to excite red fluorescence from the nile red dissolved in the tetradecane
and a 1 µm slice through the centre of a microsphere was imaged,
Figure 3.15. The 1 µm optical slice imaged is thinner than the diameter
of the microsphere, hence the red fluorescence seen in the core of
the microsphere is as a result of nile red dissolved in the tetradecane
encapsulated within the shell. The homogeneous distribution of red
within the core is evidence of encapsulation of nile red and successful
formation of oil filled lysozyme microspheresa.
aThe author wishes to acknowledge the kind assistance of Dr Adrian Rogers, at
the University of Bath Microscopy and Analysis Suite, in collecting the confocal
micrographs presented in this thesis.
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Figure 3.14: (a) Tetradecane filled microspheres, formed from tetrade-
cane saturated with nile red, (b) fluorescein isothiocyanate
stained air filled microspheres. Both samples were viewed
in aqueous suspension by optical microscopy under irra-
diation from a mercury lamp, scale bar 20 µm.
Figure 3.15: LSCM confocal micrograph of a 1 µm thick optical slice
through a tetradecane filled microsphere containing nile
red saturated tetradecane, viewed in aqueous suspension.
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As an interesting aside to the experimental protocol, high speed video
imaging was used to capture images of the lysozyme solution during
sonicationb. The imaging, which was conducted at a frame rate
of 1000 frames per second (fps), allowed clusters of air bubbles/oil
droplets to be observed in both the air filled and the oil filled protocols
(Figures 3.16 and 3.17). These clusters were not observed when
deionised water was sonicated under the same conditions (Figure 3.18)
suggesting that the clusters are stabilised by lysozyme. It is likely
that the microspheres formed from this protocol are formed in these
clusters. When the ultrasound is switched off the clusters disintegrate
and what appears to be individual bubbles are seen rising to the
surface. These bubbles are too large to be microspheres and are likely
to be simple foam bubbles. The microspheres can be observed as
a turbid phase which creams to the surface over a period of hours
after sonication. The clusters seen in the video stills provide some
illustrative evidence for the proposed formation mechanism discussed
in chapter 1. However more detailed empirical studies, outside the
scope of this project, need to be carried out in order to fully understand
the aggregation processes which occur in the formation of microsphere
shells.
bThe author wishes to acknowledge the kind assistance of Dr Timm Joyce Tiong in
providing access to and assistance in operating the high speed video equipment.
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Figure 3.16: Stills taken from high speed video footage (1000 fps) of the
lysozyme solution being sonicated during the production
of air filled microspheres, (a-f) during sonication and (g-h)
immediately after the sonicator was switched off. Scale
bar 3 mm.
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Figure 3.17: Stills taken from high speed video footage (1000 fps) of the
lysozyme solution being sonicated during the production
of tetradecane filled microspheres, (a-e) during sonication
and (f-h) immediately after the sonicator was switched off.
Scale bar 3 mm.
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Figure 3.18: Stills taken from high speed video footage (1000 fps)
of water sonicated under identical conditions to Figures
3.16 and 3.17, (a) taken before sonicating, , (b-e) during
sonication and (f-h) immediately after the sonicator was
switched off. Scale bar 3 mm.
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3.2 PMASH microspheres
3.2.1 Synthetic route to PMASH
Poly(methacrylic acid) (PMA) was chosen as a suitable polymer to
use in the initial stages of an investigation into polymer disulfide
cross linked microspheres because it is biocompatible127, water soluble
and can be functionalised via the carboxylic acid groups on the chain
to form pendant thiol groups128. In addition the surface activity
of this polyelectrolyte can be tuned by adjusting the solution pH
relative to its pKa (7.5)129. As such PMASH can fulfil the two main
criteria for sonochemical microsphere production; it can aggregate on
the oil:water interface and it can undergo disulfide crosslinking. A
synthetic route for the functionalisation of PMA with cysteamine to
form PMASH is reported in the literature128 and is shown in Figure
3.19. This was our chosen synthetic route for the production of
PMASH.
Figure 3.19: Reaction scheme for the functionalisation of PMA to form
PMASH, carried out at 22 ºC for 24 hours.
Characterisation to establish the extent of functionalisation and to
confirm the successful attachment of pendant thiol groups was
conducted via 1H-NMR. The two CH2 peaks for cysteamine shifted
from 3.15 and 2.79 ppm to 3.55 and 2.92 ppm corresponding to a
change from being adjacent to an amine to being adjacent to amide.
Percentage functionalisation was estimated by comparing the integral
of the peak at 3.55 ppm to the integral of the PMA peak at 1.56 ppm.
The PMASH used in this study had a thiol functionalisation of 33
mol%, corresponding to 15-16 thiolated units per PMA chain (DP:47).
It was shown by Zhou et al.17 that 5-30 mol% functionalisation, in their
case corresponding to 9 - 52 thiol units per PMA chain (DP: 174), was
sufficient to achieve adequate crosslinking and produce stable oil filled
microspheres.
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Diffusion ordered NMR spectroscopy (DOSY) was used to provide
further evidence in support of the argument that the cysteamine
was attached to the polymer chain, removing the possibility that the
cysteamine was present as a separate molecular species in the sample,
the theoretical background to DOSY NMR is discussed in Chapter 5.
Some side products were also observed which were shown by DOSY
to be attached to the chain.
Figure 3.20: DOSY NMR spectrum of dried PMASH in D2O at 25 ºC.
The FTIR and Raman spectra of the PMASH formed (Figure 3.21) were
measured from the same dried sample of PMASH (see section 2.1 for
details) and do not show strong S-H peaks, however peaks at 599
and 635 cm-1 can be observed in the Raman spectrum which can be
attributed to S-S and C-S stretches respectively. These peaks were not
observed in the PMA IR or Raman spectrum (Figure 3.22) which is
an accurate match to that previously reported130. The spectra were
collected after a significant period of storage under air so it may be










Figure 3.22: FTIR (blue) and Raman (green) spectra of dried PMA.
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3.2.2 Microsphere production and characterisation
Figure 3.23: Optical transmission micrograph (scale bar: 20 µm) (a)
and confocal micrograph (b) of tetradecane filled PMASH
microspheres, the microspheres were imaged in suspen-
sion and the tetradecane was saturated with nile red.
Microspheres containing tetradecane can be formed from PMASH by
using a version of the sonochemical procedure discussed above in
section 3.1. In the case of PMASH microspheres no denaturation step is
required as the thiol groups are already exposed. Instead the PMASH
solution is slightly acidified prior to sonication, resulting in a small
amount of precipitation, similar to that observed when lysozyme is
denatured. It is thought that these precipitates aggregate on the oil
droplets during microsphere formation. Figure 3.23 shows optical
transmission and confocal images of PMASH microspheres formed
with a nile red saturated tetradecane core. The red core observed in
the confocal image is the result of fluorescence from the saturated nile
red solution and, as with the lysozyme case, demonstrates that the
tetradecane has been successfully encapsulated.
The morphology of the microspheres formed is very similar to that
seen with lysozyme. The PMASH microspheres have a mean diameter
of 2.1 µm, which is similar to that of lysozyme microspheres formed
under the same conditions (2.2 µm). However the PMASH micros-
pheres formed have a narrower size distribution with a standard
deviation of 0.7 compared to 1.1 in the case of lysozyme microspheres,
this is illustrated in Figure 3.24. An estimated yield of 1.24 × 109
microspheres can be produced from 1 mL of PMASH solution with
100 µL of tetradecane, corresponding to quantitative encapsulation
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of the oil phase (the estimate was calculated from image analysis of
micrographs of a known volume of the suspension produced after
sonication, see section 2.1.3). Perfluorohexane can be encapsulated
as an alternative, more biocompatible oil131. The microspheres
produced have a smaller mean diameter (1.36 µm) and narrower size
distribution, standard deviation: 0.42 (Figure 3.24).
Figure 3.24: Size distributions of tetradecane filled lysozyme micros-
pheres, tetradecane filled PMASH microspheres and per-
fluorohexane filled PMASH microspheres formed using
14 Wcm-2 ultrasound for 60 s. (The mean diameter is
represented by the dotted line whilst the median is shown
by the black line within the grey box. The grey boxes
define the upper and lower quartiles, the whiskers the 5
and 95 percentiles and the dots represent outliers.)
Unlike lysozyme however PMASH microspheres containing a gaseous
core cannot be formed using the current method. It was suspected that
this was due to a reduced affinity for the air:water interface in the case
of PMASH which would inhibit the aggregation required for effective
shell formation. In order to test this theory the surface tensions (γ) of
lysozyme and PMASH solutions were measured using a tensiometer
fitted with a Du Noüy ring (section 2.1.16). As can be seen from
Table 3.2 the use of tris buffer in place of deionised water slightly
reduces the surface tension but its use was necessary to reflect the
conditions used during microsphere production. At pH 8 there is not
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a large difference between the surface tensions of the PMASH (60.3
mN/m) and lysozyme solutions (61.5 mN/m). In order to gain a more
accurate reflection of the experimental conditions for microsphere
production a second lysozyme solution was treated with DTT prior
to measurement which increased the surface activity of the lysozyme
resulting in a much lower surface tension (30-40 mN/m). However the
denatured lysozyme gelled rapidly preventing accurate measurement
of the surface tension. For comparison, the surface tension of a PMASH
solution at buffered at pH 5 was measured and found to be only
10 mN/m lower than that of the buffer. At pH 5 the acid groups
on the PMASH chains are fully protonated, which should result in a
more surface active polymer. Unfortunately the acidic pH resulted
in precipitation of some PMASH during the measurement depleting
the solution concentration. As a result the conclusions drawn from
this experiment are limited, surface activity may be a key factor in
microsphere production but further measurements would be required
to support this argument.
Solution γ / mN/m
Deionised water 72.3
Tris buffer, pH 8.0 68.6
Acetate buffer, pH 5.0 60.7
Native lysozyme solution, pH 8.0 61.5
PMASH solution, pH 8.0 60.3
PMASH solution, pH 5.0 50.6
Table 3.2: Surface tension (γ) data collected using a tensionometer
fitted with a Du Noüy ring. All solutions used MilliQ (18.2
MΩ·cm) deionised water, [tris]: 50 mM, [acetate]: 100 mM,
[lysozyme]&[PMASH]: 0.34 mM.
FTIR spectra of dried tetradecane filled microspheres confirm the
identity of the shells as PMASH. Comparison between the PMASH
IR spectrum and the microspheres’ IR spectrum (Figures 3.21 and
3.25) shows an increase in the intensity of the peak at 599 cm-1 which
corresponds to a disulfide bond stretch. In the Raman spectrum the
peak at 599 cm-1, associated with the S-S bond stretch is taller than
the adjacent C-S peak, in contrast to the PMASH Raman spectrum,
providing further evidence for the formation of disulfide bonds in
the shell. Further evidence for stabilisation of the microspheres by
disulfide bonding is provided in the release studies reported below
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and in Chapter 4 where DTT is used to stimulate release by cleaving
disulfide bonds and disrupting the structure of the shell. In addition
a new peak is observed in the carbonyl region of the FTIR spectrum
at 1712 cm-1 and a two strong peaks are seen at 1059 and 1056 cm-1
respectively. These peaks are in bands corresponding to C=O and
C-O bonds in a carboxylic acid group, which typically displays strong
peaks. The carbonyl peak is shifted away from the wavenumber
associated with PMA (1665 cm-1). This indicates that a different
carboxylic acid group has formed during the sonication carried out
during microsphere production. The double peak at 1059/1056 cm-1
indicates that two functional groups have been formed it is suggested
that the other is a C-O stretch associated with an alcohol group. The
Raman spectrum shows two peaks in the O-H band, 3100-3300 cm-1,
which correspond to the alcohol and carboxylic acid groups but which
could not be conclusively identified in the IR spectrum due to the
presence of water. Similar peaks are seen in the FTIR spectrum of
PMAene microspheres (Figure 3.36, section 3.3) and diblock copolymer
microspheres (Figure 5.26, section 5.5) indicating that the alcohol
groups are formed by reduction of the PMA carboxylic acid groups




Figure 3.25: FTIR (blue) and Raman (green) spectra of dried tetrade-
cane filled PMASH microspheres.
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The short term stability of the microspheres was investigated by va-
rying to the external pH of the bulk solution in a PMASH microsphere
suspension (Figure 3.26). At acidic pH’s the microspheres aggregate,
however at pH 6 and above the microspheres remain discretely
distributed. Below the pKa 7.5 of PMA129 the acid groups will
be protonated, increasing the overall hydrophobicity of the polymer
chains. As a result the microspheres aggregate with one another.
At higher pH’s the PMA in the shells is ionised meaning that the
microspheres are stable towards aggregation.
Figure 3.26: PMASH microspheres incubated at pH 4,5,6,7,8 and 9 in
100 mM phosphate buffer at 22 ºC for 2 hours (scale bar:
50 µm).
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3.2.3 Release of lipophilic dyes
The successful encapsulation of an oil phase containing nile red has
been demonstrated by transmission and confocal microscopy for both
lysozyme and PMASH microspheres. With delivery applications in
mind it was interesting to develop a method which would allow
the extent of release from the core to be measured under different
circumstances. Nile red is highly lipophilic (logP: 3.441 ± 1.435c) and
therefore very poorly soluble in water (maximum solubility: 0.018
µg/mL)132. Nile red containing microspheres were destroyed with 40
Wcm-2 ultrasound. However, due to its poor solubility, the quantity
of nile red released into the aqueous phase was below the limit
of detection by fluorescence spectroscopy, even after freeze drying
and re-dissolution in DMSO (the fluorescence intensity of nile red in
DMSO is 250 fold more intense than in water133).
Figure 3.27: Nile red and sudan III
In order to establish the quantity of nile red that could be recovered
upon complete destruction of the microspheres, a sample of micros-
pheres was soaked in DMSO. DMSO is a much better solvent for nile
red than water126. Addition of DMSO to a suspension of microspheres
which had been mechanically disrupted by 2 minutes of sonication at
40 Wcm-2 allowed the nile red that had been released to be harvested.
It was calculated from fluorescence measurements that 6-7% of the
nile red initially added during microsphere production was recovered
after destruction of the microspheres. This was lower than expected, as
the microsphere population estimated in section 3.1.3 suggested 100%
encapsulation of the tetradecane. In a control reaction, sonicating 100
µL of tetradecane saturated with nile red in DMSO resulted in 7%
release. This suggests that the low release observed in the microsphere
case was unlikely to be due to binding of nile red to protein shell
fragments and was instead due to limited transfer of nile red from
cCalculated using Advanced Chemistry Development (ACD/labs) software V11.02
© 1994-2013 ACD/labs.
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the tetradecane phase to the DMSO phase. Therefore in order to gain
a better estimation of the extent of release that can be achieved when
microspheres are ruptured the methodology was changed to utilise a
more lipophilic receptor solvent.
Isopropyl myristate (IPM) is a lipophilic solvent which is used for
in vitro release studies to mimic the solvency properties of skin132.
The encapsulated dye was changed from nile red to another red dye,
sudan III (SIII)89 (Figure 3.27). SIII is a highly lipophilic dye (logP:
4.62)134, it has a stronger absorbance in the visible spectrum than nile
red and can therefore be detected at lower concentrations by UV/VIS
spectroscopy. PMASH microspheres were formed from a saturated
solution of SIII in tetradecane. Once formed the microspheres were
treated in a variety of ways to rupture their shells; incubation with
DTT, sonication at 40 Wcm-2 for 2 minutes, incubation at pH 1 and
incubation at pH 14. After treatment the microsphere suspensions
were gently shaken with IPM in order to collect the SIII.
Figure 3.28: Release of sudan III saturated tetradecane phase from
PMASH microspheres; (a) no treatment (30 mins), (b)
incubated with 60 mg/mL DTT at 22 °C (30 mins), (c) no
treatment (60 mins), (d) incubated at pH 1 (60 mins) and
(e) incubated at pH 14 (60 mins).
Prior to solvent extraction with IPM the effects of the various
treatments could be observed with the naked eye. In Figure 3.28
tubes (a) and (b) show a comparison between an untreated batch
of PMASH microspheres and a batch that has been incubated with
60 mg/mL DTT at room temperature. The red oil which has been
released on rupture of the PMASH shells by DTT can be clearly seen
as a layer on the surface of the solution, whereas no oil layer is
visible in tube (a). Solvent extraction of these samples into 2 mL of
IPM allowed the quantity of SIII released to be measured by UV/VIS
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spectroscopy and hence the extent of release could be calculated. The
quantity of SIII harvested from an untreated sample of microspheres
that had been allowed to stand for 60 minutes corresponded to 12%
release (Table 3.3). This indicates that the encapsulation efficiency of
tetradecane/SIII in PMASH microspheres was 88%. By comparison
incubation with 60 mg/mL of DTT over a 60 minute period resulted
in 70% release. Sonication of the microspheres at 40 Wcm-2 for two
minutes did not cause such extensive release (17% compared to 12% in
the untreated case). However, when the same sample of microspheres
was sonicated for a second time with a small amount of residual IPM
a further 35% of the encapsulated SIII was released. It is suggested
that the presence of the lipophilic phase aided the disruption of the
shell and the rate of release of the oil core. For comparison a control
experiment was carried out in which the oil phase alone was sonicated
in buffer and solvent extracted into IPM, quantitative release was
observed.
% release
PMASH MSs 12 ±4
PMASH MSs incubated with DTT 70 ± 9
PMASH MSs sonicated for 2 mins 17 ± 2
PMASH MSs sonicated for a further 2 mins* 35 ± 8
Table 3.3: Quantity of sudan III recovered in IPM solvent extraction as
a percentage of the total amount of sudan III added during
microsphere production. (Microspheres (MSs) incubated for
1 hour with 60 mg/mL of DTT or sonicated at 40 Wcm-2,
*with residual IPM).
It can be seen from the photographs in Figure 3.28 that incubation
with NaOH for 1 hour results in release of the red oil phase. This
suggests that the microspheres are less stable at highly alkaline pH,
however the extent of release could not be quantified because the
alkaline solution formed a stable emulsion with IPM. In the acidic
case the microspheres can be seen to have aggregated, as expected
from the micrographs discussed in section 3.2.2, but no separated oil
phase is visible. Again an emulsion formed with IPM which prevented
quantification of release.
Hence it can be seen that tetradecane filled PMASH and lysozyme
microspheres can be formed using the sonochemical method and
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loaded with a dye (as a model for drug molecules). The PMASH
and lysozyme microspheres formed are similar in size to those
reported by Zhou et al.7;8;47. The size of the microspheres produced
can be controlled by altering the sonication intensity or time in a
similar manner to that reported by Zhou et al.47. The microspheres
formed are stabilised by disulfide bonding, as evidenced by radical
trapping experiments, FTIR, and Raman spectroscopy. The release
experiments conducted demonstrate that release of dye loaded into
the PMASH microspheres can be achieved if the microsphere shell is
disrupted prior to solvent extraction into a lipophilic solvent. This
demonstrates potential for these microspheres to be used in release
applications within the body where the external receptor is lipophilic.
Later chapters will discuss adaptions of the methodology explored
in this chapter to facilitate encapsulation (and subsequent release) of
hydrophilic species and temperature responsive release systems.
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3.3 Thiol-ene Chemistry and PMAene
microspheres
The thiol-ene reaction has been known since the early 1900s135;136 137
but has gained more recent popularity, especially in materials chemis-
try applications, as a ’click’ reaction138. The click class of reactions
was first described by Sharpless et al.139, a click reaction is defined as
having the following characteristics:
“a) high yields with by-products (if any) that are removable by
non-chromatographic processes, b) regiospecificity and
stereospecificity, c) insensitivity to oxygen or water, d) mild,
solventless (or aqueous) reaction conditions, e) orthogonality with
other common organic synthesis reactions, and f) amenability to a
wide variety of readily available starting compounds.”138
Thiol-ene reactions fulfil many of these criteria138;140;141 particularly
with respect to fast rates, near quantitative, regioselective yields,
tolerance of water and oxygen and orthogonality across a wide range
of alkenes and thiols138. This makes the thiol-ene reaction ideal
for applications in materials chemistry141–143. Thiol-ene reactions
can go via a free radical mechanism or a Michael addition, in this
investigation we focussed on the free radical mechanism, Figure 3.29.
This reaction can be initiated either thermally or via UV with the help
of an added initiator144. UV initiation is the more popular initiation
method giving fast rates of reaction and clean reaction profiles145;146.
Sonochemistry offers an alternative radical source that could be
used147;148 but which has not yet been applied to thiol-ene chemistry.
Large quantities of radicals can be produced either by thermolysis
of the solvent149;150 or by accelerated breakdown of initiators. As
ultrasound is used to produce microspheres it was of interest to
establish whether thiolene reactions could be initiated sonochemically.
This could provide additional utility to the sonochemical microsphere
protocol by providing the opportunity to cross link the microspheres
via thiol-ene chemistry instead of disulfide crosslinking, or functio-
nalise the shell with marker or biorecognition molecules in a one pot
procedure during microsphere production.
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Figure 3.29: General free radical thiol-ene mechanism140.
In order to establish whether typical thiol-ene reactions could be
initiated sonochemically, thiol-ene reactions of a number of small
molecule alkenes with 1-butanethiol were carried out. Prior to running
the reactions the rate of radical production was measured under
thermal conditions typical for thiol-ene reactions and under sono-
chemical conditions in order to establish thermal and sonochemical
conditions which gave similar rates of radical production. A radical
trap 2,2-diphenyl-1-picrylhydrazyl149;151 (DPPH) was used to quantify
the radical production in each system with toluene as the reaction
solvent and Azobisisobutyronitrile (AIBN) as an initiator152. The
change in absorbance at 520 nm was measured as the purple DPPH
changed to orange DPPH2 as a result of reaction with radicals (Figure
3.30).
Figure 3.30: Conversion of DPPH to DPPH2 by radical trapping152.
Zero order kinetics were observed indicating that radical production
was the rate determining step rather than the reaction of radicals with
DPPH. It was found that by using an ultrasonic horn at 17 Wcm-2
with 10-20 mM AIBN a rate of reaction could be achieved at 24 ºC
that was comparable to that with a 5 mM solution of AIBN at 50 ºC
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without ultrasound (Table 3.4). Without ultrasound the rate of AIBN
decomposition at 24 ºC is too slow to be adequately measured by
radical trapping. However extrapolation from measurements made at
higher temperatures153 suggests that the rate should be approximately
2 x 10-8 s-1. It can therefore be concluded that ultrasound accelerates
the rate of AIBN decomposition at room temperature. Based upon
the results of these radical trapping experiments it can be suggested
that these sonochemical conditions can be used to carry out thiol-ene
coupling at room temperature.
Initiation [AIBN] mM T /°C k /10-4mol dm-3 s-1
Thermal 20 50 ± 2 15.0 ± 2.6
10 6.8 ± 0.4
5 3.3 ± 0.4
0 0.0
23 kHz ultrasound, 20 24 ± 2 3.8 ± 0.4
17 Wcm-2 10 3.0 ± 0.4
5 2.2 ± 0.2
0 0.62 ± 0.03
Table 3.4: Rate constants for DPPH radical trapping in 0.08 mM
toluene solutions.
The conditions chosen were applied to thiol-ene reactions between
1-butanethiol and a range of alkenes listed in Table 3.5 (see sections
2.2.3-5). Good conversions were seen under sonochemical conditions
with AIBN for norbornene and N-isopropylacrylamide (NIPAm). It is
reported in the literature140 that alkene reactivity in thiolene coupling
decreases as the electron density in the double bond decreases. This
trend is followed in both the sonochemical and thermal systems
implying that the mechanism is similar in both systems.
In spite of comparable rates of radical production in the two systems
the thermal reactions can be seen to achieve much higher conversions,
which is perhaps due to competing side reactions in the sonochemical
case. Gas chromatography coupled with mass spectrometry (GC-MS)
was used to confirm the identity of the major product in each case
but no significant side products were observed. Thioether bonds are
susceptible to sonolysis in organic solvents154. This may result in some
loss of product and the radicals produced would be capable of forming
a variety of compounds whilst acting as a radical trap, therefore
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))))* )))) D* D
Alkene 24 °C 24°C 50 °C 50 °C
norbornene 63 14 99 0
N-isopropyl acrylamide 42 0 100 0
butyl vinyl ether 30 2 8 0
1-heptene 15 0 24 0
1-pentene 0.3 0.5 0 0
allyl butyl ether 0 0 0 0
allyl amine 0 0 0 0
Table 3.5: % conversion at 2 hours for thiol-ene reaction of alkenes with
1-butanethiol in toluene under inert conditions (* with 20
mM AIBN in the ultrasound reaction and 5 mM AIBN in the
thermal reaction).
reducing the concentration of radicals available to initiate further
thiol-ene reactions. An improvement to the sonochemical conversion
can be achieved by extending the reaction time, increasing the
ultrasound power, increasing the concentration of AIBN or increasing
the number of thiol equivalents. For example in the case of butyl
vinyl ether 88% conversion was achieved over 4 hours by increasing
the concentration of AIBN to 60 mM, using 5 equivalents of thiol
and using an ultrasound intensity of 21 Wcm-2 (simply extending the
reaction time to 4 hours gave a conversion of 45%). These conditions
would be less appropriate on a larger scale.
Electron deficient alkenes allyl amine and allyl butyl ether did not
show any reaction in either system, neither did 1-pentene under
thermal conditions and its sonochemical reaction was negligible. In
the case of these electron deficient alkenes significantly higher radical
production would be required to facilitate a reaction. As expected
no reaction was seen with any alkene thermally in the absence of
initiator. In the sonochemical system the more reactive alkenes did
show some small conversions without initiator present. This shows
the benefit of the sonochemical system; an initiator is not necessary for
radical production. This is useful in several applications, for example
in polymer cross linking where added initiator may cause problems
with discolouration or biocompatibility, especially as in the case of


























Figure 3.31: Reaction profiles in toluene, filled shapes: sonochemical
conditions, empty shapes: thermal conditions, squares:
norbornene, triangles: NIPAm, diamonds: butyl vinyl
ether, circles: 1-heptene.
The reaction profiles of the four most reactive alkenes in their reactions
with AIBN present are shown in Figure 3.31. In the sonochemical
system there is a steady decline in reactivity as the alkenes become
more electron deficient, the same trend is followed in the thermal case
but with a much wider difference. Some inhibition is observed in the
thermal cases, this is probably due to residual oxygen. No inhibition
is seen in the sonochemical reaction profile due to effective degassing
by the ultrasound.
Having demonstrated that it is possible to carry out sonochemically
initiated thiol-ene chemistry in inert organic conditions it was inter-
esting to transfer the methodology into water without any inertion as
these conditions more closely resemble those used in the microsphere
protocol. Potassium persulfate was used as a water soluble initiator
with the water soluble thiol, cysteamine HCl. The number of thiol
equivalents used was increased from 1.5 to 5 in light of the results
of the first investigation and in order to supress any competing
polymerisation reactions in the cases of NIPAm and acrylamide155.
Dosimetry experiments were carried out with terephthalic acid156 (TA)
which traps HO•, to estimate radical production and determine condi-
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tions where the same concentration of initiator could be used in both
the thermal and the sonochemical systems to produce comparable
rates of radical production. This was achieved by measuring the
rate of increase in fluorescence intensity over an hour as fluorescent
hydroxyterephthalic acid (HTA) was formed from reaction between
TA and a hydroxyl radical (Figure 3.32). Table 3.6 shows the results
of these experiments and again ultrasound shows evidence of radical
production without initiator whereas the thermal system does not.
Figure 3.32: Conversion of TA to HTA through reaction with a hy-
droxyl radical.
Rate of change of
Initiation [K2S2O4] T fluorescence at 410 nm
/mM /°C (au/min)
Thermal 1.75 45 ± 2 2383 ± 724
0 No rxn.
23 kHz 1.75 24 ± 2 1763 ± 113
Ultrasound 0 1296 ± 74
Table 3.6: Rate of change of fluorescence for radical trapping by TA in
a 0.2 mM aqueous solution.
The more reactive alkenes that do not polymerise show quantitative
conversion after one hour in both the sonochemical system and the
thermal system (Table 3.7). As with the organic system there are
reports of aqueous sonolysis in the literature157 but these results show
that it is not a significant problem in this aqueous system in the way
it is in the organic system under similar conditions. For both NIPAm
and acrylamide some polymerisation is observed to compete with the
thiolene reaction, 16% and 50% conversion to polymer is observed in
each respectively. It was also observed that acrylamide underwent
some reaction to form thioether in the absence of initiator. In this case
it seems that thermal decomposition of acrylamide at 45 ºC provides
sufficient radicals to initiate the thiol-ene reaction. As with the organic
case there is some sonochemical reaction in the absence of initiator
due to sonochemical radical production. Indeed pentenoic acid is
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seen to react to 100% conversion sonochemically without any initiator
present. These results present the opportunity to use ultrasound to
initiate a thiol-ene reaction without any initiator present, ideal in
cases where thermal lability of the reagents may prevent the use of
thermal conditions or the use of an initiator is not appropriate, for the
reasons discussed above. Indeed in the case of this project initiating
the thiolene reaction sonochemically without any initiator is ideal for
the microsphere protocol, especially as quantitative conversion is not
essential for cross linking reactions.
))))* )))) D* D
Alkene 24 °C 24 °C 45 °C 45 °C
4-Pentenoic acid 100 100 100 0
3-Allyloxy-2-hydroxy-1- 100 5 100 0
propanesulfonic acid
N-isopropyl acrylamide 69 0 62 0
Allyl alcohol 100 30 77 0
Acrylamide 35 12 41 28
Allyl amine 33 8 14 0
Table 3.7: % conversion at 1 hour for thiol-ene reaction of alkenes
with cysteamine hydrochloride in water under ambient
conditions (* with 1.75 mM K2S2O4in both cases).
Again the reaction profiles for the four most reactive alkenes were
studied, Figure 3.33. For the more reactive alkenes quantitative
conversion can be achieved within 10-30 minutes with both the
sonochemical and thermal conditions. As with the organic case
the thermal reactions are slightly faster but the longer reaction time
required for the sonochemical system is not inconvenient.
The high conversions observed in the aqueous system demonstrate
that thiol-ene reactions can be carried out efficiently with ultrasound in
place of thermal initiation and extend the scope of thiol-ene reactions
to encompass a system where a chemical initiator is not required.
These reaction conditions do not fulfil all of the requirements of a
’click’ reaction discussed above but do provide an effective reaction
system with which to approach applications in polymer crosslinking
at room temperature.
With this in mind this reaction was applied to the sonochemical

























Figure 3.33: Reaction profiles in water, filled shapes: sonochemi-
cal conditions, empty shapes: thermal conditions, dia-
monds: pentenoic acid, squares: 3-allyloxy-2-hydroxyl-1-
propanesulfonic acid, triangles: NIPAm and circles: allyl
alcohol.
PMAene and DTT as a crosslinking agent. This system was designed
to provide a simple model to establish whether thiol-ene chemistry
could be used to crosslink PMA in the microsphere shells with a view
to developing the system towards more complex crosslinkers which
contain, for example a biodegradable or photo labile linkage. Such
linkages could provide an alternative route to externally triggered
breakdown of the microsphere shell to that based on the polymer
behaviour discussed in Chapter 5. By using a degradation route which
utilises the crosslinker there is potential to design dual responsive
microspheres that contain a responsive block co-polymer and degra-
dable linkages. This sonochemical thiol-ene chemistry also provides
a route to ’one-pot’ surface functionalisation of the microsphere shell
by adding an alkene based ligand or marker molecule to a standard
microsphere protocol, although this option has not been explored in
this project.
In order to achieve a ’proof of principle’ for thiol-ene crosslinking in
microsphere production, as an alternative to disulfide crosslinking,
PMAene was synthesised in a similar manner to PMASH, Figure
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Figure 3.34: Reaction scheme for the functionalisation of PMA to form
PMAene, carried out at 22 ºC for 24 hours.
3.34. In the case of PMAene 15% functionalisation was achieved,
corresponding to 7 alkene units per PMA chain (DP: 47), confirmed
by DOSY NMR. The PMAene produced was used in the sonochemical
protocol together with two molar equivalents of DTT as a dithiol
cross linker. The tetradecane filled microspheres formed are shown
in Figure 3.35. In order to establish whether the shells contained
thioether linkages the microspheres produced were dried and analy-
sed using FTIR (Figure 3.35). The broad peak at 616 cm-1suggests a
C-S stretch consistent with thiol-ene crosslinking. However further
characterisation is required to provide more substantial evidence for
thiol-ene crosslinking of the microsphere shell.
Figure 3.35: Optical micrograph of PMAene microspheres crosslinked
with DTT in aqueous suspension, scale bar: 50 µm
These results demonstrate that the sonochemically initiated thiol-ene
reaction is a viable alternative to its thermally initiated analog. The
reaction rates in the aqueous system were particularly favourable,




Figure 3.36: FTIR Spectra of dried PMAene (blue) and dried
PMAene/DTT tetradecane filled microspheres (green)
sonochemical thiol-ene reaction can be transferred to the sonochemical
microsphere protocol in order to form PMAene microspheres with the
aid of a cross linker. This utility provides potential for future appli-
cations of sonochemical microspheres through the use of degradable
cross linkers.
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4 Water in oil emulsion filled
microspheres
Beyond sonochemical encapsulation of an oil phase within a protein
or polymer shell, discussed in chapter 3, it is of interest to explore
the potential to encapsulate an aqueous phase using the sonochemical
method. The presence of an aqueous phase within the core of
sonochemically produced microspheres opens up the opportunity to
deliver hydrophilic species in addition to lipophilic species.
Figure 4.1: Schematic of ideal w/o emulsion filled microsphere struc-
ture, blue: aqueous phase, yellow: oil phase and grey:
lysozyme shell.
The formation of oil filled protein and polymer microspheres via
the sonochemical method is dependent upon the emulsification that
occurs during the sonication step. In order to facilitate both emulsi-
fication and encapsulation of an aqueous phase, formation of a triple
emulsion was proposed. It was thought that by forming a water in oil
(w/o) emulsion phase which could then be emulsified in a second oil
in water (o/w) emulsion during microsphere production a water in
oil in water (w/o/w) emulsion stabilised by the protein shell could
be formed. Figure 4.1 shows an idealised schematic version of the
structures proposed. Formation of these w/o emulsion microspheres
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should facilitate encapsulation of hydrophilic species in addition to
lipophilic species, broadening the scope of sonochemically produced
microspheres for drug delivery.
4.1 Water in oil and water in oil in water
emulsions
In order to design a w/o emulsion that is sufficiently stable to undergo
sonication with a protein solution to form w/o emulsion filled micros-
pheres an understanding of the theory behind emulsion production
and stability is required. Emulsions are inherently thermodynamically
unstable due to the high surface energy of the dispersed phase158. As a
result a large input of energy is required to form an emulsion, this can
be provided by mechanical means, for example via a homogeniser or
an ultrasonic transducer159. The emulsion can be stabilised by using
surface active species (often a surfactant) to reduce the interfacial
tension between the droplets and the continuous phase160. When
emulsifying oil and water either an o/w or a w/o emulsion can be
formed, determined largely by whether the surfactant chosen is more
soluble in the water or oil phase158. In this study our interest is in
forming a w/o emulsion that is stable enough to undergo a second
emulsification step to form a w/o/w double emulsion which is then
stabilised by a protein or polymer shell.
Emulsion droplets tend to adopt a spherical shape in order to minimise
their surface area and therefore their surface energy. Interfacial tension
(g Nm-1) is a proportionality constant describing the change in Gibbs








The pressures exerted on the curved interface of the droplet are
determined by the Laplace equation which states that the pressure on
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the concave face of the interface (Pin) will always be greater than that
on the convex face (Pout)160.






This difference in pressure across the interface decreases, eventually
to zero, as the radius of curvature (r) increases, eventually to infinity
for a flat interface160. The small droplets formed in emulsions have a
small radius of curvature and therefore the pressure gradient across
the interface is large. The pressure gradient is also influenced by the
interfacial tension at the bubble surface. Hence an emulsion can be
stabilised by a surfactant which reduces the interfacial tension.
Several processes can contribute to the breakdown of an emulsion:
- Ostwald ripening: This is a thermodynamically driven process in
polydisperse emulsions that results in an increase in the average
droplet size of an emulsion162. Small droplets have a higher surface
energy than large droplets due to their larger surface area to volume
ratio. As a result small droplets dissolve into the continuous phase
more rapidly than large droplets. The dissolved molecules diffuse
through the continuous phase and join the larger droplets162;163. The
overall result of this process is a decrease in the free energy of the
emulsion and eventual phase separation. In a w/o emulsion this
phenomenon can be described as an osmotic process, water molecules
from the dispersed droplets pass through the continuous oil phase as
if it were a partially permeable membrane164.
- Droplet coalescence: If the energy barrier to coalescence between two
adjacent droplets is not sufficiently large then a single larger droplet
with a lower surface energy will form. The presence of an interfacial
membrane of surfactant molecules prevents coalescence by reducing
the interfacial tension of the individual droplets whilst providing a
physical barrier158.
- Sedimentation and creaming: Inverse (w/o) emulsions are prone
to sedimentation, whilst oil droplets in an o/w emulsion tend to
cream at the surface. Inverse emulsions can be stabilised towards
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sedimentation by reducing the droplet size, as small droplets have
greater kinetic stability165.
Sonochemical emulsification
Mechanical emulsification works by creating shear which disrupts the
interface between two phases resulting in droplet formation159;166. In
this study ultrasound will be used as the method of emulsification.
The exact mechanism of droplet disruption by ultrasound is not yet
fully understood, however the following three mechanisms are known
to contribute to droplet formation35:
- Unstable oscillations at the water:oil interface (capillary waves)
disrupt the interface resulting in the formation of droplets. This
mechanism only makes an important contribution if the wavelength
of the capillary waves is significantly shorter than the diameter of the
initial droplet. The wavelength of the capillary waves at 20 kHz is
typically 10 mm so this mechanism is only of significant importance at
the start of the emulsification process167.
- Oscillation of whole droplets followed by disruption will occur
with droplets which have a diameter matching the wavelength of the
sound wave, which at 20 kHz is 10 mm. This mechanism makes a
limited contribution to the overall emulsification process due to the
polydisperse nature of the system168.
- Cavitation is thought to be the dominant emulsifying mechanism
and it has been observed empirically that parameters which enhance
cavitation also enhance emulsification resulting in smaller droplet
diameters. Upon cavitational collapse micro jets are generated which
are thought to cause extensive droplet disruption, although this
mechanism has not yet been proven35;159;166.
It has been demonstrated that the droplet size in w/o emulsions
decreases with increasing energy density in ultrasound systems165.
Emulsions generated by sonication have dispersed droplets with
a smaller average diameter than those generated in high pressure
homogenizers and are therefore more stable35.
The purpose of this study is to create encapsulated w/o/w droplets
using a two step process. The cross-linked lysozyme shell should
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stabilise the secondary emulsion by providing a physical barrier to
coalescence. As a result the main challenges in the design of the system
are in creating a w/o emulsion that is sufficiently stable to undergo
the second emulsification step, and in maintaining the integrity of the
internal water droplets after formation of the double emulsion. The
surfactant chosen to stabilise the dispersed water droplets is sorbitan
monooleate (Span 80®) (Figure 4.2), an emulsifier commonly used in
food products such as cakes, icings and artificial whipped cream169.
Span 80® has a Hydrophile Lipophile Balance (HLB) value of 4.3
meaning that it has a greater affinity for the oil phase than the aqueous
phase169. This makes it a suitable surfactant for a w/o emulsion as it is
has been shown to be favourable to emulsion stability if the emulsifier
has a higher affinity for the continuous phase than the dispersed
phase169.
Figure 4.2: Span 80®
There are a number of factors that affect the stability of w/o and
w/o/w emulsions, below is a brief summary discussing these factors
in the context of Span® surfactants and how they can be manipulated
in order to achieve desired emulsion characteristics. The two key
factors that concern this study are emulsion stability which should be
maximised and droplet size which should be minimised.
Choice of oil: There is very little comment in the literature regarding
the properties of oils used in w/o emulsions. However it was noted
by Capdevila et al.170 that long alkyl chain oils give more stable
emulsions than those oils with short alkyl chains. Water molecules
are thought to become less soluble in the oil phase as the length of
the alkyl chains increases and therefore Ostwald ripening is inhibited
in emulsions formed with long alkyl chains170. This supports the
case for using tetradecane, the oil phase utilised in chapter 3, in
the emulsions produced for encapsulation. In a study of ultrasound
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assisted emulsification it was noted by the authors that oil viscosity
did not affect the resulting size distribution of the water droplets
formed166.
Surfactant concentration: Double emulsions are often stabilised by
two surfactants, one in the oil phase which stabilises the internal water
droplets and one in the continuous water phase which stabilises the
secondary oil droplets, for example Span 80® with Tween 80®171.
In our case we have chosen to replace the surfactant in the aqueous
phase with lysozyme which will stabilise the secondary oil droplets
by forming a cross linked shell. This has the benefit that unfavourable
surfactant interactions can be removed from the system, for example;
Tween 80® is able to solubilise Span 80® in micelles removing it
from the oil phase to the bulk aqueous phase, destabilising the
w/o phase171. Increasing the concentration of surfactant in the oil
phase decreases the internal water droplet size and decreases the
w/o/w droplet size171 169. This results in greater kinetic stability
to coalescence. However if the surfactant concentration is increased
beyond the critical micelle concentration (cmc) then the rate of Ost-
wald ripening will increase because the transport of water molecules
through the continuous oil phase will be aided by the presence of
inverse micelles172. The effect of Span 80® concentration on the
diameter of the internal water droplets in the emulsions produced
for the w/o emulsion microspheres discussed in section 4.2 will be
considered, whilst optimising the emulsion production conditions.
Sonochemical w/o/w microspheres
There are several reports of w/o/w emulsions formed under ultra-
sound irradiation and stabilised by polymer coatings173;174, however
in these cases the ultrasound is used only for emulsification and not
for sonochemical purposes. One report describes the self assembly of
egg white proteins around a benzotrifluoride oil phase, whilst under
sonication in a 35 kHz ultrasound bath for 1- 60 minutes, to form
w/o/w capsule structures175. The structures formed in this system
are based on pickering emulsions formed in an initial emulsification
step. These emulsions are simple o/w emulsions which are not
particularly stable. However when these emulsions are sonicated,
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w/o/w structures are formed which are more stable. It is suggested
by the authors that the unexpected w/o/w structure is formed as a
result of deformation of the protein shells during sonication resulting
in pinching of water droplets into the internal oil phase175. The result
is a structure made up of capsules within capsules. This system is
based on a mixture of proteins, including lysozyme, which will have
contributed in part to the formation of complex w/o/w capsules and
are likely to have undergone some sonochemical denaturation.
Characterisation of encapsulation and release
In order to use these w/o/w systems for drug delivery applications
it is necessary to characterise the encapsulation of solute within the
inner aqueous phase and also the release profile, both under storage
conditions and also as a result of triggered release. In order to achieve
this the following definitions were used:
Encapsulation efficiency176: “The amount of aqueous phase marker
that remains entrapped in the inner aqueous phase during manufac-
ture of the w/o/w double emulsion”.
Encapsulation stability176: “The amount of aqueous phase marker
which remains entrapped in the inner aqueous phase during storage
or stresses”.
Released markers can be separated from the emulsion phase (in
this case microspheres) either by centrifugation or dialysis prior to
measurement. In order to accurately quantify the encapsulation
efficiency and the encapsulation stability the chosen marker molecule
must not be degraded during production of the w/o/w system or
afterwards in release. A range of different markers and detection
methods have been reported including: vitamin B12, methylene blue
and glucose, all detected by UV/VIS spectroscopy176;177; vitamin
B1 release was detected by electrochemical methods178; release of
salt can be characterised by conductivity179;180 and finally release
can be monitored by measuring the fluorescence from fluorophores
or fluorescently labelled proteins181;182. In the following discussion
fluorescence, conductivity and UV/VIS (via HPLC) are used to detect




Encapsulation of lipophilic components dissolved in oil phases within
the microspheres is accomplished by floating a small amount of the
oil solution on the surface of the protein solution and sonicating for a
short time with the tip of the ultrasound horn at the oil:water interface
(as described in chapter 3). This methodology was modified here by
replacing the organic component with a water-in-oil emulsion, using
a continuous oil phase known to facilitate microsphere formation. The
challenges in this investigation were; to prepare a stable w/o emulsion
which could be layered on the surface of the lysozyme solution, to
maximise the quantity of aqueous phase within the inverse emulsion
and to develop the sonochemical methodology described in chapter 3
so that the emulsion maintained its internal structure once formed into
microspheres.
4.2 Inverse emulsion optimisation
The first step undertaken in the development of w/o emulsion mi-
crospheres was to find the optimum conditions for formation of a w/o
emulsion using our ultrasonic transducer. Ultrasonic emulsification
was carried out as a convenient and efficient means of forming a
finely dispersed emulsion. It was not possible to form a stable w/o
emulsion by sonicating water and tetradecane alone, instead a two
phase system formed containing an o/w emulsion phase and an excess
of tetradecane.
Djenouhat et al.183 report using Span 80® to stabilise a water in oil
emulsion made up of sulfuric acid in hexane. Span 80® is soluble
in the continuous hexane phase and stabilises the water droplets as
inverse micelles, reducing the interfacial energy and facilitating w/o
emulsion formation. Reproducing the optimised conditions reported
by Djenouhat et al. (three minutes sonication time, 5 w/w% Span 80®,
0.5 M sulfuric acid and an aqueous:hexane ratio of 1:1) using generator
B at an intensity of 45 W cm-2 a w/o emulsion was formed. The hexane
w/o emulsion was used in the sonochemical microsphere protocol
but no microspheres containing an emulsion phase were formed. It
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was clear that the emulsion was not sufficiently stable to survive
the sonication used to form microspheres. However substituting
tetradecane in place of hexane resulted in a w/o emulsion that could
be used to form w/o emulsion microspheres. The w/o emulsion in the
microspheres can be clearly discerned by optical microscopy (Figure
4.3).
Figure 4.3: Optical micrograph of w/o emulsion microspheres formed
from a 40 wt% (0.5 M sulfuric acid(aq) : tetradecane
containing 5 wt% Span 80®) w/o emulsion according to
the sonochemical method (section 2.3.2), scale bar 50 µm.
In order to optimise the conditions used to form the w/o tetradecane
emulsion the effect of varying the concentration of Span 80®, soni-
cation time and salt concentration on the dispersed aqueous droplet
diameters were studied. The emulsions formed in each case were
diluted in tetradecane containing a matching concentration of Span
80®, to allow the droplet diameter distribution to be measured by
dynamic light scattering (DLS). The aim was to minimise the droplet
diameter in order to form a well controlled, finely dispersed emulsion
that could be encapsulated reproducibly within protein microspheres.
Figure 4.4 shows the z-average droplet diameters, measured by DLS,
formed with different concentrations of Span 80® in the tetradecane
phase. The z-average diameter is defined as an average of the droplet
population’s hydrodynamic diameters weighted with the square of the
particle mass184. It can be seen that between 0.5 and 4 wt% increasing
the Span 80® concentration reduces the z-average diameter of the
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Figure 4.4: Effect of surfactant concentration on droplet diameter in a
40% v/v tetradecane emulsion measured by DLS (sample
dispersities displayed in brackets). (6 M NaCl(aq), 5 min
sonication; 45 Wcm-2)
80® concentration, as at higher concentrations no change in water
droplet diameter is observed. Early studies also showed that whilst
w/o microspheres could be successfully formed from 4 wt% Span
80® emulsions, w/o microspheres could not be formed from 0.5 wt%
Span 80® emulsions. Hence 4 wt% was chosen as the best Span 80®
concentration for ongoing investigations.
The second parameter considered was sonication time. The z-average
diameter of water droplets in emulsions formed by sonication over
different time periods are shown in Figure 4.5. Intuitively it would
be expected that the diameter of the water droplets formed would
decrease with increasing sonication time as more cavitation events
are allowed to occur. This is consistent with the results collected.
Between one and ten minutes, increasing the sonication time results
in a decrease in water droplet diameter. However after ten minutes
the change in diameter with respect to sonication time plateaus. Five
minutes was chosen as the optimum sonication time as the small
decrease in diameter between five and ten minutes did not warrant
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Figure 4.5: Effect of sonication time on droplet diameter in a 40% v/v
tetradecane emulsion measured by DLS (sample dispersi-
ties displayed in brackets). (4 wt% Span 80®, 0.06 M NaCl,
45 W cm-2)
The final parameter investigated was salt concentration. Early scoping
experiments discussed at the start of this section were carried out
using 0.5 M sulfuric acid as the aqueous phase. Sulfuric acid was not
deemed appropriate for the desired application due to the risk that
acid hydrolysis may result in degradation of drug or dye molecules
encapsulated in the aqueous phase. A stable emulsion can be formed,
with a mean droplet size of 234 nm (SD: 6 nm), using the conditions
chosen above with pure water as a dispersed phase, Figure 4.6.
However when the emulsion was used to form microspheres the
emulsion is degraded to a much coarser emulsion with a mean droplet
diameter of 2292 nm (SD: 1537 nm) (Figure 4.7a). This in turn resulted
in a very polydisperse size distribution of microspheres with varied
water loadings.
It was found that adding salt (NaCl) to the aqueous phase did not
significantly change the z-average diameter of the dispersed water
droplets in the initial emulsion, Figure 4.6. However the emulsion was
significantly more stable to coarsening during microsphere formation
(Figure 4.7). It was found that when a salt concentration of 0.5 M or






























Figure 4.6: Effect of salt concentration on droplet diameter in a 40%
v/v tetradecane emulsion measured by DLS (sample dis-
persities displayed in brackets). (4 wt% Span 80®, 5 min
sonication; 45 Wcm-2)
was retained in the microspheres formed. This was preferable to the
case with 0.06 M salt solution (Figure 4.7b) or pure water because
the fine emulsion meant that the volume percentage of water was
consistent from microsphere to microsphere. It was also observed
that, unlike the samples formed with a salt concentration of 0.5
M or greater, in the case of pure water and 0.06 M salt solution
oil filled microspheres were formed in addition to w/o emulsion
microspheres. This indicates that significant breakdown of the
emulsion occurred releasing oil into the bulk aqueous phase during
microsphere production.
There have been a number of studies reported which address the
effect of salt in the internal water phase on w/o emulsion stabi-
lity164;171;185;186. From these it seems that the most important effect of
a hypertonic internal aqueous phase is the osmotic pressure gradient
that is created. It has been reported that the osmotic pressure created
by a hypertonic internal water phase counterbalances the Laplace
curvature pressure, stabilising the emulsion by reducing Ostwald
ripening164;171;185. This effect was demonstrated in a study carried
out on w/o emulsions of NaCl in hydrocarbon oil stabilised by
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Span 80®186. It was shown that the ionic strength of the solution
could be used to control the rate at which Ostwald ripening occurred
and therefore the stability of the w/o emulsion. It was reported
that emulsions containing a dispersed aqueous phase with a salt
concentration greater than 0.012 M were stable towards Ostwald
ripening and coalescence186.
Figure 4.7: Effect of [NaCl] in the w/o aqueous phase on the micros-
pheres’ internal emulsion morphology. (a) DI water, (b)
0.06 M, (c) 0.5 M and (d) 3 M NaCl solutions respectively.
Scale bar: 10 mm.
An emulsion with a 40 vol% dispersed aqueous phase (1 M NaCl(aq))
was produced using the optimised conditions chosen above (emul-
sion: tetradecane with 4 wt% Span 80®, five minutes sonication at 40
Wcm-2). When this emulsion was used to form microspheres (30 s so-
nication at 14 Wcm-2) the microspheres produced had a mean diameter
of 5.0 µm (SD 1.5 µm), not dissimilar to the lysozyme tetradecane filled
microspheres produced under comparable sonochemical conditions;
mean diameter 4.5 µm (SD: 1.5 µm).
In order to maximise the loading of hydrophilic species in the final
microspheres the effect of varying the emulsion proportions was
investigated (Figure 4.8). Emulsions were formed containing 20, 40,
60 and 80 vol% dispersed aqueous phase (1 M NaCl), these emulsions
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were then used in the microsphere production protocol. Emulsion
microspheres could be formed from the 20 and 40 vol% emulsions
(Figure 4.8a,b), however in the case of 60 and 80 vol% aqueous phase
microsphere production was less successful and a mixture of oil filled
microspheres and protein aggregates were formed (Figure 4.8c,d). The
microspheres formed from the 40 vol% emulsion have a finer internal
structure than those formed from the 20 vol% emulsion. As such the
emulsion with 40 vol% dispersed aqueous phase was chosen as the
optimum emulsion for future microsphere production.
Figure 4.8: Microspheres formed from w/o emulsions with varying
aqueous:oil ratios. (a) 20 v/v%, (b) 40 v/v%, (c) 60 v/v%
and (d) 80 v/v% aqueous phase (1 M NaCl solution). Scale
bar: 10 mm.
Hence the final optimised conditions chosen for w/o emulsion filled
microsphere production were as follows: For the primary emulsion;
40 wt% aqueous phase, 1 M NaCl, 4 wt% Span 80® in tetradecane,
sonication for 5 minutes at 40 W cm-2. For the microspheres; 100 µL
of preformed w/o emulsion was sonicated with 1 mL of 50 mg/mL
lysozyme solution at 14 W cm-2 for 30 s. These conditions were used
when studying encapsulation of hydrophilic and lipophilic dyes and
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characterising the release of hydrophilic species, which is discussed in
the next section.
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4.3 Encapsulation of hydrophilic and lipophilic
species
Laser scanning confocal microscopy (LSCM) was used to demonstrate
encapsulation of both lipophilic and hydrophilic dyes within emulsion
microspheres. Fluorescent dyes 5,6 carboxyfluorescein and nile red
were added to the aqueous and oil phase respectively prior to
formation of the w/o emulsions. Once formed, the microspheres were
imaged using a 488 nm laser to excite green fluorescence from the
5,6-carboxyfluorescein aqueous solution and a 543 nm laser to excite
red fluorescence from the nile red oil solution.
Figure 4.9: LSCM image of w/o emulsion filled lysozyme micros-
pheres in suspension. (a) Internal aqueous phase: 1 mM
5,6-carboxyfluorescein in 10 mM HEPEs buffer, oil phase:
4 wt% Span 80® in tetradecane, external aqueous phase:
3.3 mM tris buffer, viewed under 488 nm laser. (b) Internal
aqueous phase: 1 M NaCl(aq), oil phase: 4 wt% Span 80®
in nile red saturated tetradecane, external aqueous phase:
3.3 mM tris buffer, viewed under 543 nm laser.
Figure 4.9a shows a 1 µm optical slice through a microsphere
containing 5,6 carboxyfluorescein in the internal aqueous phase of
the encapsulated emulsion and Figure 4.9b a 1 µm slice through
a microsphere containing nile red in the oil phase. In each case
the emulsion structure can be clearly observed with the green dye
highlighting the dispersed water droplets and the red dye showing
the continuous oil phase. In Figure 4.9a, in addition to the dye in
the encapsulated aqueous phase, some carboxyfluorescein can also be
seen to be trapped in/bound to the lysozyme shell. This indicates that
some degradation of the emulsion has occurred during production
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resulting in release of the dye from the internal aqueous phase.
The released dye has bound to the lysozyme shell resulting in the
green ring observed. These images provide evidence for successful
encapsulation of the emulsion phase within lysozyme microspheres
and demonstrate that large dye molecules can be encapsulated and
retained.
Figure 4.10: LSCM image of w/o emulsion filled lysozyme micros-
pheres in suspension. Internal aqueous phase: 1 mM
5,6-carboxyfluorescein and 1 M NaCl in 10 mM HEPEs
buffer, oil phase: 4 wt% Span 80® in nile red saturated
tetradecane, external aqueous phase: 3.3 mM tris buffer.
(a) viewed under 488 nm laser, (b) white light optical
transmission image, (c) viewed under 543 nm laser, (d)
viewed under both 488 nm and 543 nm lasers.
More compelling evidence for the enhanced utility of these micros-
pheres beyond that of simple oil filled microspheres can be achieved
by adding dyes to the oil and water phases simultaneously. The
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resulting LSCM images are shown in Figure 4.10 where it can be
seen that the green regions associated with the aqueous phase (Figure
4.10a) correspond to the dark regions in the red image (Figure 4.10c).
When the two channels are overlaid the green regions fit exactly into
the dark regions left by the red image (Figure 4.10d). This confirms
that successful encapsulation of an intact emulsion phase has been
achieved and that 5,6-carboxyfluorescein and nile red are encapsulated
in the two domains of the emulsion.
Yellow regions in the overlaid image (Figure 4.10d) correspond to
parts of the emulsion where the aqueous droplets are less than 1 µm
in diameter. The optical slice imaged is 1 µm thick, therefore when the
encapsulated aqueous droplets are less than 1µm in diameter the green
aqueous phase and the red oil phase overlap within the slice. Figure
4.11 shows the same image with the co-localised pixels removed. In
this image the larger water droplets can be seen as distinct green
circles, confirming the clearly defined regions of the encapsulated
emulsion.
Figure 4.11: LSCM image of w/o emulsion filled lysozyme micros-
pheres in suspension as in Figure 4.10d but with coloca-
lised pixels removed, a pixel was defined as colocalised
when both channels (488 and 543 nm) had an intensity of
greater than 100 gray187.
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4.4 Release of hydrophilic species from w/o
emulsion filled microspheres: Lysozyme
microspheres
Having demonstrated that w/o emulsion filled microspheres could be
successfully formed using the sonochemical method and that hydro-
philic species could be encapsulated it was interesting to investigate
the release profiles for hydrophilic species from these microspheres.
Figure 4.12: 5,6-Carboxyfluorescein
5,6-carboxyfluorescein was chosen as a suitable marker for release
because its tendency to dimerise at high concentrations results in self
quenching of its fluorescence188;189. Hence release can be measured
by encapsulating a quenched concentration of 5,6-carboxyfluorescein
as the internal aqueous phase and monitoring the increase in fluores-
cence as the 5,6-carboxyfluorescein is released from the microspheres
and diluted into the external aqueous phase190. Release of 5,6-
carboxyfluorescein was triggered using DTT as a disulfide cleavage
agent. It was hoped that cleaving the stabilising disulfide bonds in the
shell would provide a crude mimic of the shell degradation that would
occur within the reductive environment of a cell subsequent to uptake
of a microsphere90. A 50 µL portion of microspheres in aqueous
suspension was diluted into 2 mL of HEPEs buffer and shaken at 37
°C. The fluorescence emitted by microsphere suspensions incubated
with different concentrations of DTT was monitored over a six hour
period and the resulting release curves are shown in Figure 4.13.
In the absence of DTT, lysozyme w/o emulsion filled microspheres
are stable to 5,6-carboxyfluorescein release over a six hour period
(in fact the untreated microspheres remained stable over a 12 hour
period). It can be seen from Figure 4.13 that the rate of increase in

























Figure 4.13: Change in solution fluorescence on breakdown of w/o
emulsion filled lysozyme microspheres containing 50 mM
5(6)-carboxyfluorescein dispersed in tetradecane on incu-
bation at 37 ºC with DTT. Green diamonds: 60 mg/mL
DTT, pale blue triangles: 30 mg/mL DTT, bright blue
squares: 12 mg/mL DTT, navy blue circles: no DTT.
dependent on the DTT concentration. The microspheres in 60 mg/mL
DTT solution achieved maximum release after two hours compared
to six hours in the case of microspheres in the 30 mg/mL DTT
solution. DTT destabilises the microsphere shells by cleaving disulfide
bonds and the concentration dependence indicates that the disulfide
bonds are crucial to the integrity of the protein shell. The DTT
dependent loss of the protein shell resulting in 5,6-carboxyfluorescein
release also demonstrates that the continuous tetradecane phase alone
is insufficient to prevent leakages, so release can be triggered by
breakdown of the protein shell. Breakdown of the microspheres and
release of the internal water phase can be confirmed by viewing the
microspheres under a microscope before and after treatment with DTT
(Figure 4.14a,b). After treatment only small oil filled microspheres and
protein fragments remain.
In addition to chemical breakdown of the microsphere shells, release
triggered by mechanical breakdown of the microsphere shells was
investigated. A suspension of microspheres was sonicated at 45 Wcm-2
using ultrasound from generator B over a 4 minute period. Release
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Figure 4.14: Optical micrographs of lysozyme microspheres in suspen-
sion taken before (a), after 12 hrs with DTT incubation (b)
and after four minutes sonication (c), scale bar: 50µm
was monitored over this period (Figure 4.15) and the maximum
fluorescence was observed after 60 s sonication. The fluorescence
intensity at 60 s corresponds to the fluorescence intensity after 2 hours
incubation with 60 mg/mL DTT. Unfortunately the nature of the
experimental method and the fact that the suspension concentration
of microspheres cannot be accurately defined, means that the extent
of release cannot be expressed as a percentage of the quantity
encapsulated. Hence the results in the DTT incubation and sonication
experiments were normalised to the fluorescence at ’time zero’. Again
breakdown of the microspheres was confirmed from micrographs
taken after sonication (Figure 4.14c), in this case all that remained were
large protein aggregates and oil droplets.
Subsequent to monitoring dye release, the release of NaCl, used to
enhance the stability of the w/o emulsion phase, from emulsion
microspheres in suspension was measured. Salt release from the
microspheres was estimated by measuring the conductivity of a
suspension of microspheres before and after sonicating at 45 Wcm-2
for 2 minutes. The change in conductivity resulting from mechanical
breakdown of the microspheres during sonication is shown in Figure
4.16 for three different scenarios.
In Figure 4.16a w/o emulsion microspheres containing 6 M NaCl in
the dispersed aqueous phase were broken down by sonication. The
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Figure 4.15: Change in fluorescence due to release of carboxyfluo-
rescein on ultrasonic breakdown of w/o emulsion filled
microspheres with 50 mM 5,6-carboxyfluorescein as the
internal aqueous phase.
breakdown salt is released from the internal aqueous phase, as would
be expected. In comparison when oil filled microspheres are sonicated
there is only a very small increase in conductivity (Figure 4.16b). There
is no salt present in the internal phase in this case so it is suggested that
this small increase in conductivity is a result of small charged protein
fragments being released from the broken shell. Figure 4.16c shows
the control experiment in which an aliquot of salt solution equivalent
to 100 % release of the internal aqueous phase in (a) was added to a
suspension of oil filled microspheres prior to sonication. A decrease
in conductivity was seen after sonication which may be attributed to
binding of the salt ions to fragments of the broken protein shells. The
observed increase in conductivity in Figure 4.16(a) and the observed
decrease in conductivity in Figure 4.16(c) support the case for salt
release from the internal aqueous phase.
Whilst studying the release of dye molecules and salt is experimentally
amenable and enlightening as to the release mechanisms that occur,
when considering developing polymer microspheres for drug delivery
applications it is interesting to study the release profile of an actual

































Figure 4.16: Mean change in solution conductivity at 25 ºC upon
ultrasonic breakdown of microsphere suspensions: (a)
microspheres containing a 6.1 M NaCl solution as the
aqueous phase suspended in water; (b) microspheres
containing only tetradecane suspended in water; (c)
microspheres containing only tetradecane suspended in
NaCl solution.
used extensively in cancer therapies, particularly in the treatment
of colorectal cancers, breast cancers and cancers in the aerodigestive
tract80. It acts by replacing uracil in RNA thereby inhibiting vital
biosynthetic processes from occurring in the treated cells80. Due to
the non-specific action of the drug a number of severe side effects are
felt by patients including diarrhoea, nausea, vomiting, hair loss and
cardiotoxicity191 192. One of the key motivators in developing drug
delivery vehicles is to reduce these side effects by achieving targeted
delivery of the drug to the disease site, minimising systemic toxicity.
Figure 4.17: 5-Fluorouracil (5FU)
In order to test lysozyme microspheres as carriers for 5FU, a satu-
rated solution of 5FU (0.1 M) in a 1 M sodium chloride solution
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was used as the dispersed aqueous phase in the w/o emulsion.
Emulsion filled lysozyme microspheres were formed according to the
standard procedure discussed above. Once formed, the microsphere
suspensions were transferred to a container sealed with a partially
permeable membrane for dialysis. Deionised water (MilliQ, 18.2
MΩ·cm) was used as the dialysis receptor. The design of this
system meant that two processes occurred in the transfer of 5FU
from the interior of the microspheres to the receptor (from which
samples were taken); rupture of the microsphere shells and release of
the microsphere’s internal phase followed by transfer of 5FU across
the dialysis membrane. However the initial release of 5FU was
deemed to be the rate determining step and the use of a dialysis
membrane facilitated precise sampling of the 5FU in the receptor. The
concentration of 5FU in the dialysis receptor was measured at chosen
time intervals by High Pressure Liquid Chromatography (HPLC) of
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Figure 4.18: Release of 5FU from w/o emulsion filled lysozyme mi-
crospheres as a result of incubation in aqueous suspension
at 22 ºC with 12 mg/mL DTT (blue squares), 30 mg/mL
DTT (green triangles), 60 mg/mL DTT (light blue circles)
and without DTT (dark blue diamonds).
aThe author wishes to acknowledge the kind assistance of Wing Sin Chiu in
developing the HPLC method used and processing the results collected.
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The w/o filled microspheres were incubated with DTT in order to
measure the extent of 5FU release in response to cleavage of the
disulfide crosslinking in the microsphere shell. The microspheres were
incubated with the same concentrations of DTT used when studying
release of 5,6-carboxyfluorescein (Figure 4.13), to allow the release
profiles of the two molecules to be compared. Figure 4.18 shows
the release profiles for w/o emulsion filled microspheres loaded with
5FU. In all cases the microspheres were stable to release over a
two hour period. Between two and eight hours release occurred in
all four systems but there was no trend apparent with increasing
DTT concentration. After eight hours incubation, the microspheres
that were untreated had released 54.7 µg of 5FU, corresponding to
18.6% of that initially encapsulated, compared to 45.6 µg (15.5%
release) when an identical batch of microspheres were incubated
with 60 mg/mL of DTT. Incubation with 12 mg/mL DTT and 30
mg/mL DTT resulted in 31.1% and 8.8% release respectively. Unlike
release of 5,6-carboxyfluorescein from w/o filled microspheres, where
increasing DTT concentrations resulted in faster rates of release, it
appears that when w/o emulsion filled microspheres are loaded with
5FU and stored in aqueous suspension the extent of leakage/release
is independent of DTT concentration. 5FU is a significantly smaller
molecule than 5,6-carboxyfluorescein so it may be that the extent of
cross linking achieved in these lysozyme microspheres is not sufficient
prevent leakage from the internal aqueous phase when stored over a
period of hours.
Sonication was used as an alternative means to trigger release of
5FU, mechanical disruption had been shown to trigger release of
5,6-carboxyfluorescein and sodium chloride. In this case three samples
of microspheres were dialysed for 30 minutes before sonication and
then for a further 30 minutes after each period sonication. The
concentration of 5FU in the dialysis receptors was measured by HPLC
after each period of dialysis and the cumulative release observed
is plotted against total sonication time in Figure 4.19. From the
concentration of 5FU in the dialysis receptor before the first period of
sonication the encapsulation efficiency of the lysozyme microspheres
was estimated to be 99.3%. The total dialysis time was 2.5 hours, from
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Figure 4.19: Mean release of 5FU from w/o emulsion filled lysozyme
microspheres as a result of sonication in aqueous suspen-
sion at 40 Wcm-2 over a two minute period.
release over this time period and therefore it can be concluded that the
mean release of 5FU observed after 2 minutes of sonication (35.7 µg,
12.2%) is due to mechanical disruption of the microsphere shells and
encapsulated w/o emulsion phase.
142
4.5 Release of hydrophilic species from w/o
emulsion filled microspheres: PMASH
microspheres
Emulsion containing PMASH microspheres were formed using an
adaptation of the sonochemical method described above. As with
tetradecane filled PMASH microspheres the denaturation step was
removed and replaced with an acidification step prior to sonication. It
was found that the the optimised conditions chosen for the lysozyme
system above could be used to produce microspheres containing
a fine emulsion in a reproducible manner from PMASH. Figure
4.20a provides evidence for successful encapsulation of intact w/o
emulsion droplets, the microspheres formed are very similar in
morphology to those produced from lysozyme. Figure 4.20b shows
a 1 µm thick optical slice through a w/o emulsion containing PMASH
microsphere containing nile red in tetradecane taken using LSCM. As
with the lysozyme w/o emulsion filled microspheres the encapsulated
emulsion structure can be clearly discerned.
Figure 4.20: PMASH w/o emulsion filled microspheres in aqueous sus-
pension (a) optical micrograph, scale bar 50 µm (b) confo-
cal micrograph, viewed under the 543 nm laser, showing
fluorescence from the encapsulated nile red/tetradecane
solution.
PMASH microspheres are of interest because they are a model and
starting point for the microspheres formed from responsive block
co-polymers, discussed in the next chapter. It was therefore interesting


























Figure 4.21: Change in solution fluorescence on breakdown of w/o
emulsion filled PMASH microspheres containing 50 mM
5(6)-carboxyfluorescein dispersed in tetradecane on incu-
bation at 37 ºC with DTT. Dark blue: No DTT, bright blue:
30 mg/mL DTT.
release of hydrophilic species loaded in the internal aqueous phase.
To allow a comparison to be drawn with the lysozyme microsphere
system the release of 5,6-carboxyfluorescein in vitro was measured
using the same experimental conditions as with the lysozyme system
above. The resulting release profiles are shown in Figure 4.21. It can
be seen that in the absence of DTT, unlike the lysozyme microspheres,
PMASH microspheres are not stable over a 12 hour period. There
are two distinct regions in the release profile corresponding to two
modes of release. The initial release, between 0 and 4 hours can be
attributed to loss of 5,6-carboxyfluorescein trapped in and adsorbed
to the PMASH shell. At 4 hours the rate of release increases before
starting to plateau after 8 hours. This second phase of release is caused
by loss of integrity of the PMASH shells resulting in burst release of
the contents which are rapidly mixed into the external buffer. This
shell rupture can be attributed to insufficient cross linking in the shell
which can only prevent leakage from the internal water phase over a
short time period.
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Incubation with DTT causes accelerated release of the microsphere’s
contents (Figure 4.21). Maximum release is achieved at 5 hours after
which the fluorescent intensity remains constant indicating that no
further release has occurred. This provides evidence for the role of
the disulfide bonds in the PMASH shell in stabilising the internal core
against release. It is suggested that increasing the extent of PMASH
functionalisation would facilitate a greater degree of crosslinking in
the shell which in turn would extend the lifetime of the PMASH
microspheres for storage. The overall extent of release compared to the
initial measured fluorescence in the case with DTT incubation is lower
than the case without DTT. Due to experimental constraints there was
a delay of 5-10 minutes between adding the DTT and starting the
fluorescent measurement. It was observed that in this time the samples
incubated with DTT took on a stronger colour than those without DTT.
It is suggested that incubation with DTT caused very rapid release of
dye molecules that were adsorbed onto or trapped within the PMASH
shells prior to the start of the measurement. As a result the measured
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Figure 4.22: Release of 5FU from w/o emulsion filled PMASH micros-
pheres as a result of incubation in aqueous suspension at
22 ºC with 30 mg/mL DTT (green squares), and without
DTT (dark blue diamonds).
As with lysozyme microspheres it was of interest to study the release
characteristics of the drug molecule 5FU from the w/o emulsion
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filled PMASH microspheres. In the first instance release of 5FU from
untreated microspheres and microspheres incubated with 30 mg/mL
DTT was monitored over an eight hour period, Figure 4.22. The
same batch of PMASH was used to produce the microspheres as in the
5,6-carboxyfluorescein experiment described above. In common with
the previous experiment untreated microspheres are seen to lose their
integrity between 4 and 6 hours leading to a rapid burst release profile
and 37.1% release (109.04 µg of 5FU) at 8 hours. However no leakage
from the shell prior to this release is apparent. Treatment with DTT
triggers breakdown of the shell and immediate release of 5FU, 26.1%
release (76.6 µg) had occurred after 4 hours incubation, compared to
0.1% release (0.3 µg) in the untreated case. After 8 hours 31.2% (91.8
µg) of the 5FU loaded into the microspheres incubated with DTT had
been released and the release rate had plateaued. As in the case of
5,6-carboxyfluorescein above the extent of release at eight hours was
greater from untreated microspheres than those incubated with DTT.
Whilst this discrepancy is seen in both release experiments carried
out on w/o emulsion filled PMASH microspheres it was not observed
in the experiments carried out with w/o emulsion filled lysozyme
microspheres.
Figure 4.23 shows optical micrographs of PMASH emulsion micros-
pheres before and after dialysis, with and without DTT. Destruction of
the microspheres is clear in both cases. The untreated microspheres
appear to have undergone rupture without forming into larger
structures whereas the microspheres treated with DTT have merged to
form larger emulsion droplets. Incomplete destruction of the emulsion
in both cases is consistent with the incomplete release observed in
Figure 4.22. The existence of these large ’intact’ emulsion droplets in
the DTT treated sample may go some way to explaining why release
plateaued after four to eight hours of incubation with DTT, however
the reason for the formation of these droplets is not clear.
Sonication was used to mechanically rupture w/o emulsion filled
PMASH microspheres loaded with 5FU. The experiment was carried
out in an identical manner to that described with w/o emulsion filled
lysozyme microspheres described above. After a total of 6 minutes
sonication the cumulative release of 5FU from the microspheres
amounted to 83.5 µg (28.4 % of the 5FU initially encapsulated). The
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Figure 4.23: Optical micrographs of PMASH microspheres taken before
and after 24hrs in suspension (a,b), before and after 24hrs
in suspension with DTT incubation (c,d), scale bar: 50µm
encapsulation efficiency for the w/o emulsion filled PMASH micros-
pheres, estimated from the 5FU present in the dialysis receptor prior
to sonication, was 99.98%. It is known from the release experiment
carried out with DTT, Figure 4.22, that untreated microspheres are
stable to release for four hours. The sonochemical release experiment
was carried out over a 3.5 hour period so it can be concluded that
the release of 5FU observed is as a result of sonochemical disruption
of the PMASH shell and internal emulsion phase. Figure 4.25 shows
micrographs taken before and after sonochemical treatment of the
w/o emulsion filled microspheres, confirming destruction of the
microspheres.
Therefore it can be concluded that the sonochemical method can be
used to form w/o emulsion filled protein and polymer microspheres.
These microspheres can be used to encapsulate both hydrophilic and
lipophilic species within the internal emulsion phase, as demonstrated
in the confocal micrographs collected. Release of encapsulated
hydrophilic species including 5,6 carboxyfluorescein, sodium chloride
and 5-fluorouracil has been demonstrated providing evidence (in vitro)
supporting the case for the use of w/o emulsion filled microspheres
as drug carriers. It was observed in the case of w/o emulsion filled
lysozyme microspheres that the small drug molecule 5FU leaked freely
from the microspheres during dialysis, which was not the case for
the larger dye molecule 5,6-carboxyfluorescein. PMASH microspheres
were more robust to 5FU leakage, perhaps due to a greater extent
of crosslinking (the PMASH used had 15-16 thiol groups per chain,
compared to a maximum of eight on lysozyme.) Further studies could
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be conducted in the future to further characterise the effect of shell
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Figure 4.24: Release of 5FU from w/o emulsion filled PMASH micros-
pheres as a result of sonication in aqueous suspension at
40 Wcm-2 over a six minute period.
Figure 4.25: Optical micrographs of PMASH microspheres taken before
(a) and after (b) sonochemical breakdown, scale bar:
50µm.
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5 Responsive polymers and
microspheres
It was demonstrated in chapters 3 and 4 that it is possible to
encapsulate both hydrophilic and lipophilic molecules in the core of
sonochemically produced microspheres. Release of these molecules
has been triggered via mechanical or chemical breakdown of the
microsphere shell. It would be of greater use to applications in
drug delivery if release could be initiated by a stimulus integral
to the environment in vivo, for example a change in temperature
or pH. Stimulus responsive polymer capsules are a topic of intense
research, many different release mechanisms are under investigation,
including biological, chemical, photo, thermal, electrical and magnetic
stimuli193. To date the sonochemical method has not been used to
produce responsive polymeric microspheres.
This chapter describes a strategy which utilises the sonochemical
method described above to form hollow polymer microspheres which
have shells that respond to a change in temperature. In order to
achieve this a block copolymer of PMASH with N-isopropylacrylamide
(NIPAm) has been produced. PNIPAM was chosen as an appropriate
stimulus responsive block due to its well known coil-globule transition
at the lower critical solution temperature (LCST) which occurs close
to physiological temperature. The behaviour of PNIPAm in aqueous
solution is discussed further below. A block copolymer was favoured
over a random copolymer as it is known that the LCST of PNIPAm is
changed by its block length so a well characterised block length will
give a well controlled LCST194.
Following the work discussed in chapter 3, PMASH was chosen as
the structural cross linking block as its ability to form oil filled
microspheres under sonochemical conditions is now well understood.
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It was proposed that by forming microspheres from an ABA triblock of
PMASH and PNIPAm the cross linked sections would incorporate the
PNIPAm into the microsphere shell such that upon heating through
the LCST, the coil to globule phase change in the PNIPAm block
would trigger a change in morphology of the microsphere shell,
either to open pores in the shell or rupture the shell completely
(Figure 5.1). It is proposed that either of these responses would
facilitate temperature responsive release of the microsphere’s contents.
Such behaviour would widen the utility of sonochemically produced
polymeric microspheres in drug delivery.
Figure 5.1: Possible release mechanisms, triggered by heating above
the LCST, for block copolymer microspheres containing
PNIPAm within the shell structure.
The following chapter discusses the controlled radical polymerisation
strategy used to produce the block copolymers in question and their
use in microsphere production. Evidence is also presented as a proof
of principle to support the proposal that these microspheres could be
used for temperature responsive release of an active species. Prior
to presenting experimental results the theory of PNIPAm’s LCST
behaviour and controlled radical polymerisation is discussed.
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5.1 Poly(N-isopropylacrylamide)
Poly(N-isopropylacrylamide) (PNIPAm) is very widely used in the
field of responsive drug delivery devices because it undergoes a well
defined phase transition typically in the region of 30-35 ºC195 however
transitions at temperatures as high as 43 ºC have been observed for low
molecular weight samples194. Hence when incorporated into a drug
carrier PNIPAm can be used to trigger release at around physiological
temperature196–201.
Figure 5.2: N-isopropylacrylamide and poly(N-isopropylacrylamide)
PNIPAm is one of a family polymers which display inverse solubility
behaviour in response to increasing temperature. These polymers are
partially hydrophobic, therefore in order to dissolve in an aqueous
medium the polymer chains fold to protect the hydrophobic portions.
The water molecules surrounding each polymer chain become highly
ordered in order to hydrogen bond with the hydrophilic portions of
the chain, solubilising the polymer195. This phenomenon is commonly
known as the ’hydrophobic effect’195 and is associated with a decrease
in entropy. As a result increasing the solution temperature above
a threshold causes the free energy of mixing to become positive
and the polymer to precipitate out of solution. This threshold is
the Lower Critical Solution Temperature (LCST) and can often be
observed macroscopically as the cloud point of the solution.
The LCST varies with a number of factors including; the identity of the
temperature responsive block, chain length, tacticity and the presence
of copolymers. In principle the LCST can be anywhere between 0
°C and 100 °C, more hydrophilic analogs of PNIPAm have higher
LCSTs, resulting from more favourable polymer-solvent interactions,
and more hydrophobic analogs of PNIPAm have lower LCSTs195.
The mechanism of the solubility transition that occurs at the LCST
is not fully understood and is still the subject of active research202.
Hydrogen bonding between the polymer chain and water molecules is
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the main intermolecular interaction involved in solubilising PNIPAm.
A recent computational study has provided evidence for the change
in hydrogen bonding on heating a PNIPAm hydrogel through its
LCST202. Three types of hydrogen bonding are defined in the study;
polymer - polymer, polymer (donor) - water (acceptor) and water
(donor) - polymer (acceptor). On heating through the LCST there is
no significant change in the lifetime of the first two types of bonding
but the water (donor) - polymer (acceptor) bonds were seen to break
and not reform above the LCST. This suggests that it is these hydrogen
bonds which are most fundamental to PNIPAm solubility and that the
loss of these stabilising bonds is an important factor in the collapse of
the polymer chains out of solution202.
In a single chain system the PNIPAm chains can be observed to
collapse individually before aggregating with nearby chains to form
a macroscopic precipitate. In the case of a cross linked hydrogel
a decrease in volume is observed and the LCST is referred to as
the Volume Phase Transition Temperature (VPTT). Hydrogels with
extensive crosslinking undergo a small change in volume at the VPTT
compared to those with minimal crosslinking198.
The LCST of PNIPAm can be tuned to a desired temperature to suit
a chosen application, most simply, by varying the PNIPAm chain
length. High molecular weight PNIPAm chains have a significantly
lower LCST than low molecular weight samples (for example a 32.5
kDa chain exhibits a cloud point at 33 °C, whereas a 3.3 kDa polymer
has a cloud point at 43 °C)194. This is likely to be a result of the
larger quantity of polymer-solvent interactions in the case of longer
polymer chains. This chain length dependence means that achieving
a narrow ÐM is important in producing polymer samples that give
well defined LCSTs. Alternatively incorporating hydrophilic or
hydrophobic monomers will raise or lower the LCST accordingly203.
In the case of low molecular weight polymers the presence of an end
group (for example a controlled radical polymerisation agent) can be
used to achieve a similar effect204.
In a crosslinked gel the inclusion of ionic groups, for example acidic
comonomers, causes an increase in osmotic pressure within the gel.
The gel is subject to a high degree of swelling below the VPTT
and on heating through the VPTT undergoes a more abrupt volume
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transition than observed for PNIPAm homopolymer hydrogels. If two
thermosensitive segments are used with distinct LCSTs a two step
phase transition can be achieved205.
The tacticity of a sample of PNIPAm has a significant effect on both
its solubility and LCST. Whilst atactic PNIPAm is freely soluble in
cold water and has a typical LCST of 32 ºC206 207, isotactic rich (>
72%) PNIPAm is insoluble in cold water207. Syndiotactic PNIPAm is
soluble in cold water and, with comparable chain lengths, increasing
the syndiotactic component from 53 to 71% causes an increase in the
solution cloud point from 33.1 ºC to 35.9 ºC207;208 206. It was also
observed that syndiotactic rich PNIPAm displayed a sharper phase
transition with less hysterisis at the LCST than atactic PNIPAm208.
5.2 Diffusion Ordered NMR Spectroscopy
Diffusion ordered (DOSY) NMR spectroscopy is a 2D 1H-NMR
experiment which can be used as a complimentary technique to Gel
Permeation Chromatography (GPC) in the characterisation of block
co-polymers. First developed in 1992209 DOSY NMR correlates the
diffusion of molecules in an NMR sample to their 1H-NMR chemical
shifts. The experiment involves measuring the exponential signal
attenuation in a series of pulsed field gradient experiments. By fitting
the decay curves, the diffusion coefficients of the molecules can be
calculated210 and displayed as a map of chemical shift vs diffusion
coefficient, D. The size and shape of the molecules, solvent interactions
and temperature will determine the rate of self diffusion described
by the diffusion coefficient211. Therefore the diffusion coefficient can
be used as a measure of polymer size in solution and hence chain
length212. In the case of a mixture, diffusion coefficients corresponding
to the chemical shifts of the different species in solution will be
displayed in the map. This highlights a key benefit of DOSY NMR
over GPC analysis; the identity of the polymers in solution can be
established from their chemical shifts, a facility that is not provided
by GPC.
There have been a number of reports of the use of DOSY NMR
to measure polymer dispersities211 212, characterise block copoly-
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mers213;214 215;216, resolve polymer mixtures210, and recently to mea-
sure the Critical Micelle Concentration of amphiphilic block copo-
lymers217. However DOSY NMR, used in its simplest form to
produce single exponential 2D maps is not without its drawbacks. If
DOSY NMR is used to monitor samples which contain overlapping
signals, for example a mixture of a homopolymer macroRAFT agent or
macroinitiator and the corresponding diblock, the diffusion coefficient
for the peak associated with the overlapping chemical shifts will not
be accurate216. If only diblock copolymer is present the diffusion
coefficients of the chemical shifts associated with the two blocks will
be identical and will reflect the true molecular mass of the diblock
copolymer. If however a mixture is present the mathematical trans-
formation used will result in a peak at a diffusion coefficient which
corresponds to neither the diblock copolymer nor the homopolymer
but rather an average of the two which has no meaning216. As a result
DOSY NMR can be used as a tool to characterise the product of a block
copolymerisation because peaks that do not correspond to the same
diffusion coefficient will be evidence of an impure product. However
care must be taken not to derive a Mn value from the spectra of such a
sample.
In light of this and of the mathematical and empirical complexities
of obtaining accurate molecular mass information from DOSY spectra
the DOSY experiments discussed in sections 5.4 and 3.2 have been
employed simply to confirm diblock copolymer formation.
5.3 Controlled radical polymerisation
techniques
Controlled radical polymerisations (CRP) were first developed in the
1990’s as a means of producing polymers with well controlled archi-
tectures218. Prior to the development of CRP, ionic polymerisations
were used to form polymers with well defined chain lengths219. These
polymerisations can also be described as ’living polymerisations’:
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“Living polymers are polymers that retain their ability to propagate
and grow to a desired size while their degree of termination or chain
transfer is still negligible.”219
However the polymerisations required stringent inertion and were li-
mited in the monomer functionalities that could be accommodated220.
CRP allows access to controlled polymers from a much broader range
of monomers221.
There are a number of different methods which can be used to
carry out a controlled radical polymerisation: Stable Free Radical
Polymerisation (SFRP), a well known example of which is Nitroxide
Mediated Polymerisation (NMP)218, Atom Transfer Radical Poly-
merisation (ATRP)222 and Reversible Addition-Fragmentation Chain
Transfer Polymerisation (RAFT)223. Included within this list are two
different mechanistic approaches to CRP, the first, which facilitates
SFRP and ATRP, is the persistent radical effect224. This utilises
termination reactions between growing polymer chains in the early
stages of the polymerisation reaction to cause an accumulation of
persistent radicals (X) (Figure 5.3). These radicals are unable to
terminate by reaction with themselves but instead combine with the
propagating chain radicals to form dormant radical adducts. This
accumulation drives the initial equilibrium between dormant and
active species resulting in a steady state of persistent radicals and
dormant radical adducts facilitating controlled chain growth.
Figure 5.3: Controlled polymerisation mechanism mediated by the
Persistent Radical Effect.221.
In contrast, RAFT polymerisation occurs via a degenerative chain
transfer equilibrium which is initiated in an analogous manner to
simple radical polymerisations221. In this case control is achieved
when the propagating chain radicals combine in a reversible manner
with a RAFT agent to form a stable, dormant adduct. This dormant
species exists in equilibrium with the active propagating radicals and
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the RAFT agent is designed such that the rate of transfer is much
faster than the rate of propagation, allowing control over the rate of
monomer addition to be achieved221 (Figure 5.4).
Common to both mechanisms is the formation of a dormant radical
adduct in dynamic equilibrium with the propagating chain radicals.
Propagating chain growth is limited by the fast deactivation rate,
which in an ideal scenario limits the chain growth to one or two
monomers at a time218. Formation of the dormant adduct also protects
the polymer chain from competing termination and side reactions, for
example back biting or branching reactions, which are common in
radical polymerisations218. The polymers formed using these methods
can be synthesised to meet a pre-determined chain length and have a
very narrow dispersity (typically less than 1.3)221.
Although controlled radical polymerisations do not fulfil the true
definition of a living polymerisation a well designed reaction displays
a number of characteristics which reflect the control achieved in a
living polymerisation: chain growth is a linear function of monomer
conversion, the total number of polymer molecules present remains
constant and independent of conversion, the desired chain length can
be controlled by reaction stochiometry, the polymers produced have
narrow dispersities and subsequent monomer additions lead to chain
extension or block formation225. The minimal termination/ undesired
chain transfer reactions that occur in such systems mean that a very
high proportion of the chains produced retain a living chain end which
can be re-introduced into a second polymerisation in order to achieve
further chain growth. It is by this method that block co-polymers with
well defined architectures can be synthesised221.
There are many examples of well defined complex polymer archi-
tectures which have been produced via RAFT polymerisation in the
recent literature226 and a few are highlighted here: Coupling a RAFT
agent containing a N-hydroxysuccinimide group onto one of the
amine groups in lysozyme227, allows protein-polymer conjugates to
be formed. Star copolymers can be formed by growing the polymer
arms from the core outwards226, either with the RAFT functionality on
the outer end of each growing arm which facilitates further functiona-
lisation, for example with proteins228, or with the RAFT functionality
in the core of the star, which reduces the risk of cross polymerisation
156
between stars229. Alternatively RAFT polymerisation can be used
to form ’macroRAFT agents’ which can be coupled together with a
crosslinker to form a star, for example in the case reported by Zhu
et al.230 where polystyrene arms formed using an azide containing
RAFT agent were subsequently ’clicked’ together with a trialkyne
crosslinker. Dendritic polymers formed by RAFT polymerisation have
been reported231 as have graft copolymers232;233. Graft copolymers
can be formed by chain extension from RAFT groups attached to
a polymer backbone232. Alternatively interesting structures such as
a block-graft copolymer can be formed by using, for example, a
polystyrene ’macroRAFT agent’ with PEO macromonomers that had
been end-functionalised with acrlyate monomer units to produce a
toothbrush like structure with a polystyrene handle233.
It is the ability to form well defined block copolymers that is of
particular interest in the case of this project. The CRP method used
was RAFT which is discussed in more detail below.
RAFT Polymerisation:
RAFT polymerisations display living characteristics as a result of a
degenerative chain transfer equilibrium218. The equilibrium is so
called because the reaction starts with a chain transfer agent and the
product of the equilibrium is also a chain transfer agent, which in a
well controlled reaction should have a similar activity to its precursor,
Figure 5.4.
The addition - fragmentation equilibrium is controlled by a RAFT
agent, which can have one of several structures, shown in Figure 5.5.
The characteristics of the RAFT agent control not only the molecular
weight but also the dispersity of the polymer formed and the activity
of the polymer chain ends towards further transformations234. The
key structural features which control the RAFT agent’s activity can
best be described by considering the R and Z groups separately (Figure
5.4). These structure-activity relationships are described below but
first the overall RAFT mechanism must be considered.
The RAFT polymerisation mechanism is depicted in Figure 5.4. The
reaction is initiated by a radical initiator in a similar way to a standard
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Figure 5.4: RAFT Mechanism218
free radical polymerisation (1), indeed in most cases the same initiator
is used. Once a small number of macroradical species have formed the
macroradicals and RAFT agent can undergo a reversible chain transfer
reaction in an initial ’pre-equilibrium’ (2). The intermediate radical
formed in the reaction can either return to the starting materials via a
β-scission reaction or the R group can be ejected in a similar β-scission
reaction to form a new radical species and a dormant polymer
chain235. The ejected R radical initiates new propagating polymer
chains (3) and the main equilibrium is set up; a new macro radical can
now react with the previously formed dormant chain forming a new
radical intermediate (4). This intermediate can cleave to release either
polymer chain, retaining the second in a dormant state (4). In order
to obtain a high degree of control the RAFT agent is used in an excess
to the initiator so that the majority of polymer chains produced are
initiated by the R group from the RAFT agent235. It is the addition
158
Figure 5.5: RAFT Agent classes: (1) Xanthate, (2) Dithiocarbamate, (3)
Dithioester, (4) Trithiocarbonate235.
- fragmentation equilibrium which controls the growth of polymer
chains in a RAFT polymerisation. The chains in the intermediate have
an equal probability of being released to become propagating macrora-
dicals due to the symmetrical nature of the radical intermediate. This
together with a rapid rate of transfer ensures that all the macroradicals
grow at very similar rates yielding a polymer with a molecular weight
that is controlled by the reaction stochiometry and has a narrow
dispersity. Despite the pseudo-living characteristics observed for
many RAFT polymerisations a small quantity of termination reactions
occur (5), predominately as combination reactions between growing
radical chains218. These termination reactions should be minimised,
firstly in order to maintain control over chain length and dispersity but
also in order to maintain ‘living’ RAFT end groups on the polymers
produced. It is these RAFT end groups that, when retained, facilitate







The activity of a RAFT agent can be defined by its transfer constant,
ktr, which is a product of kadd and kbeta, see equation 5.1, compared
to the rate of monomer propagation235, kp. In designing a RAFT
polymerisation it is important to consider the transfer constant both
for the initial RAFT agent and the macromolecular RAFT agent that is
subsequently produced.
The Z group on the RAFT agent affects ktr by influencing the reactivity
of the C=S bond towards radical addition223. Dithioesters and
trithiocarbonates are the most reactive RAFT agents235 (Figure 5.5).
As a general rule the transfer constant is increased when the Z group
contains electron withdrawing groups which stabilise the intermediate
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radical that forms leading to an overall increase in reactivity with
respect to addition into the C=S bond235. However it should be
noted that if the intermediate radical is too stable then the rate of
fragmentation will be retarded and unwanted side reactions will
prevail235. If the RAFT agent chosen contains a nitrogen or oxygen
lone pair adjacent to the C=S bond then zwitterionic canonical forms
will play a significant role, reducing the double bond character of the
C=S bond and, in turn reducing its reactivity. The relative reactivities
of several common Z groups are listed in Figure 5.6.
The reactivity of the RAFT agent C=S bond must be chosen to suit
the monomer in question. Monomers can be put in order from
more activated monomers to less activated monomers. The double
bond in more activated monomers is conjugated into an aromatic ring
or carbonyl group, examples of more activated monomers include
styrene and methyl methacrylate. Less active monomers do not have
conjugated double bonds, in these cases the double bond is located
next to a saturated carbon or the heteroatom in a heteroaromatic
ring, as is the case in N-vinylpyrrolidone235. Propagating radicals
composed of more activated monomers are less active in radical
addition so a more active RAFT agent is required for good control to be
achieved. In contrast less activated monomers display poor homolytic
cleavage from the radical intermediate so a less active RAFT agent is
required in order to prevent rate retardation235.
Figure 5.6: Variation of transfer constant with Z group substituents.235.
It is the leaving group ability of the R fragment and hence the
partitioning between the precursors and the products in the first
addition-fragmentation equilibrium that defines the R group’s contri-
bution to the transfer constant223. Good control over dispersity
is achieved when fragmentation is rapid so that side reactions are
avoided and the reaction can proceed rapidly when the R group is
released in favour of the macroradical. In the case of an R group
that is a poor leaving group the polymerisation is likely to stall235.
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Characteristics general to leaving groups used in synthetic organic
chemistry have a strong influence; steric and electronic effects that
improve the stability of the R group radical will improve its leaving
group characteristics. Hence R groups that form tertiary radicals
and which contain delocalising or electron withdrawing groups are
commonly used235. In addition to having good leaving group qualities
the R group must also be efficient in re-initiating polymerisation; the
rate of re-initiation must exceed the rate of propagation in order to
achieve good control and prevent the R radicals from being consumed
in side reactions. In the case of monomers with high propagation rate
constants a primary or secondary R group may be favoured in order to
achieve a rapid re-initiation rate236. Figure 5.7 lists a series of common
R groups in order of their effect on the transfer constant.
Figure 5.7: Variation of transfer constant with R group substituents.235.
The following section discusses the current literature precedent for
using RAFT to form PMA and PNIPAm copolymers, which was used
as a basis for the following experimental work.
RAFT polymerisation of NIPAm, MA and related
monomers
There have been a number of reports of using RAFT polymerisation
to produce PNIPAm, PMA and their copolymers under controlled
conditions. The two RAFT agent types most commonly used are
dithioesters and trithiocarbonates (Figure 5.8). A dithiobenzoate (2)
has been used to produce PNIPAm237 and P(tBMA-b-NIPAm)238.
In both cases the polymers produced had narrow size distributions
but the rate of polymerisation was slow. It was suggested by the
authors that slow re-initiation by the R group had retarded the
rate of polymerisation. Yang et al.239 report the use of a different
dithiobenzoate RAFT agent (1) with a low transfer constant in the
synthesis of P(NIPAm-MA-NIPAm), the low transfer constant favours
tri-block formation as it results in a less labile RAFT end group on the
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macro-RAFT agent, if the transfer constant of the propagating chain is
similar to that of the RAFT precursor. As a result a larger proportion
of polymer chains retain their RAFT functionality facilitating growth
of the next block. However Yang et al. did report some breakdown
of their RAFT agent during the reaction and as a result Pelet et al.240
report using a RAFT agent (3) with an alternative tertiary R group in
order achieve better control in the latter stages of the reaction.
Examples of polymers of methacrylic acid or methacrylates are
also reported where dithiobenzoates have been used as RAFT
agents240–243(3-5). However the polymerisations were not trouble
free. The RAFT agents used were subject to degradation, especially
by hydrolysis in aqueous solvent240. Guillaneuf et al.241 report the
formation of dithiobenzoic acid from (3) as a side product in the
polymerisation of methacrylic acid. Dithiobenzoic acid disrupts the
addition - fragmentation equilibrium by acting as a pseudo-RAFT
agent. As a result control over dispersity and chain length was
reduced.
Trithiocarbonate RAFT agents offer an alternative to dithioesters in
the polymerisation of NIPAm244 (6), MA245;246(9) and tBMA247(7).
The trithiocarbonates used display good control and do not degrade
under the reaction conditions used. There is one example of successful
diblock formation from a macroRAFT agent formed from NIPAm
with a trithiocarbonate248(7). Although these reactions display good
control there are several reports of an inhibition period at the start of
the polymerisations246;249(8,9), attributed to slow reinitiation on the
part of the tertiary R group.
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Figure 5.8: RAFT Agents
163
Results and Discussion
5.4 PtBMA macroRAFT agent synthesis
The block copolymer synthesis was carried out in a step-wise manner
using a RAFT methodology similar to that described above. Early
synthetic attempts used dithiobenzoate RAFT agents, 4-cyano-4-
(phenyl carbonothioyl thio)pentanoic acid (3) and S-(Thiobenzoyl)thio
glycolic acid (1) (Figure 5.8), with methacrylic acid (MA), tert-
butylmethacrylate (t-BMA) and NIPAm. Homopolymers were suc-
cessfully formed from all three monomers and their identity confirmed
in each case by 1H-NMR (section 2.4.1-4). The molecular weight
distributions were measured by GPC, except in the case of PMA
which is not soluble in the chosen GPC solvent, tetrahydrofuran
(THF) (Table 5.1 entries 1-4). When the homopolymers that had been
produced were used as macroRAFT agents no diblock copolymers
were successfully formed.
# RAFT Polymer Mn DP ÐM
Agent (kDa)
1 3 PtBMA 33.1 233 1.28
2 3 PNIPAm 3.2 28 1.67
3 3 PMA n/a n/a n/a
4 1 PMA n/a n/a n/a
5 10 PNIPAm 3.9 34 1.37
6 10 PtBMA 5.7 40 1.35
7 10 P(NIPAm-b-MA) n/a n/a n/a
8 10 P(tBMA-b-NIPAm) 10.7 40+44 1.43
9 10 PMA - - -
Table 5.1: Polymers formed with dithiobenzoate and trithiocarbonate
RAFT agents in early studies (RAFT agent numbers link to
the structures shown in Figure 5.5).
Based on the evidence in the literature for more effective use of
trithiocarbonate RAFT agents in the synthesis of PMA and PNIPAm
block copolymers, polymerisations with 2-cyano-2-propyl dodecyl
trithiocarbonate (10) were trialled (Figure 5.8, Table 5.1 entries 5-8).
Initial attempts showed that PNIPAm and PtBMA polymers could be
produced readily with narrow dispersities (ÐM). A diblock copolymer
was successfully formed from a PNIPAm macroRAFT agent using
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methacrylic acid as a comonomer. However the homopolymerisation
of methacrylic acid with 10 was not successful.
The homopolymer formed from tBMA was successfully used to
synthesise a diblock copolymer with NIPAm. In light of this and the
poor PMA yields, PtBMA was chosen as a suitable substitute for PMA.
The use of tBMA as a monomer had additional experimental benefits.
The GPC equipment available used a THF solvent system, facilitating
molecular weight characterisation of PtBMA and PNIPAm polymers
but not PMA. Therefore block characterisation could be achieved
more readily with PtBMA than PMA. Utilising tBMA, essentially
as a protected methacrylic acid monomer, requires an additional
hydrolysis step to give the required polymer; however varying the
extent of hydrolysis gives an additional synthetic opportunity to
adjust the hydrophobicity of the final polymer. In light of Gedanken’s
observations53 it was thought that this additional flexibility would
be beneficial in the future for designing microspheres. Hence the
synthetic scheme shown in Figure 5.9 was chosen for the block
copolymer synthesis (for full experimental details see section 2.4.5-9).
Figure 5.9: Synthetic scheme for block co-polymer synthesis chosen for
the synthesis of P(tBMA-b-NIPAm-b-tBMA).
Dry dioxane was used as a solvent in all three steps but the polymers
were isolated at each stage in order to prevent contamination of blocks
with monomer from the preceding block. The polymers formed
were characterised by 1H-NMR and in each case the desired chain
composition was confirmed, GPC was used to measure the molecular
weight distribution of each polymer sample produced.
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In the first instance a homopolymer of tBMA bearing a RAFT end
group was required to act as a macroRAFT agent to the second
block. In order to synthesise a clean sample of diblock copolymer,
with no residual homopolymer, it was important to ensure that the
number of ’dead’ chains in the macroRAFT agent was minimised.
This was achieved firstly by using a 4:1 ratio of RAFT agent to
initiator (AIBN) when synthesising PtBMA, ensuring the vast majority
of chains initiated were capped by the RAFT agent. Secondly the
macroRAFT polymer was isolated at approximately 60% monomer
conversion. Not running the reaction to high conversion reduced the
extent to which termination reactions were likely to occur.
In order to demonstrate that the PtBMA synthesis was carried
out under controlled conditions the chain growth and percentage
conversion were monitored with respect to reaction time by GPC
and 1H-NMR respectively. Figure 5.10 shows PtBMA chain growth
with respect to time and monomer conversion. It can be seen that
the tBMA RAFT polymerisation displays controlled chain growth,
linear with respect to percentage monomer conversion, as is expected
from a CRP reaction. The linear profile indicates that the number
of polymer chains is constant throughout the reaction and that com-
peting termination reactions are negligible. Hence PtBMA produced
under the reaction conditions chosen and isolated after 13-14 hours
of reaction time will have retained a high percentage of RAFT end
group functionality. The polymer produced under these conditions
was a bright yellow powder and the anti-solvent used in the work up
was colourless, indicative of a high degree of retention of RAFT end
groups.
The presence of the RAFT end group was confirmed by 1H-NMR
using the marker peak at 3.3 ppm corresponding to the CH2 adjacent
to the trithiocarbonate group (Figure 5.12). The molecular weight
distribution was measured by GPC, shown in Figure 5.11. There is
some tailing in the distribution towards shorter chain lengths which
indicates that some termination reactions occurred in the early stages
of the polymerisation, perhaps as a result of residual oxygen or
impurities in the reaction medium. The dispersity of the sample is
1.36 (Table 5.2), high for a RAFT polymerisation but still indicating a
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good degree of control225. This polymer was used as the macroRAFT
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Figure 5.10: PtBMA chain growth with respect to time and monomer
conversion, characterised by 1H-NMR and GPC analysis
of crude reaction samples taken at timed intervals over the
course of the polymerisation. (Dashed line corresponds to
















Figure 5.11: Molecular weight distribution of PtBMA macroRAFT
agent. (Average molecular weight and ÐM listed in Table
5.2).
Figure 5.12: 1H-NMR spectrum of PtBMA macroRAFT agent.
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5.5 P(tBMA-b-NIPAm) synthesis
The NIPAm polymerisation was monitored in order to establish the
degree of control that could be achieved with the chosen RAFT agent.
A significant inhibition period was observed both in dry dioxane
(Figure 5.13) and DMSO (Figure 5.14) although the overall reaction
time was drastically shorter in DMSO. The reason for the inhibition
period was thought to be due to a mismatch between the re-initiation
rate of the R group on the RAFT agent and the propagation rate of
NIPAm, resulting in a retarded addition-fragmentation reaction. In
both cases the chain growth had a linear correlation with monomer
conversion indicating a constant number of propagating chains and
negligible termination reactions. Despite the long inhibition period,
the conditions used in dioxane were used to successfully synthesise
a diblock from the P(tBMA) macroRAFT agent (dioxane was chosen
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Figure 5.13: PNIPAm chain growth with respect to time and monomer
conversion in dioxane, characterised by 1H-NMR and
GPC analysis of crude reaction samples taken at timed
intervals over the course of the polymerisation. (Dashed
line corresponds to the theoretical Mn, PDI = Ð).
Mcalcn =
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Figure 5.14: PNIPAm chain growth with respect to time and monomer
conversion in DMSO, characterised by 1H-NMR and GPC
analysis of crude reaction samples taken at timed intervals
over the course of the polymerisation. (Dashed line
corresponds to the theoretical Mn, PDI = Ð).
Mncalc Mn ÐM DP DP D
(kDa) (kDa) (GPC) (NMR) (x 10-10m2s-1)
P(tBMA) 5.6 6.2 1.36 43 79 2.063
DB 28.8 9.5 1.31 43+30 80+40 1.028
Table 5.2: Characterisation data for the macroRAFT agent and
P(tBMA-b-NIPAm) (DB). (D: DOSY diffusion coefficient
measured by DOSY NMR)
The expected number average molecular weight Mncalc of each
polymer was calculated according to equation 5.2225 where [m]0 is
the initial monomer concentration, Mm is the monomer molecular
mass, ρ is the fractional conversion, [CTA]0 is the initial RAFT agent
concentration and MCTA is the molecular mass of the RAFT agent.
From the molecular weight distributions shown in Figure 5.17 (mea-
sured by GPC) it can be seen that the diblock sample has a higher Mn
than the macroRAFT agent, corresponding to approximately 30 units
of NIPAm in the second block. The composition of the diblock copo-
lymer was confirmed by 1H-NMR analysis (full 1H-NMR assignments





































Figure 5.15: PNIPAm chain growth from macro-RAFT with respect to
time and monomer conversion in dioxane, characterised
by 1H-NMR and GPC analysis of crude reaction samples
taken at timed intervals over the course of the polymerisa-
tion. (Dashed line corresponds to the theoretical Mn, PDI
= Ð).
at 3.9 ppm (in MeOD) corresponding to the single proton on the centre
carbon of the isopropyl group which is clearly visible in the 1H-NMR.
In addition retention of the RAFT end group was confirmed by the
marker peak at 3.4 ppm (Figure 5.16). The degree of polymerisation
was estimated from the ratio of the RAFT marker peak to the polymer
peaks for both the macroRAFT agent and the diblock copolymer (Table
5.2).
Figure 5.15 shows the chain growth of a PNIPAm block from the
macroRAFT agent with respect to time and conversion. A long
inhibition period is observed, as with homo-PNIPAm; however during
the inhibition period the ÐM increases and the monomer is consumed.
As a result there is not a linear relation between monomer conversion
and block growth, rather, block growth occurs in the final stages
of the reaction. This is due to a competing homopolymerisation
reaction initiated by AIBN and not controlled by the RAFT agent.
This was confirmed when both the diblock copolymer and PNIPAm
homopolymer were isolated from the work up. It is the growth of
this homo-PNIPAm that is responsible for the increase in ÐM and
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Figure 5.16: 1H-NMR spectrum of Poly(tBMA-b-NIPAm).
monomer consumption prior to chain extension of the macroRAFT
agent. This homopolymerisation may explain the mis-match between
Mncalcand the GPC Mn, however the agreement between the 1H-NMR
ratios and Mncalc suggest that the mismatch is in fact due to the
diblock copolymer folding in the THF in such a way that the Mn is
underestimated.
Although 1H-NMR analysis shows that PNIPAm and P(tBMA) co-
exist in the sample isolated this in itself is not evidence of a diblock
copolymer, an identical 1H-NMR spectrum could be produced from
a blend of two homopolymers. The shape of the molecular weight
distribution measured by GPC (Figure 5.17) is indicative of a diblock
copolymer, there is no sign of a shoulder in the peak which would
be expected for a blend of homopolymers. DOSY NMR can be
used to measure the diffusion coefficients of individual peaks in
the 1H-NMR spectrum in order to provide supporting evidence for
diblock copolymer formation.
The DOSY spectrum in Figure 5.18 is from the diblock copolymer
sample characterised by GPC in Figure 5.17. The PNIPAm peaks share
their diffusion coefficient with the tBMA peaks supporting the case for
diblock copolymer formation. The diffusion coefficient for the diblock
copolymer is slower than the macroRAFT agent, indicating that the
polymer formed is indeed a larger molecule (Table 5.2).
In contrast the DOSY spectrum shown in Figure 5.19 gives an example
















Figure 5.17: Molecular weight distributions determined by GPC
for Poly(tBMA) macroRAFT agent (dotted line) and
Poly(tBMA-b-NIPAm) (solid line). (Average molecular
weight and ÐM listed in Table 5.2).
weight distribution determined by GPC is shown in Figure 5.20. Two
peaks can clearly be seen in the GPC plot and the DOSY spectrum
shows a mixture of diffusion coefficients. As discussed above the
diffusion coefficients are meaningless where overlap occurs but the
DOSY spectrum can be used to identify the diblock copolymer as the
lower molecular weight species.
Based on the characterisation above it can be concluded that a
diblock copolymer has been successfully formed and isolated from
any additional PNIPAm homopolymer.
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Figure 5.18: 1H-NMR DOSY spectrum of P(tBMA-b-NIPAm) in deute-
rated methanol at 25 ºC. )
Figure 5.19: 1H-NMR DOSY Spectrum of mixture of P(tBMA-b-
NIPAm) and P(tBMA) in deuterated methanol at 25 ºC.

















Figure 5.20: Molecular weight distribution determined by GPC for a
mixture of P(tBMA-b-NIPAm) and P(tBMA).
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5.6 P(tBMA-b-NIPAm-b-tBMA) Synthesis
The triblock copolymer synthesis was carried out using a diblock
copolymer macroRAFT agent (see Table 5.3 for molecular weight
information and Figure 5.23 for the 1H-NMR spectrum). The triblock
copolymer composition was confirmed by 1H-NMR (Figure 5.24,
Table 5.3) and the diffusion coefficient calculated from DOSY NMR
indicated chain extension. Chain extension with tBMA was achieved
whilst maintaining a low ÐM in the isolated triblock copolymer
as shown by the molecular weight distributions measured by GPC
(Figure 5.22, Table 5.3).
There were however significant issues with contamination from dead
diblock copolymer chains and PtBMA homopolymer in all the batches
synthesised and in this case the yield of clean triblock copolymer was
30 mg (1.4 %). The small extent of triblock formation was likely to
be due in part to non-quantitative RAFT chain end retention on the
diblock copolymer which reduced the number of triblock chains that
could form. A subsequent result of this was a reduced ratio of RAFT
agent to initiator, which contributed to the high degree of monomer
consumption through PtBMA homopolymer formation.
Figure 5.21: Schematic of RAFT pre-equilibrium between the a PNI-
PAm macroRAFT agent and tBMA.
Formation of a tBMA bock copolymer from a PNIPAm macroRAFT
agent is challenging due to the relative reactivities of the two propaga-
ting radicals. As shown in Figure 5.21, the tertiary radical on the tBMA
monomer is more stable than the secondary radical on the PNIPAm
chain end. As a result the pre-equilibrium of the RAFT polymerisation
in Figure 5.21 (corresponding to step 2 in Figure 5.4) will strongly
favour the left hand side, in other words the tBMA monomer radical.
The balance of this equilibrium will cause PNIPAm macroRAFT agent
to remain capped and hence the RAFT polymerisation will be highly
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unlikely to proceed. Instead the tBMA monomer radical will tend to
polymerise to form a homopolymer via free radical polymerisation.
In light of the poor triblock copolymer yields achieved, the diblock
copolymer was taken forward for hydrolysis and thiolation ready for















Figure 5.22: Molecular weight distributions determined by GPC
for PtBMA macroRAFT agent (dotted line), P(tBMA-b-
NIPAm) macroRAFT agent (solid line) and Poly(tBMA-
b-NIPAm-b-tBMA) (dashed line), produced in sequential
syntheses. (Average molecular weights and ÐM listed in
Table 5.3).
Mncalc Mn DP DP ÐM D
(kDa) (kDa) (GPC) (NMR) (x 10-10m2s-1)
P(tBMA) 5.2 5.7 40 164 1.35 -
DB 22.7 10.7 40+44 164+218 1.43 7.780
TB - 17.9 40+44+51 - 1.30 1.025
Table 5.3: Characterisation data for macroRAFT agent P(tBMA),
P(tBMA-b-NIPAm) macroRAFT agent (DB) and P(tBMA-
NIPAm-tBMA) triblock copolymer (TB). See Equation 5.2 for
Mncalc
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Figure 5.23: 1H-NMR spectrum of Poly(tBMA-b-NIPAm) macroRAFT
agent.
Figure 5.24: 1H-NMR DOSY spectrum of P(tBMA-b-NIPAm-b-tBMA)
in deuterated methanol at 25 ºC. (Marker peak assign-
ments correspond to Figure 5.18).
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5.7 Hydrolysis and Thiolation of
P(tBMA-b-NIPAm)
The hydrolysis and thiolation methods used are already well known in
the literature17;200 and the synthetic scheme used in this investigation
is shown in Figure 5.25.
Figure 5.25: Synthetic scheme for hydrolysis and thiolation. (Full
experimental details given in section 2.4.10 and 2.4.11).
The extent of hydrolysis of ester groups was monitored by following
the loss of the t-butyl protons (1.5 ppm) in the 1H-NMR spectrum,
84% conversion to acid groups was achieved. The product polymer
was no longer THF soluble, preventing GPC analysis but DOSY NMR
in deuterated methanol showed that the diffusion coefficient of the
polymer had not changed, confirming that no block degradation had
occurred (D = 1.028 x 1010m2s-1). In addition it was observed during
the work up that the polymer produced precipitated from an aqueous
phase in response to both acidification and heating above 40 ºC,
indicating the presence of both the PNIPAm and the PMA block. The
loss of ester groups and the formation of carboxylic acid groups can
be observed by FTIR spectroscopy (Figure 5.26). The carbonyl peak at
1719 cm-1 shifts to 1698 cm-1 suggesting formation of the polyacid.
The thiolation protocol used was analogous to that reported in
Chapter 3 for the production of PMASH. In this case 5% thiolation
was achieved (estimated from the 1H-NMR spectrum, as in section
3.2.1). Attachment of the cysteamine functionalities onto the polymer
chain was confirmed by DOSY NMR which showed the peaks
corresponding to the two CH2 groups at the same diffusion coefficient
as the polymer peaks (D = 1.023 x 1010 m2s-1).
The structure of the polymer produced is shown in Figure 5.27. It
is this polymer that was used to form microspheres in the following













Figure 5.26: FTIR spectrum of P(tBMA-b-NIPAm) (green) and P(MA-
b-NIPAm) (blue), both samples were dried prior to mea-
surement.
the microspheres produced, the LCST was measured by observing the
cloud point of a 10 mg/ml aqueous solution of polymer buffered at
pH 7. The cloud point occurred at 37 °C and it is proposed that it is at
or just above 37 °C that a change in microsphere morphology would
occur.
Figure 5.27: Functionalised diblock co-polymer structure used for
microsphere production.
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5.8 Formation of microspheres from
P(MASH-b-NIPAm)
The thiolated diblock co-polymer, P(MASH-b-NIPAm) was used to
investigate the scope for sonochemical microsphere production from
synthetic block co-polymers. The anticipated end application of
polymer microspheres of this type is drug delivery so the focus of this
section is on oil filled and emulsion filled microspheres.
It was found that the sonochemical conditions described in Chapter
3 could be used to produce tetradecane filled microspheres from the
diblock copolymer (see section 2.3.4). The mean diameter of the
microspheres produced was 2.7 µm and the microspheres produced
had a broader size distribution (standard deviation: 1.0) than those
produced from PMASH(standard deviation: 0.7), illustrated in Figure
5.29. The microspheres had a very similar morphology to PMASH
microspheres when viewed by optical microscopy (Figure 5.28a).
Confocal microscopy showed that nile red dissolved within the tetra-
decane phase could be successfully encapsulated within the polymer
shell (Figure 5.28b). This evidence indicates that it is possible to
incorporate an additional block within the PMASH polymer whilst still
maintaining the ability to form microspheres. Qualitative observations
indicate that the microspheres formed are stable over at least a 6 week
period in aqueous suspension at approximately 22 ºC.
Figure 5.28: Optical micrograph (scale bar: 50 µm) (a) and confocal
micrograph (b) of tetradecane filled P(MASH-b-NIPAm)
microspheres formed using nile red saturated tetradecane.
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Figure 5.29: Size distributions of PMASH and P(MASH-b-NIPAm) mi-
crospheres formed under identical sonochemical condi-
tions (60 s sonication at 14 Wcm-2 with generator B). (The
mean diameter is represented by the dotted line whilst the
median is shown by the black line within the grey box.
The grey boxes define the upper and lower quartiles, the
whiskers the 5 and 95 percentiles and the dots represent
outliers.)
Figure 5.30 shows the FTIR spectra of both the diblock copolymer
and the microspheres formed. The similarity of the spectra confirms
that the diblock copolymer is forming the structural component of
the microsphere shells. The peak at 545 cm-1 suggests disulfide cross
linking in the microsphere shell. The peak at 1000 cm-1 was also seen
in the PMASH microspheres reported in chapter 3.
In addition to forming tetradecane filled microspheres, encapsulation
of a water-in-oil emulsion was also demonstrated using the methodo-
logy reported in Chapter 4 (experimental method detailed in section
2.3.4), an optical micrograph of the microspheres formed is shown
in Figure 5.31. This enables the range of these P(MASH-b-NIPAm)
















Figure 5.30: FTIR spectrum of the dried P(MASH-b-NIPAm) (green
line) and dried tetradecane filled microspheres formed
from P(MASH-b-NIPAm) (blue line).
Figure 5.31: w/o emulsion filled P(MASH-b-NIPAm) microspheres in
aqueous suspension, scale bar: 50 µm.
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5.9 Temperature responsive behaviour of
P(MASH-b-NIPAm) microspheres
The P(MASH-b-NIPAm) microspheres described above have been
designed in order to fulfil the challenge of forming microspheres
sonochemically that respond to an external stimulus, in this case
an increase in the solution temperature above the LCST of the
diblock copolymer (37 °C). At pH 8 (the pH used for sonochemical
microsphere production) it is proposed that inter- and intra-molecular
hydrogen bonding will occur between the two blocks in the polymer
incorporated into the microsphere shell. The pKa of PMA250 is
estimated to be 7.5 therefore at pH 8 approximately 80% of the acid
groups will be deprotonated. Therefore it is expected that at pH 8 the
microsphere shell will be subject to a high degree of swelling and will
behave somewhat like a hydrogel.
There is some evidence in the literature251 for partitioning of blocks
in a hydrogel as a result of hydrogen bonding which supports the
case for partitioned portions of PNIPAm within the structure of
the microsphere shell. It is proposed that upon heating through
the LCST the PNIPAm blocks within the microsphere shell will
collapse disrupting the hydrogen bonding network within the shell
and resulting in rapid deswelling of the shell. This would either cause
holes to open up in the shell between the disulfide crosslinked sections
or collapse of the shell against the oil core would result in rupture of
the shell and burst release of the contents.
In order to establish whether the microspheres produced change in
response to a change in solution temperature, three experiments were
carried out. In the first experiment a sample of tetradecane filled
P(MASH-b-NIPAm) microspheres was placed under a coverslip on a
microscope slide and heated to 40 °C on a hot plate over a period of
30 minutes. In order to provide a comparative control experiment
a sample of tetradecane filled PMASH microspheres was treated in
an identical manner. The micrographs in Figure 5.32 were taken
before heating and then after 10 minutes and 30 minutes of heating
respectively.
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Figure 5.32: Optical micrographs of a sample of microspheres on
a microscope slide heated above the phase transition
temperature of PNIPAm on a hot plate. Top row:
P(MASH-b-NIPAm) microspheres, bottom row: PMASH
microspheres. T = temperature (°C), t = time (min). Scale
bar: 50 µm.
Before heating, both samples contain discretely distributed micros-
pheres typical of polymer microspheres made previously. Upon
heating the PMASH microspheres are stable and show no significant
change in morphology or size during the 30 minute period. However
in the case of P(MASH-b-NIPAm) microspheres a significant change is
seen to occur between t=0 and the micrograph taken after 30 minutes
at 40 °C. After 10 minutes heating, some of the microspheres appear
to have grown much larger. Alternatively adjacent microspheres have
ruptured releasing oil which has coalesced into larger droplets. This
hypothesis is born out in the micrograph taken at 30 minutes where
large ’puddles’ of oil can be observed. These regions of oil were not
present in the sample at t=0 so it can be inferred that the oil which
has formed the puddles has been released by the microspheres upon
rupture. It can be seen that some small droplets/microspheres remain
indicating that 30 minutes at 40 °C is an insufficient time period to
achieve quantitative breakdown of the microspheres.
These micrographs indicate that whilst PMASH microspheres are
stable at 40 °C, P(MASH-b-NIPAm) microspheres are not and heating
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past the LCST of the diblock copolymer does result in rupture of the
microspheres. However more compelling evidence can be collected
by heating a sample of microspheres in situ on a microscope stage and
imaging fluorescent nile red in the oil phase. This experiment was
carried out using a laser scanning confocal microscope fitted with a
heated stage and chamber. A chosen region of the sample was imaged
over a 34 minute period, during which time the stage and chamber
were heated from 25 °C to 44 °C (Figure 5.33).
Micrographs of the same region were taken at regular time intervals.
This allowed the effect of heating above the LCST on a specific
population of microspheres to be monitored. The heating rate
achieved by the chamber and stage meant that the heating phase
between 25 and 38 °C took 15 minutes. The effect of heating through
37 °C was seen immediately as some microspheres coalesced into
a larger red puddle. Over the following 20 minutes the sample
was held at 43-44 °C and breakdown of the individual microspheres
can be observed as they coalesce to form larger puddles. The red
fluorescence observed clearly indicates that the oil released originated
from within the microspheres. As in the previous experiment the
time period of the experiment was not sufficient to observe rupture
of the entire population of microspheres; however it is proposed that
incubation over a longer time period would result in rupture of all
the microspheres in the population. In a control experiment a sample
of microspheres taken from the same batch was observed over a
25 minute period at an ambient temperature of 25 °C (Figure 5.34).
No change in morphology is observed indicating that the rupture
observed in Figure 5.33 triggered by heating above the polymer’s
LCST.
The third experiment was conducted using dynamic light scattering
(DLS) to look for shell fragments or collapsed P(MASH-b-NIPAm)
globules from the microsphere shells after heating (Figure 5.35). Most
of the microspheres formed from PMASH and P(MASH-b-NIPAm)
are too large to allow the whole population to be characterised
by DLS which can only detect radii up to 1500 nm. But the
smaller microspheres in the distribution can be observed and, more
importantly if P(MASH-b-NIPAm) polymer globules are formed from
shell fragments upon collapse of the microspheres, these will be
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detected. When the P(MASH-b-NIPAm) microspheres were heated
to 40 ºC in the DLS chamber for 60 minutes a bimodal distribution
formed (Figure 5.35b). It is suggested that the smaller peak at 258
nm corresponds to polymer globules formed on break down of the
P(MASH-b-NIPAm) microspheres. As a control PMASH microspheres
were heated to 40 °C in the DLS chamber for 45 minutes (Figure
5.35a). No significant change in the size distribution of observable
microspheres was seen.
It can therefore be concluded that temperature responsive micros-
pheres with a phase change in the region of 37 ºC can be formed
from P(MASH-b-NIPAm) with an LCST of 37 ºC. RAFT polymerisation
with 2-cyano-2-propyl dodecyl trithiocarbonate provides an effective
means of producing P(tBMA-b-NIPAm) with a narrow dispersity
which can be subsequently functionalised and used to produce these
microspheres. Both tetradecane filled and w/o emulsion filled
microspheres can be formed and coalescence of oil droplets released
as a result of shell rupture on heating above the LCST can be observed
by optical transmission and confocal microscopy.
Release of 5FU from w/o emulsion filled P(MASH-b-NIPAm) mi-
crospheres was measured (using the method described in Chapter
4) both at ambient temperature and after heating to 40 ºC for two
hours. Release was negligible in both cases. By comparison 12.8
% release was achieved from PMASH microspheres heated over a
two hour period at 40 ºC. The lack of leakage or temperature release
from the P(MASH-b-NIPAm) microspheres does not corroborate the
temperature responsive behaviour observed with tetradecane filled
P(MASH-b-NIPAm) microspheres. Further investigation is required
to understand the release mechanism and improve the microsphere
shell design in order to achieve triggered release of hydrophilic and
lipophilic species.
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Figure 5.33: Confocal micrographs of an aqueous suspension of te-
tradecane filled P(MASH-b-NIPAm) microspheres contai-
ning nile red saturated tetradecane on a microscope
slide heated above the phase transition temperature of
P(MASH-b-NIPAm) on the microscope stage and viewed
under a 543 nm laser. T = temperature (°C), t = time (min).
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Figure 5.34: Confocal micrographs of an aqueous suspension of tetra-
decane filled P(MASH-b-NIPAm) microspheres containing
nile red saturated tetradecane on a microscope slide held
at ambient temperature and viewed under a 543 nm laser.

































Figure 5.35: DLS trace for PMASH microspheres (a) and P(MASH-b-
NIPAm) microspheres (b) in dilute aqueous solution at 25




The aims set out in Chapter 1 of this thesis were; to extend the scope
of sonochemically produced microspheres for delivery applications
by addressing the shell material, shell stabilisation/bonding and core
composition.
In chapter 3 optimisation of the sonochemical method described by
Suslick et al. and others1;8;42;49 was set out, facilitating formation of mi-
crospheres from lysozyme or PMASH. The microspheres encapsulated
either an air bubble or an oil droplet. Evidence from radical trapping
experiments, comparison with an alternative homogenisation protocol
and FTIR spectroscopy of microsphere shells suggested that the
microspheres were stabilised by disulfide cross links, as expected from
reports by Suslick et al.1. In the case of oil filled microspheres confocal
micrographs provided evidence for encapsulation of a tetradecane
phase containing the lipophilic dye nile red. Release of the lipophilic
dye sudan III from the encapsulated oil phase was characterised in
vitro. Release of the oil and dye from the microspheres was achieved as
a result of either high intensity sonication or cleavage of the disulfide
cross links.
Further to production of disulfide cross linked microspheres, ultra-
sound initiation of the thiol-ene reaction was investigated. It was
proposed that sonochemical thiol-ene coupling would provide an
alternative means of cross-linking the microspheres providing greater
utility and the potential for surface functionalisation. It was shown
that in water, under air, reaction rates could be achieved at 24 ºC
under ultrasound irradiation that were comparable to those observed
for conventional thermal initiation at 45 ºC252. This reaction was
used in place of disulfide bonding to stabilise microspheres produced
sonochemically from PMAene with DTT as a dithiol cross linker,
however further characterisation is required to provide conclusive
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evidence for thiol-ene coupling being the main form of crosslinking
in the microsphere shells. Although more sophisticated crosslinkers
were not explored this demonstration with DTT opens up the potential
for sonochemically produced microspheres to be extended to include
cross linking molecules which contain a stimulus responsive ‘cleavage
point’, for example a photo-labile bond. The original aim to attempt
in-situ surface functionalisation of the microspheres using sonochemi-
cal thiol-ene coupling was not reached, however the work reported
has demonstrated that ultrasound initiated thiol-ene chemistry is a
worthwhile avenue for future investigations.
Novel use of the sonochemical method to encapsulate a water-in-oil
emulsion within protein and polymer microspheres was reported in
chapter 4253. Both lipophilic and hydrophilic molecules were encap-
sulated within the microspheres upon formation, via encapsulation
of a pre-formed water in oil emulsion. The optical transmission and
confocal micrographs collected clearly demonstrated that the water in
oil emulsion had been retained within the microspheres. Release of
5,6-carboxyfluroescein, NaCl and 5-Fluorouracil from w/o emulsion
filled microspheres, in vitro, as a result of high intensity sonication or
disulfide cleavage of the microsphere shells was characterised. These
results demonstrate that the sonochemical method can be used to
efficiently encapsulate an aqueous phase loaded with a dye, drug or
similar hydrophilic species within protein or polymer microspheres.
In addition the microspheres can be triggered to release their payload
as a result of mechanical or chemical disruption to the shell. Initial
indications from the release studies are that PMASH microspheres in
particular are only stable to release over a period of hours, this would
need to be addressed in order to facilitate use of w/o emulsion filled
microspheres in delivery applications.
Finally microspheres were produced from the diblock copolymer
P(MASH-b-NIPAm) (LCST: 37ºC). The diblock copolymer was syn-
thesised via RAFT polymerisation and used in the sonochemical
method discussed in chapters 3 and 4 to produce disulfide crosslinked
microspheres. This is the first report of sonochemical production
of microspheres from a synthetic block copolymer. PNIPAm was
incorporated into the polymer with a view to facilitating temperature
responsive release of a drug payload. Confocal micrographs of
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P(MASH-b-NIPAm) microspheres containing a solution of nile red
in tetradecane, heated to 43°C in-situ, display coalescence consistent
with rupture of the microspheres at approximately 37°C. These
observations were very promising, although at this stage they are
not supported by conclusive drug release studies because insufficient
polymer was produced to allow further studies to be carried out.
However this work provides a starting point from which to further
develop sonochemically produced responsive polymer microspheres
and to characterise more fully their temperature responsive release
behaviour.
The sonochemical method provides a facile and time effective means
by which to produce microspheres containing aqueous and oil phases.
The main limitation to the application of the these microspheres
as drug delivery devices still lies in narrowing their polydisperse
size distribution. It is essential for safe administration of drug
carriers in vivo that they have a predetermined size and a narrow,
if possible monodisperse size distribution. Recent work by Zhou et
al.41 has demonstrated that it is possible to form a near monodisperse
population of microspheres sonochemically. Application of this
technology to the systems reported above would facilitate a more
robust proposition for their use in drug delivery applications.
The challenge of controlled drug delivery has attracted a great deal
of research effort in recent years and many possible methods have
been reported. However, the simplicity of sonochemical microsphere
production, together with the variety of species that can potentially be
encapsulated for triggered release and the utility of the microspheres
produced as imaging agents makes sonochemically produced micros-
pheres an attractive proposition for future research.
Ultrasound is an energy intensive means of producing micros-
pheres254 which is perhaps not ideal for large scale applications.
However the speed and simplicity with which the protocol can be
carried out does have practical application in small scale batch produc-
tion. The ultrasound equipment used requires small financial outlay
compared to techniques such as microfluidics and can be carried out
more quickly than other wet chemistry methods including emulsion
and layer-by-layer techniques. This may facilitate potential for use in
hospital laboratories for the preparation of microsphere suspensions
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’on demand’ from pre-prepared drug and polymer solutions. This
method of formulation would support the trends in medical research
towards drug design tailored for individuals255 and would allow
simultaneous delivery of multiple drugs in one suspension.
In order to make a meaningful contribution to the field of drug
delivery and compete with other methods of drug delivery the
following areas should be addressed:
- Robust and extensively characterised control of the size distribution
of the populations of microspheres produced should be achieved.
- The shelf life of the microspheres produced, especially with respect
to retention of encapsulated hydrophilic species, should be improved.
This could be achieved by addressing cross linking and polymer
composition, architecture and chain length in the microsphere shells.
- Extensive release studies are needed to characterise the release of
drug molecules in response to external triggers, e.g. heating, in
vitro in order to provide a sound basis of knowledge from which to
recommend studies in vivo.
- A biocompatible alternative to the tetradecane emulsions reported
here, perhaps based on perfluorocarbons, should be developed to
facilitate application of w/o emulsion filled microspheres in vivo.
With these considerations in mind the following recommendations are
made for further work leading from the results reported in this thesis:
Following the successful formation of microspheres from P(MASH-b-
NIPAm) it would be of interest to form microspheres from P(MASH-
b-NIPAm-b-MASH). Use of a di-functional RAFT agent256;257 could be
explored to access P(MASH-b-NIPAm-b-MASH) in higher yields than
achieved in the linear synthesis above. Use of the triblock copolymer
would facilitate formation of a more highly crosslinked shell structure.
This may allow the phase change in the PNIPAm block to cause more
abrupt disruption of the microsphere structure, leading to more rapid
release of the microspheres’ contents. In addition the use of star or
graft copolymers of PMASH and PNIPAm as shell materials should be
investigated. Such architectures may provide access to microspheres
with better structural integrity for storage or more well defined release
characteristics.
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Further to the temperature responsive copolymers discussed other
block copolymers could be investigated to form analogous micros-
pheres that respond to other triggers, for example photo or enzymatic
degradation193.
The study of w/o emulsion filled microspheres could be extended
to explore the effect of shell crosslinking density and polymer chain
length on the encapsulation stability of the microspheres. Dual
release of hydrophilic and lipophilic species from w/o emulsion filled
microspheres should be characterised in order to further demonstrate
the utility of sonochemically produced microspheres as delivery
agents.
By utilising sonochemical thiol-ene coupling as an alternative means
of crosslinking, it is suggested that microspheres could be formed
from responsive block copolymers of PMAene and crosslinked using
a thiol crosslinker containing a labile bond to produce dual responsive
delivery vehicles. Sonochemical thiol-ene coupling also provides the
opportunity to ’label’ the microsphere shells with biological markers,
e.g. polysaccharides, during microsphere production. This line of
research should be addressed with a view to forming microspheres
sonochemically that can target a chosen location or cell type in vivo.
Producing stimulus responsive microspheres in one synthetic step
that are capable of targeted delivery in vivo would make a significant
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